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Nanoparticles in molecular imaging 
Molecular imaging – the ability to “see” within the living human body and understand its 
biological complexities for the treatment of disease – is one of the most exciting and rapidly 
growing fields of biomedical research. It involves the non-invasive study of biological 
processes in vivo at the cellular and molecular level. The key role for chemists is the design of 
suitable imaging probes that make molecular processes visible, quantifiable, and traceable 
over time, aiming to probe molecular abnormalities as cause for many different deseases. A 
closely connected, and also fast growing field, is the application of different imaging 
techniques in living subjects, ranging from in vitro cell based tests to in vivo whole body 
scanning. Nowadays, a lot of different imaging methods can be utilized, such as positron 
emission tomography (PET), single photon emission computed tomography (SPECT), 
ultrasound (US), optical (particularly fluorescence) imaging, magnetic resonance imaging 
(MRI), and computed tomography (CT). Each method differs in terms of sensitivity and 
resolution, and different imaging techniques are, in general, complementary rather than 
competitive. The choice of modality depends on constitution and size of the sample as well as 
nature of the question that is to be addressed. 
In parallel to the imaging techniques, during the last decade, nanotechnology developed into a 
fast growing research area, involving chemistry, biology, medicine, engineering, and more. 
Within this field, nanoparticles emerged as important players, with applications ranging from 
contrast agents in medical imaging to smart probes for analytical testing. The nanoparticulate 
systems used are typically smaller than a few hundred nanometers and are comparable to the 
size of large biological molecules such as enzymes, receptors, or antibodies. They also have a 
number of specific properties that distinguish them from bulk materials simply by virtue of 
their size, such as chemical reactivity, energy absorption, and biological mobility [1-3]. The 
application of nanoparticles as contrast agents and reporters for molecular imaging applying 
and combining these different imaging systems suggests itself due to their many advantages 
over organic molecules. They give higher contrasts due to their higher on-site concentration, 
and a greater diversity of functionalization and modification possibilities due to the versatility 
of surface chemistry. Moreover, the combination of different modalities to investigate the fate 
of one nanoparticle gives a powerful tool in molecular imaging. The most important features 
of imaging probes are the in vitro and in vivo stability, resistance to metabolic degradation, 
and non-toxicity, completed by an adequate solubility in biological environment. 
In the case of fluorescent contrast agents, high resistance against photobleaching, high 
brightness, and an emission in the NIR range of 650 – 900 nm is desirable. For CT imaging 
 General Introduction 
 – 10 – 
probes, a high radiodensity is required. All these exigencies can be met by combing different 
features in only one particle, giving the possibility of multimodal molecular imaging. 
Inorganic nanoparticles can provide high luminescence and reduced photobleaching as well as 
high radiodensity by their mere inorganic composition. Moreover, they exhibit high resistance 
against disintegration in biological environment due to their particulate character. Their 
physicochemical properties, as well as the ability for targeting and molecular recognition, can 
easily be influenced by the applied surface coating. This general introduction will give a short 
overview of nano-scaled devices in luminescence and CT imaging and their essential features 
for successful application. 
1.1. Luminescence Imaging 
Visible light is the most versatile radiation for imaging. It enables for non-invasive 
measurements and creates contrast by intensity, wavelength, polarization, coherence, 
interference [4-6], lifetime, and nonlinear effects. Out of the optical imaging techniques 
available, fluorescence based methods have emerged as one of the most powerful tools in in 
vitro and small animal in vivo imaging. This fact is founded in the availability of highly 
sensitive detection techniques and separation of excitation and emission, reducing background 
noise due to scattering. Nevertheless, an inherent problem of fluorescence imaging is the 
penetration depth of light into the body, which is limited to only a few centimeters, depending 
on the wavelength used.  
1.1.1. Principles of luminescence 
Optical fluorescence strongly depends on the inherent property of the fluorophore used. Upon 
excitation by a quantum of specific energy, three fundamental electronic processes have to be 
considered: (a) the absorption of light energy, associated with an electron transfer to an 
excited state; (b) radiationless decay within and from the excited state and (c) emission of 
radiation with various wavelengths, longer than the excitation wavelength itself. The 
difference between the wavelength required for excitation and the wavelength of the emitted 
light is known as the Stokes´ shift corresponding to the radiationless energy loss within the 
excited state. A representative method for illustrating these electronic processes is the 
Jablonski diagram (see figure 1). 
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Figure 1: Jablonski diagram for illustration of electronic processes 
Two basic pathways for radiative decay of an excited molecule, have to be considered. The 
first one is fluorescence, including vibronic relaxation of an excited singlet S1-state to the S1-
ground state, followed by the emission of the residual energy as a photon to the S0 ground 
state. This process only occurs in states of the same multiplicity, in most cases form the S1 to 
S0. Considering quantum mechanics, it is a spin-allowed process, thus resulting in short 
luminescence lifetimes. The second pathway, phosphorescence, involves intersystem crossing 
form a singlet to a triplet state, known to be an efficient crossing between states of different 
multiplicity, due to spin-orbit coupling. Nevertheless, it is a spin-forbidden process with 
therefore much longer lifetimes. Furthermore, it is known to be much more probable for Sn → 
Tn than for Tn → Sn-1, but strongly dependent on the molecule. Besides this light emitting 
processes, there are also some non-radiative pathways of energy loss shown in figure 1 [7,8]. 
The luminescence quantum yield is, in addition to the absorption coefficient and lifetime, 
perhaps the most important property of a fluorophore.  
 
nrk
Q
+Γ
Γ
=  
(1) 
Q quantum yield 
Γ rate of luminescence of the fluorophore [1/s] 
knr rate of non radiative processes [1/s] 
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It is defined as the number of emitted photons relative to the number of absorbed photons, as 
shown in equation 1. The emissive rate Γ represents the rate of the fluorophore’s 
luminescence; whereas knr includes all processes depopulating the excited singlet state in a 
non-radiative way. As can be seen from equation 1, the quantum yield reaches nearly unity, if 
the rate of non-radiative decay knr is very small. This is the case for an “ideal” fluorophore. 
One example meeting this postulate is rhodamine and its derivatives and other laser dyes [7-
10]. 
A more detailed explanation of the luminescence behavior of the particulate flourophores, 
quantum dots sand doped gadolinium oxide nanoparticles, will be given in the respective 
introduction chapters (2.3 and 6.3.1). 
1.1.2. Nanoparticles as contrast agents in luminescence imaging 
As already mentioned, the fundamental barriers of optical imaging in tissue is the poor 
penetration depth and resolution, due to high light scattering, autofluorescence and high 
absorption by omni-present hemoglobin in the mid visible range. Near-infrared light of 650 – 
900 nm, achieves the highest tissue penetration due to minimal absorbance by surface tissue 
in this spectral region. This fact is founded in hemoglobin, water and lipids having their 
lowest absorption coefficients in the NIR region [11,12]. 
In order to overcome most of these problems and to obtain adequate contrast in the images, 
the signal-emitting material has to be accumulated at the site of interest. Herein, nanoparticles 
can contribute the unique property to concentrate a higher fluorophore amount at one specific 
point. Moreover, they offer the possibility to tune the emission wavelength with retaining 
their physicochemical properties and vice versa. This makes them suitable for a wide range of 
applications, by simply changing e.g. the surface bound targeting molecules or their inherent 
emission wavelength. Additionally, they can be used for multiplexed imaging applications, 
were the same nanoparticles with different surface coatings and emission wavelengths can be 
detected simultaneously. In the last decade, a huge variety of different types of luminescent 
nanoparticles were developed. Nevertheless, some of the particles already match most, or 
even all of the desirable properties describes above. Therefore, they proved to be more 
promising than others finding broad access to modern fluorescence imaging. Two of the most 
prominent nanoparticular systems are luminescent doped silica or polymer nanoparticles and 
semiconductor quantum dots [13,14].  
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1.2. CT Imaging 
The discovery of X-ray radiation by Wilhelm C. Röntgen in 1895 revolutionized the practice 
of medicine and offered the first suitable imaging method for medical applications in the 
patient [15,16]. Physicians instantly recognized the importance of this discovery for medical 
diagnosis since it was now was possible to externally visualize the internal anatomic 
structures. Although computed tomography X-ray imaging (CT) also employs the same X-ray 
radiation for generating an image, this is very different from direct X-ray projection imaging, 
as Röntgen developed it. Computed tomography instead produces cross-sectional images and 
provides very good contrast resolution and adequate spatial resolution. Moreover, not only 
hard tissues like bone and cartilage can be investigated, but also the differentiation between 
softer tissues is possible. Nevertheless, the possibilities to acquire contrasted molecular 
images are the same as in direct projection X-ray imaging. In CT, however, contrast 
molecules can be pinpointed in three dimensions to millimeter accuracy, allowing a higher 
resolution then the mere two dimensional projections [17]. 
1.2.1. Principles of CT contrast 
When an X-ray beam transverses matter both absorption and deflection of photons will occur. 
The reduction in beam intensity, due to these processes, defines the degree of X-ray 
attenuation, as shown in equation 2. 
 
xeII µ−= 0  
(2) 
I transmitted X-ray intensity 
I0 incident X-ray intensity 
µ mass attenuation coefficient of the absorber [cm2/g] 
x thickness of matter [cm] 
 
In CT, the linear X-ray attenuation coefficient of an investigated voxel (volumetric pixel) is 
measured directly, and hence a CT number is defined as 
 
w
wpKCTnumber
µ
µµ )( −
=  
(3) 
K magnification constant 
µp linear attenuation coefficient of a pixel [cm2/g] 
µw linear attenuation coefficient of water [cm2/g] 
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When K is 1000, then the CT numbers are called Houndsfield units (HU). 
The attenuation is based on three interactions between the radiation and the transversed 
matter: (a) coherent scattering, (b) the photoelectronic effect and (c) the Compton effect. 
Considering these three processes, the coherent scattering, producing scattered radiation, is 
insignificant compared to the other both and can therefore be neglected.  
 
δτωµ ++=  
(4) 
µ mass attenuation coefficient [cm2/g] 
ω coherent scattering [cm2/g] 
τ photoelectron effect [cm2/g] 
δ Compton effect [cm2/g] 
 
The contribution of the photoelectronic effect to X-ray attenuation is high with low-energy 
radiation and with absorbers of high atomic numbers. The probability for Compton scattering 
depends on the number of electrons in the outer shell and is independent of the atomic 
number. This effect is responsible for most of the scattered photons, which both increase 
noise and decrease contrast. In fact this is more likely for absorbers of low atomic number, 
whereas at high atomic numbers the photoelectron effect dominates. 
This fact is founded in the photoelectronic effect resulting from the interaction of the X-ray 
photons with inner shell electrons. When an incident photon impacts an electron with energy 
greater than the binding energy of the encountered electron, it can eject the electron from its 
orbital. Since all energy is consumed in this process, the incident photon is absorbed and 
disappears. The ejected electron (a so-called free electron) is reabsorbed immediately, 
followed by the filling of the vacant electron “place” in the inner shell by an electron of the 
outer shell. This produces another characteristic X-ray emission. The Compton scattering 
arises from the interaction of an X-ray photon with an outer shell electron. When an X-ray 
photon with high energy collides with an outer shell electron, whose binding energy is 
relatively low, it will expel the electron from its orbital. The photon itself will be deflected as 
scattered energy. The quantity of Compton scattering decreases as the X-ray photon energy 
increases. As a result, the radiation exposure with scattered photons and therefore also the 
overall exposure, is lower with high energy X-rays [18]. 
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1.2.2. Nanoparticles as contrast agents in CT imaging 
Contrast enhancement results largely from the photoelectron effect due to high atomic 
numbers of the atoms used. Several theoretical and experimental investigations have 
demonstrated the superior X-ray contrast enhancing ability of heavy metal elements [19-24]. 
Furthermore, the condensation of these elements with high atomic number, optimal atomic 
numbers lie between 58 and 66 for tungsten tube driven X-ray sources, could even gain more 
contrast. Therefore, inorganic nanoparticles composed of heavy metal elements can provide 
the tool for molecular CT imaging, combining high contrast with the possibility to add 
targeting molecules. Unfortunately, there are very few examples of nanoparticular CT contrast 
agents in literature [25-32], due to the overpowering position of the inexpensive and nontoxic 
water-soluble iodinated contrast agents (Z = 53). Nevertheless, over the last one hundred 
years, some macro- and microparticular formulations of heavy metals composites were 
developed, and some also employed, for X-ray projection and computed tomography X-ray 
imaging [18]. However, all these formulations display certain drawbacks, as the inappropriate 
size for i.v. application or the adverse effects due to inherent heavy metal toxicity. 
1.3. Aim of the work 
Acting on the assumption of the increasing demand on nanoparticlular contrast agents for 
luminescence and CT imaging, as well as the possibility of combining both to overcome the 
limitations of each, the enhancement of existing and development of new particles is a 
promising field of research. 
As already mentioned, the development of nanoparticular contrast agents in the field of 
luminescence imaging is quite advanced. Considering the existent systems, the enhancement 
of quantum dots systems, especially in terms of emission wavelength and size of the coated 
particles, appears to be the most promising approach. Due to the broad range of possible 
applications, the requirements for semiconductor quantum dots in terms of stability, size, 
water-solubility as well as biocompatibility have grown tremendously in recent years. In order 
to satisfy all these demands, different strategies with polymers as capping agents have been 
used (chapter 2). The aim of this work was the development of an easy synthesis strategy 
leading to long-term stable, long-wavelength emitting, and biocompatible quantum dots as 
versatile label for biological experiments and for the development and characterization of new 
drug delivery systems (part I of the thesis). Therefore, an optimization of the synthesis 
parameters was carried out, aiming at long emission wavelengths and high quantum yields 
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(chapter 4.1&4.2). Subsequently, different functionalized and non -functionalized surface 
ligands were applied, intending to produce water-dispersable non-toxic and functionizable 
quantum dots (chapter 4.3&4.4).  
In contrast to luminescence imaging, the field of nanoparticular CT imaging agents is a quite 
new area of research, attracting growing attention with the evolving molecular imaging 
techniques. Even more, the fabrication of bi- or multimodal contrast agents, is an exiting new 
research subject (chapter 6). They enable for overcoming the resolution limitation of CT 
imaging and the penetration problem of luminescence imaging. Considering the requirements 
for nanoparticular contrast agents, the development of doped gadolinium oxide nanoparticles 
is most promising (part II of the thesis), giving even the possibility of MR imaging and 
neutron capture therapy. To reach this goal, first of all, a synthesis strategy yielding 
differently coated nanoparticles of different sizes for CT imaging applications were applied 
(chapter 8.1). Nevertheless, to realize the bimodality of the particles, another preparation 
route was utilized. Herein, water-dispersable particles of varying sizes and emission 
wavelengths could be produced (chapter 8.2).  
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2. Introduction and General Aspects 
2.1. Introduction  
In the last decade, colloidal quantum dots have drawn tremendous attention as a new class of 
fluorophores for a wide range of diagnostic and sensoric applications. Their unique optical 
properties lead to major advantages in fluorescence detection and imaging in molecular and 
cell biology [1]. Linking these inorganic semiconductor nanoparticles to biological molecules 
like peptides [2], proteins [3-5] and DNA [6,7] was achieved just as well as adapting them for 
the development of multicolor fluorescent labels in in-vitro and in-vivo imaging [8,9]. 
Successful sensing applications of these systems were developed for analytes, like small ions 
and more complex molecules, like sugars or neurotransmitters [10,11,12]. The most 
commonly used quantum dots are of the cadmium chalcogenide group due to ease of 
synthesis and handling. Their inherent optical properties emerge from their semiconductor 
nature and are namely the bright and stable fluorescence and the broad excitation spectra with 
high absorption coefficients. These unique properties are the reason why quantum dots have 
significant advantages over common organic dyes and genetically engineered fluorescent 
proteins in many biological and biomedical applications. Compared to organic dyes they offer 
possibilities like multiplexed imaging and long-term investigations, e.g. for cell uptake studies 
and in-vivo imaging, due to their tunable emission wavelength and an increased photostability 
up to several months [4,8]. Nevertheless, quantum dot surfaces have to be protected and 
functionalized to provide biocompatibility, biostability and suitable surface functions for these 
applications. 
A major step toward the applicability of the nanoparticulate systems for sensorics and 
diagnostics is therefore the design of an adequate coating of their inorganic surface. This 
coating should provide three functions, a chemical and physical stabilization of the quantum 
dots the ability to modify them for a wide range of applications by attaching certain surface 
groups as well as suppressing the toxicity. The beginning of this continuous evolution was 
made with the first water-soluble quantum dots coated with mercaptopropionic acid, already 
applicable to chemical functionalization utilizing the free carboxylic group (figure 1). These 
quantum dots were further improved by a rapid development of a wide range of polymeric 
ligands and amphiphilic polymers coordinating on top of the nanocrystal surface. These 
polymer and ligand coatings are focused on the different facets of the biological applications 
and even extend into new fields of relevance, like the technique of lifetime imaging or special 
applications, such as single molecule detection. Consequently, various polymers and ligands 
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have been developed for the differing application areas. Moreover, also two fundamentally 
different ways of surface coating for the similar applications were adapted, each with its own 
advantages and disadvantages. This chapter will provide a summary and comparison of the 
different polymer based coating strategies and the relevant organic polymers used for the 
modifications. 
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OHO
n
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P
 
Figure 1: Schematic drawing of the quantum dot surface with (A) a hydrophilic mercaptoalkane acid applied for 
water-solubility and (B) a lipophilic trioctylphosphine ligand from synthesis 
2.2. Quantum dots 
Nowadays quantum dot probes are photostable and water-soluble nanoparticlulate systems, 
which display a bright luminescence and offer the possibility to tune their size and emission 
wavelengths [13]. All these improvements can be ascribed to a series of technological 
developments providing new functionalities to the inorganic materials. It has started with the 
first highly crystalline and monodisperse cadmium selenide nanocrystals published by 
Bawendi et al. in 1993 [14], synthesized in a hot coordinating solvent. This evolution was 
followed by improving the photostability and brightness of these quantum dots by coating 
them with different semiconductor materials thereby passivating the oxidation-sensitive 
semiconductor surface [15]. In 1998, the first synthetic approaches to water soluble 
semiconductor nanocrystals were published [3,4]. Today quantum dots are not only composed 
of cadmium selenide (CdSe) but of many other semiconducting materials derived from the II 
and VI elemental groups (e.g. CdTe, CdS, CdHg, ZnS) and III and V elemental groups (e.g. 
InAs, InP, GaAs) of the periodic table. The emissions of these quantum dots span the whole 
spectral range from ultraviolet to near-infrared [16-20].  
Possessing a size range of 1 to 10 nm diameter, quantum dots (QDs) are so-called quasi zero-
dimensional, single, mostly spherical semiconductor nanocrystals [21,22]. Due to their small 
dimensions, they exhibit several exciting new optical properties in addition to the classical 
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properties of bulk semiconductors, distinguishing them from common organic fluorescent 
dyes, e.g of the cyanin or rhodamine group.  
2.2.1. Optical Properties 
A classical attribute of quantum dots is their broadband absorption of light with increasing 
absorption coefficients at higher energies (i.e. smaller wavelengths) [23], which are an order 
of magnitude larger compared to organic dyes [24].  
Furthermore, quantum dots exhibit many non-classical characteristics, as their tunable 
emission spectra with highly confined Gaussian distributions of the emission wavelengths. 
Emission peaks of CdSe quantum dots are as narrow as 25 nm full-width at half maximum 
(fwhm) at room temperature, unlike common organic dyes displaying asymmetric emission 
peaks with up to several 100 nm width. Additionally, the energetically lowest absorption peak 
of these dots is located only a few nanometers lower than the maximum emission wavelength. 
These characteristics allow an excitation of multiple QDs of different emission wavelength 
with only one excitation wavelength (figure 2), making multiplexed imaging of differently 
modified particles possible. Besides the spectral attributes, the semiconductor nature of 
quantum dots gives rise to a long photostability, up to several weeks or even months [25]. The 
slow decay rates of the exited states correspond with a long luminescence lifetime. The 
general luminescence lifetime of CdSe quantum dots at room temperature is composed of 
mulitexponetial decay rates with different lifetimes of 5 ns, 20-30 ns and 80-500ns, resulting 
in a general lifetime of 20-30 ns [26,27]. However, the chemical and physical cause of the 
multiexponential decay rates still remains vague and has to be further investigated.  
The unique optical characteristics of semiconductor nanocrystals are based on an effect called 
quantum confinement (hence the name quantum dots), caused by the restriction of electrons 
and holes in all three dimensions [28]. Quantum confinement describes an effect arising in 
nanocrystals smaller then their so-called Bohr exciton radius. Like classical semiconductors, 
the nanoparticles possess a valence and a conducting band. However, in quantum dots these 
bands are quantisized with energy values directly related to the nanocrystal size (figure 3). 
This quantization of the energy results in discrete size dependent emission wavelengths of a 
single quantum dot. The overall energy bandgap between the valence and the conducting band 
changes its value dependent on the variation of nanocrystal size, and can be described similar 
to the quantization arising from the ‘particle in a box’ model [29]. The moment a photon 
enters a quantum dot, a quasi-particle is created. This so-called ‘exciton’, an electron-hole 
pair, is formed when the electron is promoted from the valence band to the conducting band 
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by energy absorption. The missing electron in the valence band leaves a hole of opposite 
electric charge behind. This hole is bound to the promoted electron by the Coulomb force. 
Upon recombination of the electron with its hole, light of a certain wavelength is emitted, 
corresponding to the respective badgap energy. 
2.2.2. Synthesis 
Among various synthesis routes leading to cadmium chalcogenide quantum dots, the high 
temperature synthesis in coordinating solvents is the best-investigated strategy [30]. This 
synthetic route for nanoparticles of high monodispersity and high crystallinity [31] is 
performed via the decomposition of metal-organic or organometallic precursors at elevated 
temperatures. The precursors are composed of an organic part coordinating or binding to the 
added metal or metalloid. In general, the formation of the quantum dots is carried out at high 
temperatures between 180 – 310° C, depending on the selected precursors and solvents. 
During the reaction, the chosen temperature and the reaction time determine the size of the 
nanoparticles, since nucleation of seed crystals and deposition of new material on existing 
crystals attend depending on the respective temperature of the solvent. 
The reasons for the development of a broad range of synthetic strategies are the various 
possibilities of solvents and precursors. The chosen coordinating solvent is capable to 
“dissolve” the metal precursors and moreover it frequently also acts as ligand or capping 
agent for the resulting quantum dots (figure 1). Essential for these coordinating components 
are the functional groups (phosphines, phosphineoxides, amines and carboxy groups) suitable 
to graft on the nanocrystal surface. The attached groups stabilize the quantum dots during 
their formation, but they are also essential for later solubilization and capping strategies (fig. 
5). Frequently, toxic and pyrophoric components, like mixtures of trioctylphosphine oxide 
(TOPO), trioctylphosphine (TOP) and hexadeclyamine (HDA) [32,33] are used. Nevertheless, 
nowadays also some other, less toxic coordinating substances, like fatty acids, or also 
mixtures of coordinating solvents with less pyrophoric non-coordinating solvents, like 
octadecene (ODE) [34,35], are utilized for nanocrystal synthesis.  
However, not only the used solvents but also the used precursors have changed since the first 
organometallic approaches. The initially applied precursor dimethylcadmium [Cd(CH3)2] was 
highly toxic and pyrophoric resulting in difficult conditions for the synthesis. Most recently, 
Peng and Peng and other groups have applied less toxic and easier manageable cadmium 
precursors, like CdO or Cd(CH3COO)2; for the formation of high-quality CdX (X = S, Se, Te) 
quantum dots [31,36,37]. 
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A common procedure to enhance the photoluminescence properties of CdX (X = S, Se, Te) 
quantum dots is the overgrowth of an additional passivating inorganic shell. This shell is 
composed of a second semiconducting material with a larger bandgap, e.g. ZnS or ZnSe 
(figure 4). The larger bandgap here provides a protection of the surface against oxidation, and 
additionally entraps the excitons in the core, resulting in reduced luminescence quenching 
caused by CdX surface defects. Furthermore, particularly Zn-containing shells exhibit a much 
greater affinity to thiol groups than the mere core material [38,39], which is of high 
importance for the later applied coating strategies leading to functionalized quantum dots. The 
general synthesis procedures, as well as the core formations, are all organometallic 
approaches in contrast to later described organic polymer coating strategies.  
2.3. Biocompatible Quantum Dots  
Nowadays quantum dot probes are photostable and water-soluble nanoparticlulate systems, 
which display a bright luminescence and offer the possibility to tune their size and emission 
wavelengths [13]. All these improvements can be ascribed to a series of technological 
developments providing new functionalities to the inorganic materials. It has started with the 
first highly crystalline and monodisperse cadmium selenide nanocrystals published by 
Bawendi et al. in 1993 [14], synthesized in a hot coordinating solvent. This evolution was 
followed by improving the photostability and brightness of these quantum dots by coating 
them with different semiconductor materials thereby passivating the oxidation-sensitive 
semiconductor surface [15]. In 1998, the first synthetic approaches to water soluble 
semiconductor nanocrystals were published [3,4]. Today quantum dots are not only composed 
of cadmium selenide (CdSe) but of many other semiconducting materials derived from the II 
and VI elemental groups (e.g. CdTe, CdS, CdHg, ZnS) and III and V elemental groups (e.g. 
InAs, InP, GaAs) of the periodic table. The emissions of these quantum dots span the whole 
spectral range from ultraviolet to near-infrared [16-20] (figure 2).  
Water-solubility, high stability against oxidation and subsequent degradation, small diameters 
and funtionalizable groups are essential for the application of quantum dots in biological 
systems. Since unmodified nanocrystals exhibit extremely hydrophobic surface ligands, like 
trioctylphosphineoxide or hexadeclyamine resulting from the organometallic synthesis, they 
are not suited for biological applications due to their insolubility in aqueous media. Due to 
this fact, a hydrophilization of their surface is an essential prerequisite for their application in 
most of the here described experiments. 
  
- 25 - 
300 400 500 600 700 800 900
A
bs
o
rb
a
n
ce
wavelength /nm
CdSe/ZnS CdTe CdTe/CdSe
300 400 500 600 700 800 900
N
o
rm
.
 
Fl
u
o
.
 
In
te
n
sit
y 
wavelength /nm
A
bs
o
rb
a
n
ce
N
o
rm
.
 
Fl
u
o
.
 
In
te
n
sit
y 
 
Figure 2: Absorbance and fluorescence spectra of CdSe/ZnS, CdTe and CdTe/CdSe quantum dots of various 
sizes  
Since first reports on water-soluble QDs were published, a wide range of coating and capping 
strategies providing a water-soluble shell arose, having different effects on the properties of 
the modified particles. The strategies can be divided into two fundamentally different ways 
solving this problem via functional polymers. One approach completely replaces the surface 
bound ligands remaining from synthesis; the other only caps the present ligands on the QDs 
with suitable amphiphilic polymers (figure 3). Both approaches have advantages and 
disadvantages for the obtained water-soluble particles. Replacing the original hydrophobic 
surface ligands by amphiphilic ones leads to particles with a small final diameter. These 
composites are often only a few nanometers larger than the core quantum dots. Nevertheless, 
the exchange of the surface coating often results in poor quantum yields and strongly affects 
the physicochemical and photophysical stability of QDs in aqueous solutions. Instead, surface 
capping chemistries retain the original surface ligands and therefore preserve the 
photophysical properties of the nanocrystals. However, this approach results in particles with 
a final size three or four times larger than the original nanocrystal diameter. 
The huge variety of different surface modifications results in quantum dots of very different 
optical and chemical properties. Indeed this diversity is necessary for the multiplicity of 
applications semiconductor nanocrystals undergo in diagnostics and sensorics. Properties like 
particle size and charge, as well as application relevant parameters, like chemical and 
photophysical stability, photoluminescence intensity and cytotoxicity have to be considered to 
choose the optimal system for each application. 
The focus of the following chapter will be set on coating strategies with organic substances. 
For completeness, it has to be mentioned that there are various possibilities for inorganic 
coating of quantum dots with silica or titania. These coating strategies are based on the same 
two principles of ligand exchange or ligand capping to anchor the inorganic coating on the 
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nanocrystal surface. This is followed by the formation of another inorganic layer, shielding 
the quantum dot and rendering it water-soluble [21,40-48]. 
A
B
= grafting functional group
= optional functional group
= alkyl chain
= arbitrary spacer
 
Figure 3: Scheme of the (A) ligand exchange and (B) the ligand capping strategy. 
2.3.1. Effects of surface coating 
Coatings can change the quantum dot properties in tree different aspects, one is the 
photophysical, one the physicochemical and the last is the toxicological point of view (figure 
4).  
Cytotoxicity
Stabilization in biological environment
Photostability
Protection of the
nanocrystal surface 
against chemical and
physical factors
Prevention of leakage
of toxic compounds from
nanocrystal surface
Quantum dot Polymeric shell
Solubilsation in water,
Prevention of protein adsorption
Unspecific binding,…
 
Figure 4: Functions and influences of polymeric coating on quantum dots 
The affected photophysical characteristics are the emission wavelength, the quantum yield 
and the photostability, directly influencing each other due to the physics of the quantum dots. 
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The physicochemical aspects influence the size, the charge and the aggregation of quantum 
dots in biological environments and therefore determine the stability of quantum dot probes in 
biological environments. The cytotoxicity of quantum dots is an essential point to consider 
especially in cell cultural or in vivo applications.  
Photophysical aspects 
The natural quantum dot capping, resulting from synthesis, protects the surface against 
oxidation and can compensate surface defects. Too many surface defects result in a decrease 
of quantum yield, because excitons can emit their energy in a non-radiative way. 
Additionally, the photostability is largely influenced by the occurring photooxidation at the 
surface, and the larger the likelihood for an oxidation due to imperfect coating, the worse the 
observed photostability of the quantum dots. Finally, the occurring surface oxidation is also 
responsible for an effect called ‘blueing’ of the quantum dots, which is a shift of the emission 
wavelengths towards blue color [49-52]. In case the surface of a nanocrystal gets oxidized, the 
remaining emitting semiconductor core gets smaller (figure 5). When the core gets smaller the 
emission wavelength shifts to higher energies and therefore smaller wavelengths [53,54]. 
Consequently, the exchange of the original capping causes an increased likelihood to suffer 
damages due to incomplete coverage and imperfect grafting of the newly added ligands. 
Additionally, thiol-containing ligands used in many approaches are themselfes susceptible to 
oxidation of the thiol group, leading to detachment of the coating from the surface. Here again 
the mere capping of the initial ligands with amphiphilic polymers reduces the likelihood to 
suffer from surface defects and in most cases provides a much better protection against 
oxidation due to the much thicker shell on top of the particles. 
Toxicological aspects 
Having biological experiments in mind, the cytotoxicity is an tremendously important factor 
to be considered. quantum dot size, charge and concentration, their outer shell bioactivity and 
oxidative, photolytic or mechanical stress are all factors that, collectively and individually, 
can determine their cellular toxicity. For biological applications, it is notable that especially 
protection of the nanocrystal surface is not only important for the probe stability, but it is also 
vital to prevent leakage of cytotoxic semiconductor components from the inorganic core, e.g. 
due to occurring photooxidation. In addition, some coating materials can also have toxic 
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effects on cells on their own, if they are released from the composites, which is especially the 
cause for amphiphilic substances.  
An oxidation of the surface happens through a variety of chemical pathways, mostly through 
radical reactions of oxygen combined with UV-irradiation. This leads to the formation of 
chalcogenoxides (e.g. SO2, SO3, SeO2, TeO2) and reduced cadmium. These chalcogenoxides 
can then desorb from the surface and dissolve (e.g. resulting in H2SO3, H2SO4, H2SeO3, 
TeO2(aq)), the residual reduced cadmium is oxidized back to Cd2+-ions, leading to the 
subsequent release of free cadmium ions [50-52] (figure 5). These soluble Cd2+-ions make the 
biggest part of the toxic effect that is ascribed to QDs. Consequently, with increasing 
impermeability of the surrounding polymer shell, for these ions, the overall cytotoxicity 
decreases. The toxicity of the used coating material is closely related to the toxicity of the 
utilized polymer compuonds. 
However, at the low concentrations of quantum dots needed especially for cellular 
experiments most reports did not find adverse effects on cell viability, morphology, function 
or development. Semiconductor nanocrystals are therefore not completely innocuous, but a 
safe range for their biological application certainly exists [55-57]. This range eventually can 
be further extended with increasing quantum yields of the particles and subsequently 
decreasing detection limits and applied amounts. 
Quantum Dot
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free radicals,
metal ions
Metal ions,
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Cd Cd2+ (aq)Radicalic pathways
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Figure 5: Schematic drawing and reaction scheme of the photooxidation on the nanocrystalsurface of CdSe. 
Physicochemical aspects 
The physicochemical attributes of the nanocrystals affected by different coating strategies are 
their size, their charge and the aggregation stability of the particle suspension in biological 
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systems. However, these particle attributes are often the most critical subject for the design of 
a new coating, as they have significant impact on the application of the quantum dots. The 
ligand exchange method on the one hand yields particles of a small final diameter, but 
together with an increased oxidation sensivity of the thiol grafting ligands. This furthermore 
may also result in an aggregation of the quantum dots, due to the loss of surface shielding. 
However, the beneficial small dimensions of the QDs with exchanged ligands prevail in some 
applications the comparable low stability against aggregation. The capping of the ligands on 
the other hand produces comparatively large polymer coated particles, which in some cases 
even have more than one QD inside the coating layer [58]. Nevertheless, these bigger 
particles provide a good chemical stabilization of the surface and a reliable protection against 
aggregation. 
Occurring in both modification methods is the aqueous solubilization by additional charged 
groups on the surface. The mostly used chemical moieties are carboxyl and amino groups, 
which additionally offer the possibility for further functionalization with specific 
biomolecules. However, the use of these highly charged systems raises the risk of aggregation 
in biological environments caused by ionic interactions with proteins and ions present in 
biological fluids. The destabilization of anionic shells happens for example, caused by an 
increased ionic strengths of the aqueous solutions, increased temperature or complex salt 
mixtures, which all reduce the repulsive forces of the ionic groups. Therefore, another 
frequently-used technique altering the physicochemical attributes of the particles is the 
PEGylation of an existing polymer shell, yielding uncharged sterically stabilized colloids. 
This modification furthermore results in a reduced unspecific uptake in cells and moreover, 
prevents adsorption of proteins on the polymer shells. Also the risk of agglomeration in 
biological fluids is remarkably reduced [59]. 
2.3.2. Ligand Exchange Strategies  
There are various different suitable molecules for ligand exchange, however all depend on a 
functional group grafting on the nanocrystal surface. Different chemical groups were utilized, 
mainly thiol, amine and phosphine groups. The other part of these molecules should provide 
the solubilization of the quantum dot. For this task, different strategies are used, like charged 
groups, hydrophilic spacer or combinations of both.  
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Thiols 
Among the different strategies of ligand exchange (table 1, figure 5), various thiol ligands, 
including dithiols and also thiol dendrimers have been studied extensively. One of the easiest 
ways to obtain water-solubility is the attachment of acidic ligands as thioglycolic acid, 
mercaptopropionic acid or dihydrolipoic acid [60]. The introduced second functional group of 
the ligand, e.g. carboxy groups, provides the possibility of further functionalization steps. 
Additionally, these modified QDs can subsequently be covered using an oppositely charged 
polymer, e.g. with derivatives of poly(acrylamide) causing a stabilization of the ligand shell 
or by functinalisation with poly(ethylene glycols) [61]. 
Thiolated poly(ethylene glycol) polymers, obtained by attachment of terminal thiol groups are 
often synthesized for coating of quantum dots [62-66]. Main advantages of the thiolated PEGs 
are the easy synthesis, ease of handling and the versatile applications. Due to these facts, the 
PEG ligands are widely used for solubilization. An extra benefit of poly(ethylene glycol) 
coatings is the reduced unspecific cellular uptake of the modified uncharged particles [59] as 
mentioned earlier. Depending on the strived goal, varying polymer chain lengths and number 
of binding dentates are used. The two mainly applied types are the mono [65,66] and the 
bidentate [63] thiols. The latter ligand obviously grafts more effectively on the nanocrystal 
surface and therefore provides a much better stabilization of the nanocrystals in aqueous 
solution. Nevertheless, the remaining disadvantage of these simple coating agents is the 
reduced photoluminescence intensity of the obtained particles and the lack of long-term 
chemical stability of the thiol groups. 
Not only synthetic polymers can attach onto a charged layer,as mentioned above, also proteins 
readily adsorb on it [5]. What could be a problem, some work groups turn into a benefit by 
attaching specific proteins on the nanocrystal surface. Furthermore, the application of 
engineered peptides and proteins for functional coatings of quantum dots is a fast growing 
field in nanocrystal modification. For these custom-designed proteins biologically relevant 
domains, like targeting sequences, are fused with attachment domains for the quantum dots, 
like thiol containing cysteine domains, cationic histidine tags [67] or the leucine zipper 
peptides [5]. Nevertheless, also simply thiolated proteins are utilized for direct attachment on 
nanocrystal surfaces providing modified nanoparticles [67]. A further improvement is the 
coattachment of thiolated PEGs and engineered peptides on one particle surface [69]. This 
method provides specific binding on the one hand, but on the other hand also reduces the 
adsorption of different other proteins on the quantum dots and enhances their overall 
biocompatibility. 
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Another possibility to exchange existing surface ligands is the application of grafting 
dendrons or dendrimers, which are three-dimensional, highly branched and almost 
monodisperse macromolecules [70]. Dendrons and dendrimers themselves are core-shell 
nanostructures consisting of a core, starting point for the step-wise polymerization, interior 
branch cells and an exponentially increasing number of functional groups on the surface. The 
mostly used dendrimers for nanocrystal capping are for example functionalized 
poly(amidoamine) (PAMAM) polymers [71-73]. An important attribute of these cationic 
PAMAM polymers is their ability to effectively penetrate cell walls, making them also useful 
as commercial transfection agents. The PAMAM polymers possess a large number of primary 
and tertiary amine groups at the surface and in the interior branches of the molecule, which 
are known to allow for DNA complexation and which can also graft to quantum dot surfaces, 
while additionally improving the fluorescent properties of the modified semiconductor 
nanoparticles [74]. Nevertheless, they only posses poor affinities to nanocrystal surfaces and 
do not offer stabilization against particle aggregation because of their charged groups. Due to 
this fact, the utilized PAMAM dendrimers have to be further modified with additional thiol 
groups, known to graft better on the surface of quantum dots. Hence, a significant 
improvement of their affinity to nanocrystal surfaces is achieved. Surprisingly, these 
dendrimer coated quantum dots even seem to transfect better than higher generation dendrons 
alone in first cell studies [73], which can be explained with altered particles sizes compared to 
the free polymers. Thus, the composites may be a promising innovation for the transfection of 
cells. 
A new multidentate poly(acrylic acid) derivative uses not only thiol groups but also amine 
groups for grafting on the nanocrystal surface. For this, a denser polymer shell than with 
monodentate ligands can be achieved, and on that account the resulting nanocrystals display 
sufficiently small hydrodynamic diameters. However, also a luminescence enhancing effect of 
the amine groups takes place [74].  
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Table1: Examples of thiol ligands and polymers used for ligand exchange with their mechanism of interaction 
with the semiconductor and the intended application. 
Ligands Mechanisms of 
interaction 
Applications  References 
SH
OH
O
n
 
 
Mercaptoalkane acid 
monodentate thiol bond metal ion sensing [108], 109], 
[110] 
SH SH
OH
O
 
Dihydrolipoic acid 
bidentate thiol bond FRET experiments, ion 
sensing 
[11], [12] 
SH SH
O
O
O
OHn
 
 
PEGylated dihydrolipoic acid 
bidentate thiol bond cancer marker detection, 
live cell labelling, 
organelle tracking 
[63], [65], 
[66] 
OH
O
Peptide Grafting Group
 
Peptide or Protein 
monodentate thiol group, 
leucine zipper, cystein 
domain, histidine tag 
tumor vascular imaging,  
intracellular targeting  
[68], [69] 
N
SH
N
H
N
H
O O
NH2NH2
 
1. Generation Poly(amidoamine) 
dendrimer 
monodentate thiol bond transfection agent  [73] 
* *
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H
N
H
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O
OH
NH2 SH
x
 
y
 
z
 
 
poly(acrylic acid) based multidentate 
polymer 
multidentate thiol and/or 
amine bond 
 [74] 
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Amines 
An alternative is the attachment of polymers to nanocrystals via the use of amines (table 2). 
As mentioned above, this chemical moiety is known for only a weak binding to 
semiconductor surfaces. However, some work groups succeeded in functionalizing quantum 
dots with mere amine containing polymers, like poly(ethyleneimine) (PEI) [75], also being an 
effective transfection agent. The PEI coated quantum dots exhibited an effective 
lipophilic/hydrophilic phase-transfer and a good solubility in polar solvents. However, the 
coatings with PEI polymers unfortunately seemed to enhance the photooxidation of the 
quantum dots and therefore increased the darkening of the so coated nanocrystals. Other 
applied amine-containing polymers are poly(N,N-dimethylaminoethyl metharcylate)s, which 
exhibit ternary amine groups [76-78]. It was shown that these polymers do not only 
effectively passivate the surface of the nanocrystals, but also provide robust colloidal 
stabilization in various biological environments. Additionally, the polymer-coated particles 
exhibit an increase in quantum yields compared to the uncoated ones, which can be ascribed 
to the photoluminescence enhancing effect of the amines. 
Table2: Examples of amine ligands and polymers used for ligand exchange with their mechanism of interaction 
with the semiconductor and the intended application. 
Ligands Mechanisms of interaction Applications References 
N
NNH2
NH2
N
NH
NH2
NH2
NH2
 
branched poly(ethyleneimine) 
multidentate amine bond transfection agent [75] 
*
O
N
n
 
O
 
poly(N,N-dimethylaminoethyl methacrylate) 
multidentate amine bond - [76] 
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Phosphines 
To overcome the drawback of reduced photoluminescence intensity with all the previously 
described grafting groups, several phosphine-containing polymers were developed, which 
show more similarities to the original ligands used in synthesis (table 3). In 2003, Bawendi et 
al. synthesized multidentate phosphine oxide polymers [79,80] composed of three sublayers 
enclosing the nanocrystal, an inner phosphine layer, a liking layer between the phosphine 
group and an outer functionalized layer. The attachment of phosphines here provides quantum 
yields up to 40%, while the oligomeric outer layer can be easily modified with functional 
moieties, for example PEG chains [80]. Taken together, these multidentate ligands provide 
chemically stable and highly fluorescent quantum dots. A potential application for these 
particles is for example the lymph node mapping due to their exceptionally small 
hydrodynamic radii of 15 to 20 nm, allowing successful penetration through tissues. 
Table 3: Examples of phosphine ligands and polymers used for ligand exchange with their mechanism of 
interaction with the semiconductor and the intended application. 
Ligands Mechanisms of interaction Applications References 
P O N
H
O
O
OH
P O N
H
O
O
OH
L
L
L
 
multidentate phosphine polymer 
multidentate phosphine bond lymph node mapping [80] 
P
O
O
O
2
O
O
O
OH
OH
OH
OH
OH
OH
OH
OH
OH
 
Poly(ether) dendron 
monodentate phosphine bond - [81] 
 
Similarly, on the sector of dendrons and dendrimers, poly(ether)s modified with aryl 
phosphine focal points were developed [81]. The incorporated phosphine group here provides 
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a strong coordination to the surface without affecting the particle´s quantum yield. Moreover, 
the conic shape of the attached dendrons seems to be ideal for an adsorption onto the 
nanoparticles, because the formation of a closely packed polymer shell is possible. These 
obtained shells then effectively suppress subsequent diffusion of quenching substances like 
oxygen or other small ions from the surrounding solution to the nanocrystal surface. 
2.3.3. Ligand Capping Strategies 
A wide rage of amphiphilic polymers for quantum dot surface modification was developed 
since the first publications describing water-solubilization using capping strategies (figure 5). 
Many different ways utilizing di- or triblock copolymers or other amphiphilic polymers 
(amphipols) were published. The common functionality of all these different polymers is the 
lipophilic part, intercalating between the aliphatic chains of the surface ligands, and finally 
covering or encapsulating the whole quantum dot with the original ligands from the synthesis 
still in place. 
Amphiphilic polymers 
One possibility is to use amphipol triblock-copolymers of poly(acrylic acid) (table 4, A), a 
polymer that is commercially applied to solubilize membrane proteins in aqueous solutions 
[82]. A few years ago, related diblock copolymers were developed for the preparation of 
biocompatible semiconductor nanocrystals in large scale. The used polymer shell here is 
composed of octylamine-modified poly(acrylic acid) additionally crosslinked with lysine 
(table 4, B). The modified QDs can further be improved by PEGylation of the carboxylic 
groups to reduce unspecific binding [83,84]. 
Another polymer type, which is used for quantum dot functionalization, are the amphiphilic 
poly(maleic anhydride-alt-1-olefin)s with different alkyl chain lengths (table 4, C) [85-87], 
which can be further cross linked with a diamine to stabilize the shell, or functionalized with 
PEG. Also a poly(isobuthylene-alt-1-maleic acid) functionalized with dodecylamine is 
synthesized for capping of quantum dots (table 4, D) [88]. All these amphipols have a 
hydrophilic backbone with attached hydrophobic side chains, interacting with the aliphatic 
chains of the ligands present on the nanocrystal surface, bridging between the lipophilic 
surface ligands and the hydrophilic solution. Solubilization of the nanoparticles in water is 
mainly funded in the carboxylic groups of acrylic or maleic acid, forming the backbone of the 
amphipol shell. The shell architecture with the functional group then provides the possibility 
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for further functionalization with antibodies or proteins, suitable to target cancer cells, using 
standard carbodiimide chemistry [83]. 
Table 4: Examples of amphiphilic polymers used for quantum dot capping with their application. 
Capping polymers Applications References 
A
*
O O OO
x
 
y
 
O OHO
OH
O N
H
z
 
 
Triblock copolymer 
- [82] 
B
*
OH
O
N
H
O
x
 
y
 
 
Poly(acrylic acid) derivate  
multiphoton imaging in vivo, 
labelling of cancer markers and cellular 
targets, transfection experiments 
[83], [84],  
C
*
O
O
*n
 
OH
OH
 
Poly(maleic acid-alt-1-olefin) derivative 
transfection experiments [87] 
D
n
 
N
H
O
O OH
 
Poly(isobutylene-alt-1-maleic acid) derivative 
FRET experiments [88] 
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Micelles 
An often-used alternative to coating with amphiphilic polymers is the encapsulation of 
quantum dots in micelles, e.g. composed of polymer modified surfactants (table 5). The 
advantage of this method is the applicability of a wide variety of surfactants/lipids with 
different functionally terminated groups. As micelle building compounds mostly PEG 
derivatisized phospholipids are applied due to their improved solubilization capability [89-
91]. Also many other suitable surfactants, like lipids containing paramagnetic gadolinium 
complexes, can be used for nanocrystal encapsulation [92,93], providing the possibility for 
luminescence imaging as well as for MRI (magnetic resonance imaging). The QD containing 
micelles preserve the optical properties of the encapsulated quantum dots and additionally 
offer a high biocompatibility. The drawback of this method is that only nanocrystals of 
predefined diameters and consequently emission wavelength can be encapsulated by certain 
micelle building surfactants or lipids. This fact is founded in a given micellar size of a 
particular surfactant, defining the inner free space available for the incorporated quantum dots 
[89].  
Table 5: Examples of surfactant used for quantum dot capping with their application. 
Capping polymers Applications References 
NH2O
N
H
O
P
O
O
O
O
O
H
O
O
 
Phospholipid 
tracking of plasmid DNA, in-
vivo imaging, cell detection 
[89],[90], 
[92] 
Heterocyclic amphiphiles 
A coating method aiming at the sensoric application of quantum dots is the use of different 
cyclodextrines, where an interaction of the coating with the core is still desirable [94,95]. 
Here, the hydrophobic pockets of the saccharide oligomers interact with the aliphatic chains 
of the TOPO present on the nanoparticle surface. Nevertheless, the immobilized 
cyclodextrines retain their capability of engaging molecular recognition. Due to this fact and 
the observation of fluorescence changes while analyte binding, this modification method is 
very promising for possible sensing applications [95]. Another benefit of this capping strategy 
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is the resulting small diameter of the QDs, which is achieved due to the small space 
requirements of the cyclodextrines. A related approach to small water-soluble quantum dots 
without a ligand exchange is the use of calixarenes, similarly structural organic polycyclic 
systems [96,97]. This coating also preserves the emission intensity of the quantum dots and 
their small diameter. Calixarenes are cyclic oligomers based on a hydroxyalkylation product 
of phenol and an aldehyde. It was also shown that calixarenes could be derivatisized with 
sugars or peptides to allow biological applications of these systems [96]. However, also 
derivatization with aliphatic and sulfonato groups was achieved for optical detection of small 
molecular weight molecules, like acetylcholine [97] (table 6). 
Table 6: Examples of heterocyclic amphiphiles used for quantum dot capping with their application. 
Capping polymers Applications References 
OH
OH
O
O
OH
O
OH OH
O
O
OH
OH
OH O
O
OH
OH
OH
O
O
OH
OH
OH
O
O
OH
OH
OH
O
OOH
OH
OH
O
OH
 
β-Cyclodextrin 
molecular recognition [79] 
O
O
O
O
R1 R1
R1R1
R2
R2
R2
R2
 
Calix[4]arene 
acetylcholine detection [81] 
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2.3.4. Application of surface coatings 
The various coating methods, substances and the different characteristics of the resulting 
nanoparticles open a wide range of application areas, particularly the field of sensorics and 
diagnostics. For sensorical approaches, it is important to have a surface coating that allows an 
interaction of the analytes or the reporter molecules with the quantum dot. In contrast the 
diagnostic applications rely on biocompatibility, especially concerning the cytotoxicity and 
the undesirable adsorption of proteins and possible subsequent particle aggregation.  
Sensoric applications 
The basis for sensoric applications of quantum dots is, in most cases, the interaction of the 
analyte molecule or ion with the nanocrystal surface, leading to a change in the apparent 
fluorescent properties of the particle. Following this approach, quantum dots were coated with 
cystein, thioglycolic acid or related ligands for the detection of metal ions like Ag+ [89], Cu2+ 
[99], Zn2+ [100] and also small toxic anions, for example cyanide [101]. Additionally, coated 
quantum dots were applied to optical temperature detection [102-104]. The conjugation of 
selective reagents or reporter molecules to the surface of luminescent nanocrystrals is also 
utilized for quantum dot probes. Particularly dihydrolipoic acid can be modified with 
functional moieties for selective K+[11] or even glucose [12] sensing. Nevertheless, these 
approaches seem to be restricted to a small number of analytes interacting with the surface 
coatings and the underlying quantum dots. Additionally they possess only a low stability in 
biological systems and limited applicability in realistic sample arrangements due to many 
possible interactions with similar ions present in solution. 
The potential of QDs to be used in much more analyte specific FRET (Förster resonance 
energy transfer) based sensors can expand the applicability of semiconductor nanocrystals in 
sensorics. Here, the tunable wavelengths and the high quantum yields of the nanocrystals 
theoretically enable efficient energy transfer with a wide number of conventional dyes. Indeed 
it should be mentioned, that FRET efficiencies obtained with QDs as donor species today are 
still low compared to efficiencies of common dyes, which is mainly founded in the 
comparatively large size of even thin-coated quantum dots, making it very complicated to 
bring the acceptor into close proximity to the donor for efficient FRET. Nevertheless, a 
variety of quantum dot FRET applications were yet developed and strategies arose to improve 
the energy transfer. Protein binding-sites were studied by FRET investigations, whereas the 
acceptor dyes are bound to a protein affording FRET when the assembly is adsorbed on the 
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QD surface [105]. Therefore, even inside of cells different sensing applications can be 
achieved, as pH, nuclear cleavage or protease activity detection [106-109]. In addition, 
immunoassays for specific cancer marker detection are developed [110]. Not only 
conventional fluorescent dyes are utilized as acceptors, also several so-called dark quenchers, 
molecules or nanocrystals only absorbing and not re-emitting the light, were bound to QDs for 
FRET applications. This consequently results in a detectable decrease of the fluorescence 
signal upon increasing FRET events. Examples for these systems are the use of functionalized 
gold nanocrystals for DNA hybridization investigations [111,112], inhibition assays [113], 
glucose sensing [114] or alternatively, the application of an organic dark quencher dye for pH 
sensing [115] or maltose binding assays [116]. 
Diagnostic applications 
The diagnostic approaches of modified quantum dots, on the other hand, are more dependent 
on impermeable polymer shells and efficient physical and biological shielding of the quantum 
dot to prevent unspecific adsorption of proteins and fast degradation leading to fluorescence 
loss. This can mainly be achieved with densely packed polymer shells and subsequent 
PEGylation. On the one hand these water soluble and often targeted quantum dots can be used 
for in-vitro cellular imaging, e.g. histology, on the other hand for in-vivo imaging of tumors, 
e.g. in small animals. The applied in-vivo imaging here is a non-invasive possibility to detect 
highly sensitive and in a high contrast deep tissue regions in mice and even larger species 
without the use of radioactive radiation or larger instrumental setups, like computed 
tomography. The intravenous injection of biocompatible quantum dots was performed for 
blood vessel imaging [84], targeting of tissue specific vascular markers [68], or lymph node 
mapping [117]. A promising application is also the targeting of tumor cells in-vivo using 
specific antibodies against Her2 markers [83]. Another improvement in the field of in vivo 
imaging are self-illuminating quantum dots, these polymer coated and luciferase modified 
nanocrystals need no external light for excitation. In this system the chemical energy of the 
substrate coelenterazine is converted into photon energy by the enzyme luciferase. This 
photon energy excites the quantum dot through bioluminescence resonance energy transfer 
(BRET). With this excitation mechanism the autofluorescence is virtually eliminated, 
however the emitted photons are still absorbed or scattered in the surrounding tissuemaking 
sensitive detection necessary [118-121]. 
In the area of cellular imaging, quantum dot probes are as well used for the tagging of whole 
cells as for the investigation of single intracellular processes. Many studies here are focused 
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on membrane specific markers due to the easy access form the outside of the cells and the 
unnecessary passage through the cell membrane. Additionally, also several attempts for the 
internalization of quantum dots in live cells have been performed. One approach to internalize 
the nanoparticles is the use of membrane translocation peptides [122], also attempts utilizing 
electroporation or established transfection reagents [123] were preformed. The latter strategy 
to internalize QDs allows then the targeting of sub-cellular compartments as for example 
mitochondria or the nucleolus using specific targeting peptides allowing for the labeling of the 
small compartments in living cells for subsequent studies of cellular biology [68,124,125]. 
Recently, quantum dot conjugates for combined cancer imaging and therapy were developed. 
An apamer, which is able to target cancer cells and simultaneously bind a cancer drug was 
immobilized on the surface of the quantum dot. The fluorescent properties of the drug quench 
the luminescence of the quantum dot by a FRET mechanism, and by the release of the drug 
the luminescence of the nanocrystal is restored. Therfore, a targeted QD imaging system that 
is capable of differential uptake, imaging and therapy of prostate cancer cells was build [126]. 
2.4. Conclusion  
A great variety of polymeric surface coatings for quantum dots is currently applied for a wide 
range of different applications. All applications require distinct characteristics of the quantum 
dots, which are adjustable by the used surface coating polymer. The size and photostability of 
water-soluble quantum dots here strongly depend on the used capping strategy and the 
resulting particle architecture.  
Ligand exchange on the one hand can produce small particles, but often lacks the long-term 
stability and photoluminescence intensity. Their resistance against acids or bases and, in some 
cases, against chemical oxidation is only very week. Nevertheless, FRET experiments, for 
example, urgently require small hydrodynamic radii, and also other sensoric applications 
depend on the accessibility of the nanocrystal surface, which can only be achieved by the 
attachment of short ligands. For ligand exchange procedures the recent adaptation of 
phosphine groups is very beneficial due to the improved stabilization of the nanocrystal 
surface and the additional surface passivation against oxidation, while mere PEGylation 
mainly provides protection against unspecific protein absorption. For transfection 
experiments, substitution with cationic polymers, like branched PEI or PAMAM dendrimers, 
is suggestive. 
On the other hand, the ligand capping strategies with their effective shielding of the 
nanocrystal surface, their subsequently low cytotoxicity and high stability in biological 
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environments are ideal for cellular and even in-vivo experiments. These studies rely on a 
sustained fluorescence in the presence of oxidizing agents and low cytotoxicity. Also in 
assays conducted in high salt buffers, uncharged and sterically stabilized nanocrystals, like 
PEG coated QDs, can be of avail. Therefore, protection of the quantum dots with an 
amphiphilic bilayer, e.g. using phospholipids or amphiphilic polymers is very useful. The 
amphiphilic capping then can be easily modified with targeting sequences or proteins using 
carbodiiminde chemistry. Subsuming the different strategies, none of the encapsulation 
methods can be universally optimal for several biological and sensorical applications at once. 
2.5. Future Outlook 
The different polymeric surface coatings developed in the last decade combining biological 
materials with inorganic nanocrystals have not only been crucial for the successful use of 
quantum dots in cell and tissue imaging. Additionally, they have afforded new systems in 
materials science for the controlled assembly of nanomaterials used in the biological 
environment. As research continues to produce different nanomaterials with novel unique 
properties, it will become possible to gather new multimodal imaging agents. Combining QDs 
for fluorescence imaging with magnetic resonance imaging (MRI) or computed tomography 
(CT) contrast agents, like Fe2O3 [127], FePt [128] or Gd complexes [92] allows deep tissue 
imaging and fluorescence tracking of one system for sophisticated diagnostic applications. In 
the area of sensorics, QDs can moreover function as effective protein carriers and exciton 
donors for prototype self-assembled FRET nanosensors for the detection of many relevant 
signal molecules, like acetylcholine [82] or others. Furthermore, they could even drive more 
biosensors through a two-step FRET mechanism overcoming inherent donor-acceptor 
distance limitations, already realized with the FRET maltose-binding sensor [102]. To this 
time, mostly intensity-based measurements with quantum dots have been employed in the 
fields of sensing and imaging. Indeed, lifetime-based methods will draw more and more 
attention due to their superior resolution, independence from fluorescence intensity and 
concentration at the detection point and, finally, the possibility to out-gate the tissue 
autofluorescence present in all living biological systems, like cell cultures or whole animals. 
For these developments QDs are an especially powerful tool due to their long excited state 
lifetimes compared to the common organic dyes and the interfering tissue autofluorescence. 
However, for all that semiconductor nanocrystals will not overcome the use of conventional 
organic dyes in biological and sensorical applications. They could complement dye 
deficiencies in particular approaches such as in vivo imaging and break up to new 
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applications as long-term imaging and lifetime measurements. Moreover, adapting QD 
nanoparticles for biological use will teach us important lessons about creating future 
inorganic-organic hybrids for many other applications. 
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3. Materials and Methods 
3.1. Quantum dots 
Cadmiumoxide (99.99+%), elemental selenium (99.5%, 100 mesh) and tellurium (99.997%, 
30 mesh), zinc stearate (techn.), oleic acid (techn.), tributylphosphine (techn.), 
trioctylphosphine (techn.), trioctylphosphine oxide (techn.), octadecene (techn.), 
hexadecylamine (techn.) for synthesis were obtained from Sigma-Aldrich (Sigma-Aldrich 
Chemie GmbH, Munich, Germany). Sulfur (sulfur praecipitatum Ph.Eur.) was purchased at 
Caelo (Ceasar&Lorenz GmbH, Hilden, Germany). Lauric acid was purchased at Henkel 
(Henkel&Cie GmbH, Düsseldorf, Germany). Methanol (p.a.), ethanol (p.a), nitric acid, 
fuming (p.a) were purchased at Merck (Merck KGaA, Darmstadt, Germany). Acetone (p.a) 
methylenechloride (p.a.), hexane (p.a.) were obtained from Acros (Acros organics, Fischer 
scientific GmbH, Nidderau, Germany) 
3.2. Dihydrolipoic acid 
The used lipoic acid (>89%) was obtained from Sigma-Aldrich (Sigma-Aldrich Chemie 
GmbH, Munich, Germany), sodium borohydride (p.a.), and sodium hydrogen carbonate (p.a.) 
were purchased at Merck (Merck KGaA, Darmstadt, Germany) 
3.3. Synthesis of amino Poly(ethylene glycol)mercaptoundecyl ether  
Ethylene oxide (purum), potassium bis(trimethylsilyl) amid (0.5 M in toluene), di(tert-
butyl)dicarbonate (purum), 11-bromoundecen (p.a.), thioacetic acid (p.a.), 
α,α´azoisobutyronitrile (p.a.) were obtained from Sigma-Aldrich (Sigma-Aldrich Chemie 
GmbH, Munich, Germany). Potassium hydroxide (p.a.) and sodium hydride (p.a.) were 
purchased at Merck (Merck KGaA, Darmstadt, Germany). Dioxane p.a. was obtained from 
Acros (Acros Organics, Fischer scientific GmbH, Nidderau, Germany) hydrochloric acid in 
methanol 
3.4. Coating of Quantum Dots 
The hexa(ethylene glycol)mercaptoundecyl ether and tri(ethylene glycol) mercaptoundecly 
ether and mercaptouncedanol (purum), were provided from Sigma-Aldrich (Sigma-Aldrich 
Chemie GmbH, Munich, Germany). Amino poly(ethylene glycol)2000 mercaptodecyl ether 
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was custom made in the Department of Pharmaceutical Technology, University of 
Regensburg, according to an established procedure [1]. 
3.5. Fluram assay 
The sodium tetraborat decahydrat (p.a.) was obtained from Merck (Merck KGaA, Darmstadt, 
Germany). Fluram ® (>99%) and 6-aminohexanoic acid (98%) were provided from Sigma-
Aldrich (Sigma-Aldrich Chemie GmbH, Munich, Germany). 
3.6. Cytotoxicity Test 
Fetal Bovine Serum (FBS) was purchased from Biochrom (Biochrom KG, Berlin, Germany), 
0.25% Trypsin-EDTA was obtained from Invitrogen (Invitrogen GmbH, Karlsruhe, 
Germany). 3-[4,5-Dimethylthiazol-2-yl]-2,5- diphenyltetrazolium bromide (MTT) was 
purchased from AppliChem (AppliChem GmbH Darmstadt, Germany). Dulbecco´s modified 
Eagle´s medium (EMEM) and nutrient mixture F-12 HAM were obtained from Sigma-
Aldrich (Sigma-Aldrich Chemie GmbH, Munich, Germany). Titriplex® III 
(ethylendinitrilotetraacetic acid disodium salt dihydrate) (p.a.) was obtained from Merck 
(Merck KGaA, Darmstadt, Germany). 
3.7. Syntheses of Quantum Dots 
Due to the fact, that quantum dot synthesis is highly susceptible to water and oxygen, all 
syntheses were carried out under nitrogen atmosphere using a combined stock /schlenck 
technique. The nitrogen as well as all reactants and experimental setup were dried before use. 
For heating either a metal bath (wood´s alloy) in combination with a heated stirrer (Heidolph 
3001 K, 800W), or a heating mantle with controller (Isopad TD 2000) was applied. 
Furthermore, the use of silicone-free grease for all glassware was necessary. All quantum dot 
syntheses are based on the procedures developed by Wang et al. for the CdSe cores, Huang et 
al. for the ZnS coating, and Yu et al for the CdTe cores [2-4]. 
3.7.1. Synthesis of Cadmium selenide Quantum Dots 
For the synthesis of cadmium selenide quantum dots, 0.1 mmol cadmium oxide (12.7 mg, 
1eq) and 0.8 mmol lauric acid (160 mg, 8eq) were heated up to 220 °C until the cadmium 
oxide was completely dissolved. Subsequently, 5 mmol of trioctylphosphine oxide (1.94 g) 
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and 8 mmol of hexadecylamine were added under nitrogen atmosphere, and the temperature 
was raised to 280 °C. In parallel 1.0 mmol of elemental selenium (80 mg, 10eq) dissolved in 
8.0 mmol trioctyphosphine (2 mL, 80eq) and this as-obtained trioctylphosphine selenide 
precursor solution was quickly injected to the cadmium laureate precursor solution 
afterwards. The heating bath was removed and the as synthesized quantum dots were 
precipitated with anhydrous methanol [2].  
The precipitated quantum dots were centrifuged (8000 g, 10 min, 18 °C) for purification. 
Then, the methanolic supernatant was removed and the precipitate was dispersed in hexane. 
Afterwards, the dispersed quantum dots were again precipitated with methanol and the 
procedure was repeated for another two times. 
3.7.2. Synthesis of Cadmium selenide/Zinc sulfide Core/Shell Quantum Dots 
The zinc sulfide shell precursor was prepared by dissolving 1.3 mmol (43.0 mg, 13 eq) of 
elemental sulfur and 10 mmol zinc stearate (613 mg, 100eq) in 10 mmol trioctylphosphine (5 
mL, 100 eq). The cadmium selenide quantum dots for the core were synthesized in analogy to 
2.1.1. After injection of the trioctyphosphine precursor to the cadmium precursor solution, the 
temperature was lowered to 200 °C and kept constant for 3 min. Afterwards, the zinc sulfide 
precursor was slowly injected to the cadmium selenide quantum dot solution. The temperature 
was kept constant at 180 °C for one hour, and subsequently, the reaction was cooled to 50 °C 
and quenched with methanol [3]. The purification was done analogue to 3.7.1. 
3.7.3. Synthesis of Cadmium telluride Quantum Dots 
For the cadmium telluride quantum dots 0.1 mmol elemental tellurium (12.8 mg, 1eq) and 0.6 
mmol trioctylphosphine or tributhylphosphine (267 or 149 µL, 6eq) were combined in 5 mL 
octadecen. The tellurium was dissolved under slight warming (approx. 50 °C). In parallel, 0.2 
mmol cadmium oxide (25.6 mg, 2eq) and 0.8 mmol oleic acid (253 µL, 8eq) dispersed in 10 
mL octadecene were heated up to 300 °C, until all cadmium oxide was dissolved. 
Subsequently, the tellurium precursor was quickly injected into the cadmium precursor 
solution. The reaction was cooled to 260 °C and kept constant for 5 min. Afterwards, the 
quantum dot solution was cooled down to room temperature and was purified [4]. 
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Figure 1: Reaction scheme of CdTe synthesis 
For purification, the quantum dots were precipitated with ethanol and centrifuged (8000 g, 10 
min, 18 °C). Subsequently, the ethanolic supernatant was removed. The precipitate was 
dispersed in methylenechloride and the quantum dots were again precipitated with ethanol. 
This procedure was repeated two times. A reaction scheme of the CdTe quantum dot 
synthesis is shown in figure1. 
3.7.4. Synthesis of Cadmium telluride/Cadmium selenide Core/Shell Quantum Dots 
The cadmium telluride/cadmium selenide quantum dots were synthesized following a related 
procedure as for the cadmium telluride quantum dots. For the cadmium telluride core 0.2 
mmol (25.7 mg, 2eq) cadmium oxide were dissolved in 3 mmol trioctylphosphine (1.33 mL, 
7.5eq) at 320 °C. Thereafter, the precursor solution was cooled down to 280 °C. 
Simultaneously, 0.1 mmol elemental tellurium (12.8 mg, 1 eq) were reacted with 2.15 mmol 
trioctyphosphine (962 µL, 21.5eq) under slight heating (50 °C), giving a clear solution. The 
cadmium selenide shell precursor was prepared by first synthesizing a cadmium precursor 
analogue to the cadmium precursor for the core. Therefore, 0.1 mmol (7.9 mg, 1eq) cadmium 
oxide was dissolved in 0.46 mmol trioctylphosphine (204 µL, 4.6 eq) and cooled to 50 °C. 
Then the selenium precursor was produced, whereas 0.1 mmol selenium (12.9 mg, 1eq) 
dissolved in 4.0 mmol trioctylphosphine (1.80 mL, 40eq). These two precursor solutions were 
then combined at room temperature. 
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The tellurium precursor solution for the core was quickly injected to the cadmium precursor 
for the core. The temperature was lowered to 250 °C and was held for 2 min. For shell 
growth, the temperature was lowered to 120 °C and the shell precursor was injected. The 
temperature was kept constant for 20 h, to obtain shell growth. The purification was 
performed according to 3.7.3 [5]. 
3.7.5. Synthesis of Cadmium telluride/Cadmium zinc sulfide Core/Shell Quantum 
Dots 
The core of the cadmium telluride/cadmium zinc sulfide quantum dots was synthesized in an 
analogue procedure as 2.1.3. For the cadmium zinc sulfide shell a precursor was prepared. 
Therefore, 0.5 mmol elemental sulfur (16 mg, 5eq) and 0.36 mmol zinc stearate (228 mg, 3.6 
eq) were dissolved in 2 mL trioctylphosphine at 120 °C. This zinc sulfide precursor solution 
was injected into the cadmium telluride quantum dot solution at 180 °C and the temperature 
was kept constant for 15 min, allowing the shell growth [3,4]. The purification was achieved 
according to 3.7.3. The reaction sheme of the shell synthesis is displayed in figure 2. 
180°C
TOP;
120°C
OO
OO
Zn/Cd S+
CdTe CdTe
Zn/CdS
 
Figure 2: Reaction scheme of Zn/CdS shell synthesis 
3.8. Syntheses of Ligands 
3.8.1. Synthesis of Dihydrolipoic acid 
For the coating of quantum dots with dihydrolipoic acid, the cleaving of the disulfide bond of 
lipoic acid was necessary. This reaction was carried out in aqueous solution. 0.5 mmol of 
lipoic acid (0.103 g, 1 eq) were dissolved in 25 mL of 0.25 M NaHCO3 solution and was 
cooled to 0°C in an ice bath. Subsequently, 2 mmol sodium borohydride (76 mg, 4eq) were 
added slowly to the reaction solution and the temperature was kept below 4°C. After stirring 
for 2 h, the mixture was acidified with 6 M hydrochloric acid to pH 1 and extracted three 
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times with toluene. The organic phase was dried using magnesium carbonate. After 
evaporation of the product remained as a clear colorless oil [6]. The product was applied as 
obtained after purification. 
OH
O
S S
OH
SH SH
O
NaBH4
 
Figure1: Reaction scheme of the disulfide cleaving of lipoic acid. 
3.8.2.  Synthesis of amino Poly(ethylene glycol)750mercaptoundecyl ether 
The synthesis of the amino poly(ethylene glycol)750mercaptoundecyl ether was carried out 
according to the route developed by Knerr [1]. 
Synthesis of Poly(ethylene glycol)750 monoamine 
For the synthesis of poly(ethylene glycol)750monoamine, 0.45 mol (20 g, 360 eq) of ethylene 
oxide gas were condensed in 150 mL of dried THF at -79°C, cooled by a dry ice – methanol 
bath. Subsequently, 40 mL of 0.5% potassium bis(trimethylsilyl) amide (1.25 mmol, 1eq) in 
toluene were added and the solution was stirred for 36 h at room temperature, according to 
figure 3. The solvent was evaporated and the oily raw product was dissolved in methylene 
chloride. For purification, the solution was centrifuged, removing unsoluble impurities, and 
washed with ice cooled ether. The unsoluble product was collected from the ether solution by 
means of centrifugation (-10°C, 8000g, 5 min).  
Si N
Si
K
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O N
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O
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+
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Figure3: Synthesis of poly(ethylene glycol) monoamine. 
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Protection of the primary amine group 
To avoid the alkylation of the amine group during Williamson ether synthesis, this group has 
to be protected as shown in figure 4. Therefore, 2.5 mmol (1.8 g, 1 eq) of the poly(ehtlyene 
glycol)750 monoamine and 10 mmol (0.6 g, 4eq) of potassium hydroxide were dissolved in 15 
mL of water at 0°C. In parallel, 7.5 mmol (1.64 g, 3 eq) of di(tert-butly)dicarbonate were 
dissolved in 15 mL of dioxane. Subsequently, the dioxane solution was added dropwise to the 
aqueous solution of the poly(ehtlyene glycol)750 monoamine. The reaction mixture was stirred 
for four hours at 0°C, followed by warming to room temperature over night. Afterwards, the 
product containing solution was concentrated and again dissolved in acetone, filtrated to 
remove insoluble salt, and washed with ice cold ether. The reaction product was obtained 
after centrifugation of the etheric solution (-10°C, 8000 g, 5 min). 
O O O
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Figure 4: Synthesis of BOC-protected poly(ethylene glycol) monoamine. 
Synthesis of BOC-protected Amino poly(ethylene glycol)750-1-
undecene 
For the synthesis of BOC-protected amino poly(ethylene glycol)-1-undecene (see figure 5), 2 
mmol (1.8 g, 1 eq) of BOC-protected amino poly(ethylene glycol) were mixed with 6 mmol 
(0.144 g, 3eq) of sodium hydride and allowed to react at 110°C for 30 min. After the reaction 
has stopped, observable from the stopping hydrogen development, 10 mmol (2.18 mL, 5 eq) 
of 11-bromoundecen were added and the reaction was stirred for another 24 hours. 
Subsequently, the reaction was quenched with methanol and the excess solvent was 
evaporated. Finally, the same purification procedure as for the BOC-protected amino 
poly(ethylene glycol) was applied. 
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Figure 5: Synthesis of BOC-protected amino poly(ethylene glycol)-1-undecene. 
Addition of thioacetic acid to BOC-protected Amino poly(ethylene 
glycol)750-1-undecene 
The addition of the thiol functionality was carried out by a radicalic reaction of amino 
poly(ethylene glycol)750-1-undecene with thioacetic acid as displayed in figure 6. 1.5 mmol 
(1.6 g, 1eq) of amino poly(ethylene glycol)750-1-undecene was dissolved in dry methanol, 
2.25 mmol (0.369 g, 1.5 eq) α,α´azoisobutyronitril (AIBN) and 18 mmol (1.3 mL, 12 eq) 
thioacetic acid were added and the reaction solution was refluxed under nitrogen atmosphere 
for 72 hours. 
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Figure 6: Synthesis of BOC-protected amino poly(ethylene glycol)-1-undecane thioester. 
Hydrolysis of BOC-protected Amino poly(ethylene glycol)750-1-
undecane thioester 
The BOC-protected amino poly(ethylene glycol)-1-undecane thioester was hydrolyzed to 
yield the free thiol and the unprotected amine group as showed in figure 7. For this reaction, 
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20 mL of hydrochloric acid in methanol was added to the reaction mixture and refluxed 
overnight. After evaporation of the solvent, the poly(ethylene glycol)mercaptoundecyl ether 
was purified by repeating the procedure described for the synthesis of BOC-protected 
poly(ethylene glycol) monoamine several times. The resulting reaction product was analyzed 
by HPLC and 1H NMR, and used as obtained after purification. 
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Figure7: Hydrolysis of BOC-protected amino poly(ethylene glycol)-1-undecane thioester to amino poly(ethylene 
glycol)mercaptoundecyl ether. 
3.9. Coating of Quantum Dots 
3.9.1. Coating of Quantum Dots with dihydrolipoic acid 
The coating of the quantum dots with dihydrolipoic acid was achieved by combining 500 µL 
raw quantum dot solution with 100µL of the pure dihydrolipoic acid. The mixture was stirred 
for 30 min, and afterwards 2 mL of purified water were added. The dispersion was stirred for 
another 30 min. Meanwhile a phase transfer occurs. The aqueous phase containing the coated 
quantum dots was separated and purified. For the purification, the quantum dots were 
centrifuged (15000 g, 30 min, 18 °C) 3 times and the aqueous supernatant was removed. 
Finally, the coated quantum dots were dispersed in purified water. A reaction scheme of the 
ligand exchange on the quant um dot surface is depicted in figure 8. 
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Figure 8: Reaction scheme of ligand exchange 
3.9.2. Coating of Quantum Dots with Poly(ethylene glycol)mono-11-
mercaptouncedyl ether derivatives 
For the coating of quantum dots with poly(ethylene glycol)mono-11-mercaptouncedyl ether 
derivatives, unpurified quantum dot reaction solution was used. 250 µL of this dispersion 
were precipitated with ethanol and centrifuged (12000 g, 10 min, 18 °C). The precipitate was 
dispersed in 400 µL solution of the respective ligand, or a mixture of different ligands in 
mehtylenechloride (10-15 mg/mL). Subsequently, 2 mL of ethanol were added and the 
methylenechloride was evaporated. This ethanolic solution of the now coated quantum dots 
was transferred into an ultrafiltration spin column (Vivaspin 2, Satorius; MWCO 5000 Da), 
centrifuged and diluted with water (12000g, 30 min, 18°C) three times, to achieve a solvent 
exchange and purification. Afterwards, the purified quantum dots were transferred into 
another ultrafiltration spin coloum (Vivaspin 2, Satorius; MWCO 300000) and centrifuged 
(8000 g, 30 min, 18 °C) to accomplish a separation of bigger particles aggregates and 
precipitated byproducts. 
3.10. Analysis of particles 
3.10.1. Spectroscopic analysis 
The absorbance spectra of the quantum dots were measured with a UVIKON 941 two-beam 
spectrophotometer (Kontron Instruments). The excitation and emission spectra were measured 
with a Perkin-Elmer LS 55 (Prekin-Elmer) equipped with a R928 red-sensitive 
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photomultiplier and the FL WinLab V4.00.03 software. 1 cm quartz cuvettes were used for all 
measurements. 
The quantum yields (ΦF) of the quantum dots were measured in methylenechloride. The 
quantum yields of the coated quantum dots were determined in purified water. For the 
identification a reference fluorophore with a known quantum yield and appropriate absorption 
and emission spectra was used (see table 1)[7].  
Table 1: Quantum yield standards  
Standard 
fluorophore 
quantum 
yield 
Solvent Applied spectral range 
Fluorecein 0.9 0.1 N sodium hydoxide 400 – 590 nm 
Rhodamin 6G 0.94 Ethanol 580 – 640 nm 
Oxazin 127 0.6 Ethanol 630 – 820 nm 
 
The absorbance spectra of sample and reference solution were measured. Therefore the 
absorbance of the solutions have to be lower than 0.1 for avoiding an inner filter effect. After 
that, the emission spectra of sample and reference solution were determined. The excitation 
wavelength of the quantum dots used herein was 400 nm. Subsequently, the emission spectra 
were corrected using the spectrum correction file of the fluorimeter and the areas under the 
corrected spectra were determined via integration, using the integration function of the 
software. 
For the calculation of the quantum yields, following formula was used:  
 2
2
RRs
ssR
RS
nAE
nAE
⋅⋅
⋅⋅
⋅Φ=Φ  (1)
ΦS quantum yield of the substance to be determined 
ΦR quantum yield of the reference 
ES absorbance at the excitation wavelength of the tested substance  
ER absorbance at the excitation wavelength of reference fluorophore 
AS integrated area under the corrected fluorescence spectrum of the tested substance 
AR integrated area under the corrected fluorescence spectrum of the reference fluorophore 
n2S square of the refractive index of the solvent for the tested substance  
n2R square of the refractive index of the solvent for the reference fluorophore 
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3.10.2. Analysis of composition 
The composition of the quantum dots was analyzed using a Jobin Yvon 70 P (S+S) (Horiba 
Yovin Ivon GmbH) inductively coupled plasma optical emission spectrometer (ICP-OES) in a 
sequential analysis mode. The standard stock solution for calibration was composed of 
cadmium, selenium, tellurium and zinc in 3% nitric acid solution. The concentration of each 
element was 1000 ppb, respectively. 
The quantum dot samples for the ICP-OES measurement were prepared from the unpurified 
reaction solution. First, 0.5 mL of the reaction solution was purified 3 times according to the 
method described in 2.1.3. Afterwards the precipitated quantum dots were disintegrated with 
0.3 mL concentrated nitric acid and diluted with purified water to a volume of 10 mL and a 
nitric acid concentration of 3%, using a 10 mL volumetric flask. 
3.10.3. Size analysis with photon correlation spectroscopy 
The solvodynamic or hydrodynamic diameter of the quantum dots were measured with a 
ZetaSizer 3000 A (Malvern Insruments Inc.) photon correlation spectrometer (PCS). Purified 
water was used as solvent for coated quantum dots. Furthermore, all water-soluble samples 
were filtrated through a 0.22 µm PES syringe filter before measurement. The uncoated 
quantum dots were measured in methlyenechloride, and filtrated through a 1.0 µm glass fiber 
syringe filter. All measurements were carried out at 20 °C. 
3.10.4. Size and concentration calculation  
The size, size distribution, and resulting absorbance coefficients of the quantum dot solutions 
were calculated according to following, empirically determined, equations [4], based on the 
first absorbance peak and it respective broadness. 
For CdSe based quantum dots 
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D diameter of the nanaoparticles [nm] 
D± size distribution of the diameter of the nanoparticles [nm] 
λmax wavelength of the first absorbance maximum [nm] 
ε = decadic molar absorbance coefficient [L/mol*cm] 
 
For CdTe based quantum dots 
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12.210043 D⋅=ε  (7)
D diameter of the nanaoparticles [nm] 
D± size distribution of the diameter of the nanoparticles [nm] 
λmax wavelength of the first absorbance maximum [nm] 
ε = decadic molar absorbance coefficient [l/mol*cm] 
 
The concentration can be calculated from the determined absorbance coefficient and the 
measured absorbance according to Lambert Beer´s law: 
Lambert Beer´s law 
 
dcA ⋅⋅= ε  (8)
A absorbance of sample 
c concentration of sample [mol/L] 
d length of penetratured medium [cm] 
ε decadic molar absorbance coefficient [L/mol*cm] 
3.10.5. Morphologic analysis with transmission electron microscopy/Cryo-
transmission electron microscopy 
For the morphologic analysis a Zeiss EM 10 C/CR (Carl Zeiss AG) transmission electron 
microscope (TEM) with 60 kV operating voltage was used. The specimen were prepared on 
3.05 mm formvar/carbon coated copper grids (300 mesh). They were dropped on the grids in 
methylenechloride or water and dried using a vacuum pump. 
The Cryo-TEM measurements were carried out on a Zeiss 922 Omega (Carl Zeiss AG) 
transmission electron microscope in the cryo mode. The samples were prepared by spreading 
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of a diluted (ca 1 Vol%) aqueous solution of quantum dots on a 3.05 mm formvar/carbon 
coated copper grid (300 mesh), followed by a fast freezing of the specimen in liquid nitrogen. 
3.10.6. Amino group determination with a modified Fluram® assay 
The amount of free amino groups on the surface of coated quantum dots was determined 
using a fluorescamin (Fluram®) assay. The fluorimetric Fluram® (4-Phenylspiro-[furan-
2(3H),1-phthalan]-3,3′-dione ) assay is based on the reaction of the non-fluorescent reagent, 
which converts with primary amines to a stable, highly fluorescent compound (see figure 9). 
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Figure 9: Reaction scheme of fluorescamin with primary amine 
For the borate buffer (50 mM, pH 8.5) 19,06 g sodium tetraborat decahydrat was dissolved in 
approx. 900 mL purified water and thesolution was adjusted to pH 8.5 with 3 M hydrochloric 
acid or 3 M sodium hydroxide. The solution was transferred into a 1 L volumetric flask and 
filled up to 1000 mL. The fluorescamin stock solution (0.3 mg/mL) was prepared by 
dissolving 15 mg Fluram® in a 50 mL volumetric flask using acetone as solvent. For the 
stock solution of 6-aminohexanoic acid (0.01 mg/mL), 5 mg 6-aminohexanoic acid were 
dissolved in borate buffer using a 500 mL volumetric flask. Subsequently, the stock solution 
was diluted to a standard solution (0.005 mg/mL). 5.0 mL of the 6-aminohexanoic acid stock 
solution were diluted to 10 mL with borate buffer using a 10 mL volumetric flask. 
First, a calibration curve for the Fluram® assay was recorded with the 6-aminohexanoic acid 
standard solution as reference. Due to the strong absorbance of the quantum dots, it was 
necessary to substitute the Fluram® stock solution for the calibration with the same amount of 
a solution of poly(ethylene glycol) coated quantum dots. These reference quantum dot 
solutions were adjusted to the same optical density as the measured samples. For the 
measurement, all samples of the amino poly(ethylene glycol) coated quantum dot were 
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adjusted to the same optical density ranging from 0.05 - 0.1. Subsequently, Fluram® solution 
was added and the samples were diluted with borate buffer to the same volume as the samples 
for the calibration. Afterwards, the micoplate with the calibration samples and the quantum 
dot samples was incubated for 10 min at room temperature in the dark. The assay was carried 
out in a 96-well plate utilizing the well-plate-reader accessory of the Perkin-Elmer LS 55 
fluorimeter with 390 nm as exaction and 480 nm as emission wavelength, additionally a 390 
nm cut-off filter was used.  
3.10.7. Cytotoxicity Test 
The cell lines used for the cytotoxicity test were L929 and CHO cells. The L929 cells were 
grown in T-75 cell culture flasks containing 20 mL EMEM supplemented with 10% FBS. The 
CHO cells were grown in T-75 cell culture flasks containing 20 mL of HAM supplemented 
with 10% FBS. Both cell lines were cultured at standard cell culture conditions (37°C, 95% 
relative humidity, and 5% CO2). The growth medium was changed every third day. The cells 
were harvested at 90% confluence by exposure to a 0.25% trypsin-EDTA solution (3 
mL/flask) and resuspended at a density of 50000 cells/mL for the MTT assay.  
The colorimetric cytotoxicity assay is based on the conversion of yellow, water-soluble MTT 
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] by the mitochondrial 
dehydrogenases of viable cells, to the purple, water insoluble end-product formazan (see 
figure 10). 
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Figure 10: Reaction scheme of MTT to MTT formazan 
All MTT assays were carried out in 96-well plates. The cells were seeded at a density of 
10,000 cells/well and the solution of MTT was prepared by dissolving 2.5 g MTT/mL in 
sterile PBS. The L929 cells were grown for 24 h in 200 µL EMEM supplemented with 10% 
FBS at standard cell culture conditions; the CHO cells were grown for 24 h in 200 µL HAM 
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supplemented with 10% FBS at standard cell culture conditions. 200 µL of nanoparticle 
dispersions of different concentrations in the respective medium containing 10% FBS were 
added to the cells and were incubated for 4 h at standard cell culture conditions. After 
incubation, the nanoparicles were removed and the cells were washed with 200 µL sterile 
PBS. The MTT stock solution was diluted to a concentration of 0.625 mg/mL with the 
according medium, was added to the cells and incubated for 4 h at standard cell culture 
conditions. Afterwards, the MTT solution was removed carefully. Finally, 200 µL of 10% 
SDS in PBS were added to each well and incubated additional 24 h [9-11]. The absorbance of 
each well was determined on a TitertekPlus Microplate Reader (Friedrich S. Bartolomey) 
with 550 nm as probe wavelength and 630 nm as reference wavelength. 
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Chapter 4 
Quantum dots - Results 
 Quantum dots - Results 
 – 72 – 
Synthesis and optimization of Quantum Dots 
The objective of the quantum dot syntheses was the preparation of stable, highly luminescent, 
NIR-emitting, and non-toxic nanoparticles. For the optimization of these properties, quantum 
dots of different compositions, and sizes were synthesized and coated with different inorganic 
and organic materials, respectively.  
The emission wavelength of quantum dots depends on the one hand on the size of the 
quantum dot core , and on the other hand on the chemical composition [1-4]. The elements 
used herein belong to the II and IV elemental group, namely cadmium, zinc, tellurium, 
selenide and sulfur. Futhermore, varying synthesis methods based on the “hot injection 
method” were utilized.  
4.1. Cadmium Selenide based Quantum Dots 
The CdSe and CdSe/ZnS quantum dots were synthesized according to the method described 
in 3.7.1 and 3.7.2. In figure 1, the absorbance and emission spectra of both quantum dot 
species are displayed. The CdSe nanoparticles show an emission maximum of 561 nm and a 
full width at half maximum (fwhm) of 26 nm. Upon the shell growth according to the coating 
with ZnS, the emission maximum is shifted to 572 nm. Nevertheless, the fwhm (27 nm) does 
not broaden significantly.   
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Figure 1: Absorbance and emission spectra of CdSe and CdSe/ZnS quantum dots. 
However, it is not possible to synthesize CdSe/ZnS quantum dots exceeding an emission 
wavelength of approx. 635 nm. Therefore, the composition of the quantum dots was changed 
to CdTe as core material, providing the opporiunity of longer emission wavelengths. 
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4.2. Cadmium Telluride based Quantum Dots 
4.2.1. CdTe Quantum Dots 
The CdTe quantum dots were synthesized according to the method described in 3.7.3. In 
figure 2 on the left side, representative absorbance and emission spectra of CdTe quantum 
dots are displayed. On the right side, the evolution of the emission wavelength as well as the 
fwhm of the quantum dots with reaction time of the synthesis is depicted. The maximum 
emission wavelength achieved applying this method was about 720 nm. Nevertheless, the 
fwhm broadens significantly upon quantum dot growth, too. Until a reaction time of 30 min, 
the wavelength increases almost linear and the fwhm is quite low for CdTe quantum dots [6]. 
After 30 min, the emission maximum barely increases, whereas the fwhm strongly increases. 
This can be ascribed to a rising Ostwald ripening [7]. 
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Figure 2: Absorbance and emission spectrum of CdTe quantum dots; development of the emission wavelength 
and fwhm with reaction time. 
Unfortunately, blank CdTe quantum dots are not very stable against oxidation, and they 
therefore loose luminescence intensity, upon coating with water-soluble polymers. 
Accordingly, a further shell growth with a more stable inorganic material is needed. It seems 
to be most promising to use CdSe as a shell for CdTe quantum dots, because the lattice 
parameters of these two materials match quite well [8], which is a prerequisite for satisfying 
shell growth. 
4.2.2. CdTe/CdSe Quantum Dots 
The CdTe/CdSe quantum dots were prepared according to the method presented in chapter 
3.7.4. A characteristically absorbance and emission spectrum is presented in figure 3. The 
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maximum emission wavelength of this kind of quantum dots is not altered compared to blank 
CdTe quantum dots.  
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Figure 3: Emission and absorbance spectrum of CdTe/CdSe quantum dots. 
This quantum dot core/shell system is suitable in terms of emission wavelengths and stability. 
However, the remaining toxicity of the Cd in the CdSe shell is likely to be too high for 
application (see chapter 2.5.1). Another material with appropriate lattice parameters of CdTe 
is CdS [8]. However, this does not solve the toxicity problem. Another common material for 
shell growth is ZnS. Unfortunately, its lattice parameters do not fit with those of CdTe [9]. 
Nonetheless, this problem can be avoided by the growth of a mixed CdZnS shell. This 
minimizes the toxicity and alters the lattice constants to an adequate extent. 
4.2.3. CdTe/CdZnS Quantum Dots 
The CdTe/CdZnS quantum dots were synthesized following the method described in chapter 
3.7.5. In figure 4 the dependence of the quantum dot size and the corresponding emission 
wavelength on the growth temperature is presented. The addition of the ZnS shell precursor to 
the CdTe reaction solution induces no additional wavelength shift. Therefore, the ZnS shell 
does not contribute to the maximum emission wavelength. This finding is in contrast to the 
shell growth in CdSe/ZnS quantum dots (chapter 4.1), where a wavelength shift of up to 30 
nm can be observed. 
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Figure 4: Development of the emission wavelength with reaction time for two different growth temperatures. 
Due to the fact that the CdTe/CdZnS quantum dots have the most promising characteristics 
concerning emission wavelength, stability, and toxicity, the synthesis procedure of these 
nanoparticles was optimized and fine-tuned in terms of wavelength, quantum yield and 
stability. 
A quite interesting finding was the formation of tetrapod-shaped nanoparticles under the same 
conditions, if silicon grease instead of silicon free grease for the glassware in synthesis is 
used. A cryo-TEM picture of these irregularly shaped quantum dots in hexane is shown in 
figure 5. The photophysical characteristics only differ in terms of quantum yield, which is 
quite low for these quantum tetra-pods compared to quantum dots. 
100 nm
 
Figure 5: Cryo-TEM picture of tetra-pod shaped CdTe/CdZnS nanoparticles in hexane 
The ICP-OES analysis gave a ratio of core:shell of 1:14, thus indicating that the “arms” of the 
tetrapods are composed of the shell material. 
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Figure 6: Elemental composition of CdTe/CdZnS quantum tetra pods. 
This formation of tetra-pods by addition of mediators, which intensify the growth of certain 
crystal facets, is described in literature [10]. Nevertheless, the influence of silicon grease is 
not yet described. 
4.2.4. Optimisation of CdTe/CdZnS Quantum Dot synthesis 
For further optimization of the synthesis, all variables were altered based on the “standard 
conditions”, namely 0.076 mmol/mL Te-precursor, 0.152 mmol/mL Cd-precursor, 300°C 
injection temperature, 180°C growth temperature, the use of oleic acid for Cd-precursor, 5 
min growth time for CdTe, and 15 min shell growth time for CdTe/CdZnS quantum dots 
according to the synthesis described in 3.7.5. 
Effects of Tellurium precursor 
First of all, the effects of the type of tellurium precursor on the reaction speed and the 
corresponding emission wavelength were investigated. Hence, two different tellurium 
precursors were synthesized, one with the short-chained tributylphosphine (TBP) reactant, the 
other one with the longer-chained trioctylphosphine (TOP) reactant. The two reactions were 
carried out under standard conditions. The emission spectra of quantum dots prepared with 
these two different Te-precursors, respectively, are displayed in figure 7.  
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Figure 7: Emission spectra of CdTe/CdZnS quantum dots synthesized with TBP or TOP Te-precursor 
The use of the TBP based Te-precursor yields in quantum dots of approx. 80 nm longer 
emission wavelength, compared to those synthesized applying the TOP based precursor. This 
is due to the faster reaction speed of this short chained reactant. Nevertheless, the quantum 
yields of the as synthesized nanoparticles are approx. 15% lower. This is on the one hand 
founded in the longer emission wavelength, which results in lower quantum yields, and on the 
other hand maybe in a more imperfect surface of the quantum dots (see chapter 2.5.1). 
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Figure 8: Development of the emission wavelength and quantum yield with time, for TBP and TOP precursors 
In both reactions, the addition of the Zn/S-precursor (after 5 min) leads to a strong increase of 
the quantum yield, which, however, is independent of the emission wavelength. The quantum 
yield increase is caused by the overgrowth of the ZnS shell and the resulting stabilization of 
the CdTe core surface [11]. 
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The composition and the overall yield of the quantum dots synthesized with the two different 
Te-precursors were investigated with ICP-OES. The yield of the synthesis using the TOP 
precursor is 11%. 16% are reached with the TBP precursor. This result supports the 
assumption of different reactivities of the precursors. Concerning the composition of the 
quantum dots, a higher amount of Cd in the shell was achieved applying the TOP precursor 
compared to the TBP precursor, as can be seen in figure 9. All following syntheses were 
performed with both Te-precursors, due to the fact that the TOP precursor results in higher 
quantum yields and the TBP precursor leads to higher emission wavelengths. 
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Figure 9: Composition of quantum dots synthesized with TBP and TOP precursors. 
Effects of Reaction Temperatures 
The influence of the two reaction temperatures used was investigated in the next step. The 
temperature for the core growth was varied between 270°C to 300°C, whereas the temperature 
for the shell growth was phased in a range from 180°C to 230°C. The nucleation heat was 
lowered in order to study the influence on the emission wavelength, which should lower with 
decreasing temperature. The shell growth heat was increased in order to examine the effect on 
the core growth rate, and therefore the quantum yield. This increase was supposed to result in 
a quantum yield increase, due to a bigger shell and thus a better protection of the core. In 
figure 10, the emission wavelengths and quantum yields for the synthesis with TOP and TBP 
Te-precursor at different nucleation and shell growth heats is shown. 
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Figure 10: Influence of the reaction temperatures (nucleation temperature/shell growth temperature) on emission 
wavelength and quantum yield. 
In both cases the variation of the temperatures does not result in the expected dependence of 
the emission wavelength and quantum yield. This effect can be ascribed to the lack of 
sufficient temperature control of the chosen experimental setup and the comparable large 
volumes to be thermostatted. Nevertheless, a better temperature control could not be achieved 
without a complete change of the experimental setup. 
Effects of cadmium precursor 
By the reason that the Te-precursor effects the formation and growth of the nanoparticles 
quite strong, different Cd-precursors were tested as well. For this experiment, elemental Cd 
was reacted with different fatty acids of the same chain length, but increasing amounts of 
double bonds (stearic acid, oleic acid, linoleic acid). The dependence of the emission 
wavelength and quantum yield on the Cd-precursor used is displayed in figure 11. 
With both Te-precursors, the same results for the varying Cd-precursors were achieved. The 
highest emission wavelengths, but lowest quantum yields, are reached with linoleic acid, 
whereas the lowest emission maxima and highest quantum yields are obtained with the use of 
olecic acid as Cd-precursor. 
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Figure 11: Influence of the Cd-precursor on emission wavelength and quantum yield. 
These outcomes suggest that the oleic acid stabilizes the quantum dots during the synthesis to 
a bigger extent than the other fatty acids investigated, whereas the linoleic acid exhibits a 
higher reaction rate.  
Effects of precursor concentration and reaction scale 
The effect of precursor concentration and reaction scale was investigated, since these 
parameters also influence both growth speed and nucleation of the quantum dots.  
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Figure 12: Influence of precursor concentration and reaction scale on emission wavelength and quantum yield. 
As can be seen from figure 12, an increased concentration of the TOP Te-precursor yields an 
increased emission wavelength and quantum yield. Applying the TBP precursor, a maximum 
in the quantum yield is reached at a concentration of 0.076 mmol/L, whereas the emission 
wavelength shows the same dependence as using the TOP precursor. The results of this 
experiment can be explained with the ascending amount of reactable Te in the reaction 
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solution, which increases the reaction speed, and thus resulting in a higher emission 
wavelength. The higher quantum yields may also depend on the Te concentration, because the 
phosphine precursors also act as surface ligands for the nanoparticle, and preferably bind to 
Te atoms at the surface. This results in an enclosed Te shell around the quantum dot, thus 
protecting the CdTe core more efficiently [12]. Accordingly, a bigger amount of Te results in 
a more effective protection of the core. The investigation of the influence of the reaction scale 
clearly indicates, that upscaling results in increased emission wavelength but decreased 
quantum yield for both the TOP and the TBP precursors. This may be, again, founded in the 
experimental setup. By increasing the reaction scale, an inferior mixing, and a worse 
thermostatting are given. Therefore, the reaction conditions in the flask are inhomogeneous, 
resulting in a lowered quality of the synthesized quantum dots. 
Comparison of differently synthesized CdTe/CdZnS Quantum Dots 
The determination of the quantum dot stability against aggregation and of the shape of the 
synthesized quantum dots was carried out with TEM and PCS analysis. For a comparison of 
the different syntheses three conditions for the two Te-precursors were chosen (standard 
conditions, linoleic acid as Cd-precursor, 0.304 mmol/L precursor concentration). In figure 13 
a1-a3, TEM images of different quantum dots using the TOP Te-precursor are displayed. The 
as synthesized quantum dots show spherical shapes and only a low extent of aggregation. In 
figure 13 b1-b3, TEM images of different nanoparticles using the TBP Te-precursor are 
shown. The images of the quantum dots prepared under standard conditions and with linoleic 
acid Cd-precursor show spherically shaped quantum dots, whereas the nanoparticles 
synthesized with 0.304 mmol/L precursor exhibit tetra-pod shape. Nevertheless, the tetrapods 
are not that pronounced as in figure 5, synthesized with silicon grease. This irregular shape 
growth may be due to the high precursor concentration and fast reaction speed of the TBP Te-
precursor. 
In image b2, the aggregation of quantum dots is displayed, observable by the particles 
clustering and lying on top of each other. This finding is supported by the determination of 
the solvodynamic radii of the quantum dots in methylene chloride, where the aggregation 
tendency is even more pronounced as shown in the TEM picture. The calculated and 
measured radii are compared in table 1. The differences between these two values are founded 
in the fact that the calculated radius of the CdTe/CdZnS quantum dots only considers the 
CdTe core. 
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Figure 13: TEM pictures of quantum dots synthesized with TOP (a1)Std. cond., (a2) linoleic acid, (a3) 0.304 
mmol/mL; TBP (b1) Std. Cond., (b2) linoleic acid, (b3) 0.304 mmol/mL 
Furthermore, the measured diameter is a solvodynamic diameter which takes the size of the 
bound ligand shell and the associated methylene chloride molecules into account. Therefore, 
the contribution of the inorganic and the organic shell adds to about 4 nm. 
Table 1: Comparison of the calculated and the measured sizes of quantum dots synthesized under different 
conditions 
 Reaction 
conditions 
Calculated 
radius  
Particle size 
distribution 
Solvatodynanic 
radius 
Polydisperisty 
Index 
Std. cond. 4.11 0.45 12.40 0.12 
Linoleic acid 4.47 0.53 8.70 0.16 
TOP 
0.304 mmol/L 4.22 0.63 8.90 0.3 
Std. cond. 5.82 1.99 12.40 0.13 
Linoleic acid 5.96 1.86 550.00 0.16 
TBP 
0.304 mmol/L 5.96 0.39 341.00 0.13 
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Overall there are no “perfect” reaction conditions for preparation CdTe/CdZnS quantum dots. 
However, there are different variables that enable for the tailoring of quantum dots for 
different applications. The choice of the type of Te-precursor and its respective concentration 
in the reaction solution is a crucial factor. The reaction scale has great influence on the quality 
of the synthesized quantum dots, which unfortunately limits the fabrication of bigger batches. 
In contrast the effect of the Cd-precursor is quite low, and the influence of the temperature 
was not observable in this experiments. Nevertheless, for the TOP precursor, the use of a high 
precursor concentration, low reaction scale and the oleic acid cadmium precursor gives the 
best results. The TBP precursor based synthesis, on the other hand, yields the best particles 
with a comparably low precursor concentration.  
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Coating of Quantum Dots 
The ligand syntheses and coating procedures of the quantum dots aimed to produce water-
soluble, stable, and non-toxic particles. Therefore, different water-soluble ligands and coating 
procedures were applied (see chapter 3.9). The molecules used herein provide a thiol group 
for grafting on the quantum dot surface, an alkyl chain as a spacer and a hydrophilic end 
group or chain to introduce water-solubility. 
4.3. Dihydroliponic acid coated CdTe/CdZnS Quantum Dots 
The dihydroliponic acid coating was performed according to method 3.9.1, using the 
CdTe/CdZnS quantum dots described in chapter 3.7.5. and the ligand synthesized according 
to chapter 3.8.1., The photophysical characteristics shown in figure 14 were recorded after 
phase transfer and purification of the nanoparticles. Nevertheless the absorbance and emission 
spectra are not significantly altered compared to the uncoated quantum dots. The cryo-TEM 
analysis illustrates slightly aggregated quantum dots in aqueous dispersion (figure 14), which 
also correlates with the hydrodynamic diameter of approx. 50 nm measured with PCS.  
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Figure 14: Absorbance and emission spectra of dihydrolipoic acid coated quantum dots; cryo-TEM image of 
dihydrolipoic acid coated quantum dots in water. 
The TEM images and PCS data indicate an aggregation tendency of the coated nanoparticles, 
which can be ascribed to a poor stabilization capability of the dihydrolipoic acid. The single 
carboxy group of this molecule provides not enough hydrophilicity to keep the nanoparticles 
dispersed in aqueous solution. Therefore, a more hydrophilic ligand for the preparation of 
stable, water-soluble quantum dots has to be applied. A molecule group which provides 
 Quantum dots - Results 
 – 85 – 
promising characteristics for the application as coating material are poly(ethyleneglycol) 
mercaptoundecyl ether (see chapter 2.5.2). These molecules are widely used to coat gold 
surfaces and nanoparticles [13,14]. 
4.4. Poly(ethyleneglycol)mercaptoundecylether coated CdTe/CdZnS 
Quantum Dots 
All coating procedures were conducted according to the method described in chapter 3.9.2. 
Three different non-functionalized ligands, namely mercaptouncdecanol (UD), tri(ethylene 
glycol) mercaptoundecyl ether (PEG3), hexa(ethylene glycol) mercaptoundecyl ether (PEG 
6), and two amino-functionalized ligands namely, amino poly(ethylene glycol)750 
mercaptoundecyl ether (PEG750-NH2) and amino poly(ethylene glycol)2000 mercaptoundecyl 
ether (PEG2000-NH2) were used for coating experiments. 
4.4.1. Non functionalized Quantum Dots 
First of all, quantum dots with ligands of varying chain length were produced (see figure 15), 
in order to investigate the influence of hydrophilicity on the photophysical and 
physicochemical characteristics. 
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Figure 15: Ligands of increasing hydrophilicity used for the quantum dot coating 
Upon coating of the quantum dots, all emission spectra exhibit a slight hypsochromic shift of 
the maximum. By replacing of the lipophilic phosphine ligands from synthesis with more 
hydrophilic molecules, the surface of the quantum dot is harmed, resulting in a loss of 
material. In fact, this causes a decrease in quantum dot size, and a smaller emission 
wavelength. This assumption is supported by the observation of the coated quantum dots 
taking about one week to restore their fluorescence (see figure 16). This time is presumably 
needed to “heal” the defects of the surface by dissolution processes [15]. 
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Figure 16: Emission spectra of differently coated CdTe/CdZnS quantum dots; development of fluorescence 
intensity over time after coating of quantum dots. 
Furthermore, the quantum yields of the coated nanoparticles show highly solvent dependent 
quantum yields (see figure 17). Nanoparticles measured in ethanol exhibit a higher 
fluorescence as the respective particles measured in water. The quantum yield appears to be 
dependent on the lipophilicity of the surrounding solvent and, accordingly, on the degree of 
surface shielding achieved by the ligand. The higher the degree of protection is, the higher the 
quantum yields are, and the more hydrophilic the solvent is, the lower the quantum yields are. 
The short mercaptoundecanol ligand protects the surface less good than the molecules with 
the oligo(ethylene glycol) chains. Furthermore, this lipophilic ligand, with only a hydroxyl 
group, is not even able to render the quantum dots soluble in water.  
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Figure 17: quantum yields of differently coated quantum dots in different solvents. 
In figure 18 TEM images of quantum dots coated with the oligo(ehtlyene glycol) ligands in 
water are shown. There is no tendency of aggregation visible, indicated by particles lying in 
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one layer, not clustering. The appearance of quantum dots “sticking” together is an artifact 
caused by the drying process of the sample on the TEM grid. 
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Figure 18: TEM images of oligo(ehtlyene glycol) coated quantum dots. 
The PCS analysis of the particles confirms these results (see figure 19). Whereas the 
oligo(ehtlyene glycol) coated particles display a very small hydrodynamic diameter of under 
10 nm, the mercaptoundecanol functionalized quantum dots exhibit strong aggregation in 
water. The small diameters of the stable nanoparticles are in the same range as the 
solvodynamic diameter of the non coated quantum dots, indicating that the organic shell and 
the associated water molecules sum up to about 4 nm only. 
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Figure 19: Hydrodynamic radii of differently coated quantum dots. 
Therefore, the coating with oligo(ethylene glycol) mercaptoundecyl ethers seem to be likely 
to fabricate small, stable, and luminescent quantum dots. Nevertheless, these quantum dots 
lack the possibility of linking them to other molecules of interest in order to allow for 
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targeting or receptor mediated uptake in cells. To establish a reactive moiety, the introduction 
of amino groups was evident. 
4.4.2. Amino-functionalized Quantum Dots 
The amino groups on the surface were introduced by larger amino functionalized 
poly(ethylene glycol) mercaptoundecyl ether of two different chain lengths (750 : n = 17; 
2000 : n = 45). The longer chain length compared to the non functionalized ligands was 
chosen to assure a good availability of the functional group on top of the particles with mixed 
surface, as shown in figure 20. 
Quantum dot
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Oligo or poly(ethylene glycol) chain
Amino group
 
Figure 20: Schematic drawing of amino-functionalized quantum dot structure 
The coating procedure was the same as for non functionalized ligands. For the “mixed” 
functionalized - non functionalized nanoparticles, hexa(ethylene glycol)mercaptoundeyl ether 
and one of the amine group carrying ligands were mixed in the molar ratios 1:0, 1:3, 2:2, 3:1, 
0:1. Subsequently, the amount of amino groups per quantum dot was determined with the 
adapted fluorescamine assay described in chapter 3.10.6. 
In figure 21, the increasing amount of amino groups per quantum dot is displayed for both 
amine containing ligands. If a part of the added ligands is non-functionalized, only few amino 
groups per nanoparticle can be detected for both types of amine containing ligands. The 
development of the detectable groups per quantum dot is quite similar for both types of 
ligand, whereas the detectable amount for the nanoparticles with mere amino ligands differs 
by the factor 3.3. 
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Figure 21: Detected amino groups per quantum dot with increasing amount of added amino groups. 
These findings can be explained by the affinity of the different ligands to the quantum dot 
surface. It seems that the shorter non functionalized ligands have a higher affinity the 
nanoparticulate surface than the long-chained amino ligands. This may be due to the lower 
hydrophilicity of the shorter ligands. On the other hand, the difference for the two mere amino 
group carrying ligands is founded in a difference in assembling on the surface. The longer the 
chain is, the more space is needed and the less ligands can bind to the dot.  
Therefore, the fabrication of quantum dots with different amounts of available amino groups 
on the surface was successful.  
4.4.3. Cytotoxicological investigation of water-soluble Quantum Dots 
The cytotoxicity of the quantum dots, the mere ligands and free cadmium ions was 
investigated using the MTT assay described in chapter 3.10.7. For the assay, freshly prepared 
dispersions of samples in medium with two different concentrations were used (see table 2). 
The chosen dilutions of the quantum dot samples are based on known cytotoxic 
concentrations of mercaptopropionic acid coated CdTe quantum dots (10µg/mL) and 
uncoated CdTe quantum dots (1µg/mL) [16]. For the ligands, the amount of the coating 
molecules in the corresponding quantum dot sample was used as standard. The cadmium ion 
concentrations conform to the known toxic cadmium amount (400 - 100 µM) [17]. 
Nevertheless, the investigated range of cadmium concentration also covers the theoretical 
amount of cadmium present in the quantum dot samples (100 – 60 µM). The slight variations 
in the quantum dot amounts result from the preparation procedure.  
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Table 2: Concentrations of quantum dot, ligand and cadmium ion samples and their respective cytotoxicity 
Concentration a Cytotoxicity /% Composition of sample 
/µmol/L /µg/mL L929 CHO 
0.29 (64.9) 15.6 (7.29) 98 65 QD@PEG750NH2 
0.03 (6.5) 1.6 (0.73) 81 44 
0.40 (87.7) 21.1 (9.82) 71 36 QD@PEG2000NH2 
0.04 (8.8) 2.1 (0.98) 52 42 
0.48 (105.4) 25.3 (11.80) 86 67 QD@PEG6 
0.05 (10.5) 2.5 (1.18) 54 62 
15.7·103 14.1·103 69 58 
PEG750NH2 
1.6·103 1.5·103 65 73 
5.7·103 12.5·103 86 67 
PEG2000NH2 
570.0 1.3·103 54 62 
8.5·103 5.1·103 100 98 
PEG6 
850.0 500 100 97 
389.0 44.7 82 70 
Cd2+ 
38.9 4.5 23 22 
a
 (corresponding cadmium concentration) 
The investigated quantum dot samples show, as expected, an observable cytotoxicity in the 
investigated concentration ranges (see figure 22). Nevertheless a significant concentration 
effect can be seen upon 1:10 dilution of the samples with the L929 cell line. The analysis of 
the control experiments with ligands and cadmium ions indicate that the bigger part of the 
toxic effect can be ascribed to the coating molecules. Regarding the ligands, the smaller ones 
(hexa(ethylene glycol)mercaptoundecyl ether and amino poly(ethylene 
glycol)750mercaptoundecyl ether) are highly toxic, whereas the longer chained ligand 
(poly(ethylene glycol)2000mercaptoundecyl ether) is less harmful. This is mainly caused by the 
amphiphilic nature of these molecules and the adsorbtion-desorbtion equilibrium of the 
ligands from the quantum dot surface. The significant lower cytotoxicity of the longer amine-
containing ligand may be ascribed to the higher likeliness of these molecules to form 
micelles, due to their longer hydrophilic chain. This also can explain the constant toxicity 
upon dilution of the samples, because the ligands should be non-toxic when bound in 
micelles, nevertheless, always the same amount of free, toxic ligand is present in solution due 
to the critical micellar concentration. 
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Figure 22: Viability two different cell lines under treatment with quantum dots, ligands and cadmium ions; H 
marks the higher, L the lower concentration; * significantly different p < 0.01. 
The investigated cadmium concentrations display middle toxicity and a significant lowering 
upon dilution, implying that the free cadmium concentration in the quantum dot samples, 
which should be even lower, can not cause the observed cytotoxicity. Nevertheless, taking 
into account that the necessary quantum dot concentration for cell experiments covers a range 
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of 10 – 40 nM [18], which is about 103 lower than the concentrations used herein, it can be 
assumed that, within this scope, the investigated quantum dots are not cytotoxic. 
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5.1. Discussion  
For the synthesis of the quantum dots the applied “hot injection” route was chosen due to their 
numerous advantages. It is quite easy to adapt this technique to the different requirements 
fabricating a wide range of different quantum dots. Additionally, these nanoparticles exhibit 
low size dispersity and very good optical properties. On the other hand, there is one big 
handicap, the necessity to detach the lipophilic ligands and replace them by hydrophilic ones 
(see chapter 2.3.2). There are also other possibilities to synthesize quantum dots, like the 
synthesis in aqueous medium, providing the water-dispersability as inherent property of the 
nanoparticles [1,2]. Nevertheless, these strategies have their drawbacks as well. The 
fabrication of quantum dots in aqueous environment needs for example the use of hydrogen 
selenide or telluride, which is highly toxic and difficult to handle. Moreover, it is quite 
challenging to fabricate nanoparticles of low size dispersity and high quantum yields, and 
finally, the need for ligand exchange is also given for these dots. They may be water 
dispersable after synthesis, but to add the required biocompatible and targeting features a 
modification or exchange of the surface ligands is a prerequisite for application in biological 
environment. Summarizing, the synthesis in organic solvents seemed the best possible way 
the reach the goal of water-soluble, long-wavelength emitting, and functionizable quantum 
dots. 
To initially test the quantum dot properties and the adaptability of the synthesis route, the 
“easiest” quantum dot system, cadmium selenide particles, was chosen. These nanoparticles 
with high quantum yields and emission wavelengths up to 600 nm turned out to be the 
optimal system for establishing the synthesis techniques and the respective analytics. 
Moreover, the method for shell growth could be optimized for cadmium selenide/zinc sulfide 
nanoparticles. Nevertheless, CdSe/ZnS quantum dots do not allow to fabricate long-
wavelength emitting particles, exceeding an emission maximum of 635 nm [3]. Therefore, 
applying the improved synthesis setup, the switch to other more complex quantum dot 
systems could be achieved. The cadmium telluride based nanoparticles provide the required 
optical properties, and hence an optimization of this nanoparticulate system was carried out. 
Comparing the different cadmium telluride based systems, blank CdTe, CdTe/CdSe and 
CdTe/CdZnS nanoparticles, the latter offer the most promising characteristics, not only in 
terms of emission wavelength but also in terms of stability against oxidation under ligand 
exchange. The coating of the CdTe particles with a ZnS shell was only possible with 
admixing Cd, to alter the lattice parameters of the shell material to match the lattice 
parameters of the core [4]. This was necessary to achieve a satisfactory shell growth, and 
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therefore an adequate stability and non-toxicity. The reduced toxicity of the stabilized 
quantum dots is based on a protection of the CdTe core from reaction with oxygen, and 
therefore the suppression of reactive oxygen species and the dissolution of the toxic core 
components [5]. Furthermore, the ZnS shell provides a better grafting of the thiol groups 
bound to the water-soluble ligands and hence a better stability of the polymeric shell. The 
reaction parameters of the quantum dot synthesis were investigated to optimize the 
nanoparticles in terms of quantum yield and emission wavelength. Herein, the biggest 
influence on has the tellurium precursor, as well on the emission wavelength as on the 
quantum yield. By only changing this precursor, and keeping all other parameters constant, a 
tuning of the emission wavelength in the range of 50 nm is possible. This big difference in the 
use of the tellurium precursors derives from a considerable discrepancy in the reactivities of 
both investigated types. The tributylphosphine reactant is much more instable, and therefore 
more reactive as the trioctylphosphine based one. This fact can be easily seen in the high 
sensitity of TBP against ambient air oxygen compared to TOP. This difference in reactivity 
leads to a higher reaction speed and therefore to the formation of bigger particles, which, of 
course, gives higher emission wavelengths. The loss of quantum yield with the use of the TBP 
precursor, is, as already mentioned in chapter 4.2.4, based on the longer emission wavelength 
and maybe also the less perfect surface of the dots. This insufficient surface is caused, again, 
by the higher reaction speed. Concerning the other investigated parameters, cadmium 
precursor, precursor concentration and reaction scale, optimal conditions for highly 
luminescent nanoparticles could be found. 
The importance of the ligands used for the exchange, and hence for the water-dispersability, 
was also proved in an experiment with coating molecules of different hydrophilicity. A 
clearly visible trend connecting the quantum yield and the ligand and also the solvent 
hydophilicity could be seen. The more lipophilic the ligands and solvents are, the higher the 
quantum yield is. This is, of course a not very satisfying result, keeping the application of the 
quantum dots in aqueous medium in mind, nevertheless it was an expected one. As already 
mentioned, the quantum dot surface is very susceptible to oxidation and degradation (see 
chapter 1.5.1), and the better this surface is protected by lipophilic ligands, the less oxygen or 
water may diffuse to the surface. The problem with the disintegration of the surface is not 
only a toxicological, but also an optical one. Under oxidation of the surface, defects can arise, 
acting as “traps” for the absorbed energy and opening a non radiative pathway for energy loss 
[6,7]. This mainly affects the quantum yield of the particles, but also can lead to a loss in 
maximum wavelength. A very good example for this purpose is the “recovery time” the 
 Quantum Dots - Discussion 
 – 98 – 
quantum dots need after ligand exchange. Due to the defects arising from ripping off the 
“native” phosphine ligands, the quantum dots loose all luminescence. It takes about one week 
of slow adsorption-desorption and dissolution processes to restore their optical characteristics 
to some degree. Nevertheless, a considerable shift of the emission wavelength can be 
observed. In figure 1 an overview of all synthesized quantum dot species, their stability and 
hydrophilicity is depicted. 
 
Figure 1: Overview of all synthesized quantum dot species, their stability and hydrophilicity. 
To “bolster” the hydrophilic effect on the quantum dots, a ligand architecture with an alkyl 
spacer was chosen. This molecule part can retain a more lipophilic environment around the 
quantum dot surface and therefore provide a better protection. For the hydrophilic part 
poly(ethylene glycol) chains of various length were employed. The poly(ethylene glycol) is 
known for its biocompatible properties, stabilizing nanoparticles very well in biological 
environment and preventing unspecific adsorption of proteins [8]. Moreover, the use of short 
pol(ethylene glycol) ligands gave the possibility to fabricated very small, under 10 nm, stable 
water-dispersable semiconductor particles. To add functionality, and therefore provide the 
possibility to attach targeting molecules, ligands with a terminal amino group were applied. 
The amount of terminal amino groups was adjusted by mixing non-functionalized and 
functionalized ligands together. Moreover, the accessibility of the amino groups was ensured 
by using longer chained amino ligands. Subsequently, the amount of bound amino 
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functionalities, with two different amino ligands, was detected by a modified fluorescamine 
assay. The quantum dots show a strong absorption in the emission range of the reacted 
fluorescamine, and therefore the results can be falsified. Hence, the modification of this assay 
was necessary, to guarantee an accurate and reliable result. To avoid the problem, all samples, 
including the calibration samples, contained the same amount of quantum dots, adjusted by 
their optical density. The obtained results of the amino group amounts indicate that there are 
only three possibilities of polymeric surface composition, (1) no amino groups, (2) about 20 
amino groups per quantum dot and (3) only amino groups on the surface. In the third case the 
overall amount of amino groups depends on the used polymeric ligand. This non-linear 
composition of the functionalized and non-functionalized ligands may be based on the 
different affinities of the ligands towards the surface. The “small” unfunctionalized PEG 
ligand seems to have a higher likeliness to bind to the surface due to its lower hydrophilicity. 
Hence, independent of the added concentration only a small amount of amino ligands can 
attach. The difference in the amount of bound amino ligands with the pure amino surface is 
due to the differing length, resulting in an unequal space demand of both molecules. 
Therefore, applying the “shorter” ligand, a higher amount of amino groups on the surface is 
realizable. 
The tested cytotoxicity of the coated quantum dots is significant. Hence, the experiments 
demonstrated that this toxicity can be mainly ascribed to the coating ligands and not, as 
normally assumed to the cadmium ions. Nevertheless, this toxic effect occurs in a 
concentration range much higher than the normally applied dilutions used for cell tests [9]. 
Therefore, it can be supposed that the quantum dots are not toxic under normal cell culture 
conditions. However, they are certainly not suitable for diagnostic applications. Summarizing, 
the synthesis and functionalization of long wavelength emitting, stable, very small, 
biocompatible quantum dots was successfully achieved. Moreover, a way to adjust the 
amount of functionalizable groups on the surface could have been developed.  
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6.1. Introduction 
For a long time, especially gadolinium ions are widely used as active cores in chelate-based 
MRI contrast agents [1-20]. Moreover, the gadolinium complexes also seem to be adaptive 
for contrast enhancement in CT imaging, due to their heavy metal nature [20-25]. They 
therefore open up the way to alternative detection methods in vivo. In the course of 
developing more potent and non-toxic MRI and CT contrast agents, the step towards 
inorganic nanoparticulate systems is quite short.  
Nevertheless, the research on gadolinium containing inorganic particles was dominated by 
their application as optical materials due to their luminescent properties upon doping with 
different ions. They are called “phosphors” and normally used for trichromatic lamps, cathode 
ray tubes, or color television [26-30]. These phosphors are composed of an inert host lattice 
and an optically excited activator, typically a 3d or 4f electron material. Especially rare earth 
ions are good activators for luminescent materials, and oxide phosphors have recently gained 
much attention not only as optical or electronic materials, but also in the field of molecular 
imaging [31-34]. The unique optical properties are the reason why these nanopartilces have 
significant advantages over common organic dyes and genetically engineered fluorescent 
proteins in many biological and biomedical applications. Compared to organic dyes they offer 
possibilities like multiplexed imaging and long-term investigations, e.g. for cell uptake studies 
and in-vivo imaging [35,31]. They have been investigated as emerging materials for 
fluorescent labeling due to their large stokes´ shift, sharp emission peaks, long luminescence 
lifetime, flexibility of excitation wavelength, suitability for multiphoton excitation, 
luminescence up-conversion excitation and reduced photobleaching [36-40]. In rare earth 
doped nanophosphors, the lanthanide ions´ 4f electronic states are spatially localized to 
dimensions much smaller than the size of the nanoparticles and thus are not affected by the 
nanostructure. Therefore, the wavelength of the rare earth doped nanoparticles is independent 
of the particle size, in contrast to quantum dots, as the Bohr exciton radius in such materials is 
very small [41]. Hence, particles of user-defined size for various applications and size-
independent emission wavelengths can be obtained by controlled doping of lanthanide ions 
into the host material. Therefore, the combination of both research areas and the application 
of doped gadolinium oxide nanoparticles for multimodal imaging was obvious. Moreover, 
these gadolinium oxide nanoparticles open up the way for combined imaging and therapy, due 
to their high neutron capture cross section, making neutron capture therapy possible [42-45]. 
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These luminescent materials in nanosize crystal form have been fabricated by sol-
lyophilization, emulsion, precipitation, combustion, polyol mediated and spray-pyrolytic 
methods. 
6.2. Synthesis of doped Gadolinium Oxide Nanoparticles 
As already mentioned above, the quite contrarian applications of the particles lead to a lot of 
different ways for synthesizing luminescent rare earth oxides. Nevertheless, most of the 
utilized synthesis routes are based on the same principles, as doping is achieved by mixing 
host and activator educts in the respective ratio. Two main techniques can be identified. One 
method originates from the “phosphor” fabrication, where the monodispersity, morphology, 
and surface characteristics of the particles are less important than the luminescent properties. 
High temperature annealing is used as last step, leading to particles in the size range of 60 – 
300 nm. The other method was developed in the imaging research area, where high value is 
set on small size, dispersability in aqueous medium, and monodispersity. These are 
approaches using organic solvents as medium, yielding very small particles from 4 – 30 nm. 
Nevertheless, it has to be considered that the different syntheses methods lead to particles of 
not only different size, but size distribution, morphology, and surface. For that, the synthesis 
method should be chosen with respect to the application, as normally the “polyol” routes are 
utilized to produce ultra small, dispersable particles for imaging and the annealing routes to 
fabricate sub-micron powder “phosphors” for optical devices. However, the imaging 
applications can also benefit from the characteristics of particle syntheses normally used for 
“phosphor” production. 
The majority of the organic solvent mediated syntheses are so called “polyol” routes. 
Herefore, the starting materials are dissolved in a high boiling medium, mostly diethylene 
glycol, followed by an addition of sodium hydroxide and heating to temperatures between 
180-260°C for several hours. Bazzi et al. developed this “polyol” route in 2003 [46], based on 
syntheses for sub-micrometer transition metal particles [47]. They dissolved lanthanide 
chlorides in diethylene glycol at evelated temperatures, added sodium hydroxide in diethylene 
glycolic solution, and stirred the mixture for 4h at 180°C. As a result, sub-5 nm lanthanide 
oxide particles could be detected. During the following years, some changes in the mediator 
used [48], the temperature [49], or the heating device [50] were introduced. However, the 
concept of the polyol route is still the same. Nevertheless, also some other organic solvent 
based routes are applied, using different lanthanide precursors as reactants. One of the 
underlying reaction concepts is the degradation of a fatty acid based precursor in a high 
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boiling solvent, supported by surface-active molecules, in analogy to “hot injection” quantum 
dot syntheses [51]. 
The diversity of annealing-based synthesis routes is much bigger. There are different methods 
of producing gadolinium containing nanoparticles, which are converted to gadolinium oxide 
by means of high temperature annealing (500 – 1300 °C) under oxygen containing 
atmosphere. The two most prominent ways of fabricating the precursor particles are the so 
called “combustion” synthesis and a homogeneous precipitation method. For the combustion 
synthesis rare earth nitrates and a reaction partner, mostly glycine, are mixed in aqueous 
solution, followed by heating the mixture to dryness. After further overheating of the 
precipitate, combustion occurs, yielding a pure fluffy white powder of lanthanide containing 
nanoparticles [52-54]. The homogeneous precipitation synthesis is founded in a reaction of a 
reducing agent, e.g. urea, with rare earth chlorides in boiling water. The emerging 
nanoprecipitate can be separated by centrifugation. In both cases gadolinium oxide carbonate 
is formed [55]. Nevertheless there are also precipitation methods producing gadolinium 
hydroxide precursor particles, as the sol-lyophilisation technique [56]. Another related 
method for the fabrication of rare earth nanoparticles is the spray-pyrolysis or hydrogen flame 
pryolysis technique. It is a more technological way of preparation, where the solution of 
lanthanide nitrates is sprayed via carrier gas jet in a combustion chamber for pyrolysis. 
Afterwards the particles annealed in a high temperature furnace, carried by the combustion 
flow [57,40].  
6.3. Physical and toxicological properties of Gadolinium Oxide Nanoparticles 
Within the lanthanide containing nanoparticles, the doped gadolinium oxide has the most 
versatile properties. It is not only possible to fabricate luminescent nanoparticles, but they 
also exhibit highly MRI active properties. Moreover, the good accordance oft their X-ray 
absorbance edges with common tungsten tube emission make them ideal candidates for CT 
imaging applications. A fascinating characteristic of gadolinium is the high neutron capture 
cross section, giving them great potential for neutron capture therapy, perhaps even exceeding 
those of normally applied boron compounds. 
6.3.1. Optical properties 
The luminescence phenomena described for doped gadolinium oxides or oxyhalides are, as 
already mentioned in chapter 1.1.1, that the transitions involve a change in electronic state or 
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a change in electronic and vibrational states of the system. Furthermore, the luminescence 
emissions originate from point defects, foreign ions substituting normal constituents of the 
crystalline lattice. If these are present in sufficiently low concentrations, the point defects or 
impurity centers can be regarded as independent of each other, as shown in figure 1. It can be 
assumed that the ground and lower excited states of the impurity centers do not enter into 
compositions of the electronic band states of the host lattice. In other words, the energies of 
the relevant vibronic transitions for luminescence in the impurity center are below the 
absorption edge of the host lattice. Normally, the spectra of point defects such as transition 
metal ions or rare earth ions in host lattices can be best described with the crystal field 
approximation. 
host lattice
luminescent center
 
Figure 1: Luminescent centers in a host nanocrystal lattice 
This theory accounts for the symmetry and strength of the crystal field imposed by the 
surrounding ions on the impurity ion energy levels. Nevertheless, lanthanide ions with partly 
filled and screened 4fn orbitals are much less sensitive to the crystal field. Since the crystal 
field effect is so small, the energy levels of the rare earth ions resemble strongly those of the 
free ion [58]. 
This is caused by the electronic structure of the lanthanide ion, consisting, in the most 
common trivalent state, of a regular xenon core and a 4fn shell, which is progressively filled 
through the series. Imperfect shielding of 4fn electrons results in them being drawn inside of 
the 5s25p6 closed shells of the xenon core, leading to the effect known as lanthanide 
contraction. Consequently, such 4fn electrons interact weakly with any external environment, 
and only a small crystalline Stark splitting of 4f levels takes place. As a result, absorption and 
emission spectra of rare earth(III) ions appear as sharp, narrow bands, whose positions are 
barely dependent on the environment or crystal fields. Additionally, the f – f transitions are 
partially forbidden and many of them are spin forbidden, too. Therefore the optical transitions 
are generally very slow. The fine structure of these bands can provide important information 
about the crystallography and position of lanthanide ions in crystal structures [59]. 
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Figure 2: Jablonski diagram with energy transfer pathways of a europium doped gadolinium oxide nanocrystal. 
As an example, figure x displays the typical energy transfers of the lanthanides occurring in a 
europium doped gadolinium oxide or oxyhalide crystal. The excitation of this system is 
dominated by the energy uptake of europium and gadolinium ions in the UV range, completed 
by energy charge transfer from the oxide ions to the lanthanide ions in the VUV region (not 
shown). Additionally, an energy transfer from the gadolinium excited states to the europium 
takes place. Therefore, the absorbance spectra of the nanocrystals are very broad, whereas the 
emission characteristics of these nanocrystals only depend on the 5D0 → 7Fn transfers of 
europium [60,61], resulting in sharp emission lines. The same transfer pathways are given for 
terbium and erbium doped crystals [62,63]. 
6.3.2. MRI and CT active properties 
As already mentioned, the gadolinium oxide nanoparticles provide also alternative 
possibilities of detection. Magnetic resonance imaging has a high spatial resolution; however, 
its use as a tool for the investigation of cellular molecular events in normal and pathological 
processes is hampered by its low sensitivity. Therefore, a relatively large local concentration 
of contrast agent is required to achieve the desired contrast enhancement [64]. The technique 
relies upon the relaxation of water protons depending on the magnetic fields, on the pulse 
sequence, and on the heterogeneous distribution and environment of water in an organism. 
Nowadays, gadolinium complexes are used in MRI examinations of patients, where the 
 Gadolinium Oxide Nanoparticles- Introduction and General Aspects 
 – 107 – 
function of the contrast agent in the human body is to reduce the 1H spin relaxation times of 
water. This is accomplished by the paramagnetic properties of the gadolinium(III) ion, 
stemming from its seven unpaired electrons. The close contact of water with positive contrast 
agents as gadolinium-based ones, is revealed by a brightness which reflects the shortening of 
the longitudinal relaxation time T1 [65]. 
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Figure 3: Structure of [Gd(DTPA)(H2O)]2- (Magnevist ® ) 
These relaxivities depend on the number of bound water molecules. The higher the hydration 
number, the higher are the relaxivities. In commercially available chelate-based contrast 
agents, the hydration number is normally one, as displayed in figure 3. With nanoparticulate 
gadolinium oxide, an enhancement of the positive contrast can be induced [66]. There are two 
possible reasons for that fact. The first is the higher concentration of gadolinium ions at the 
site of interest, and the second is the higher possible hydration number of the gadolinium ions.  
The CT active properties of gadolinium depend, as already mentioned in chapter 1.2.2, on 
their heavy metal nature and the good accordance of their X-ray absorbance with the tungsten 
X-ray tube emission. Herein, the intensity of the filtered energy spectrum for a commonly 
used scanner set, for 100-140 kV, is 50-70 keV. This is actually a better match to gadolinium 
having a K-edge of 50 keV, than to iodine having a K-absorbance-edge of 30 keV [67]. In this 
energy range gadolinium attenuates photons roughly twice as well as iodine. Nevertheless, 
until today the use of gadolinium compounds in CT imaging is limited by the lack of 
concentrating enough of the gadolinium chelate used at the site of interest. Herein, the 
maximal approved gadolinium concentration per kilogram in humans is too low to achieve 
sufficient contrast in deeper tissues [68]. Therefore, the application of nanoparticles with 
higher on-site concentration of lanthanide ions, and additional targeting moieties is a 
promising way to overcome this problem. 
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6.3.3. Neutron capture properties 
Moreover, therapy is also possible with gadolinium containing nanoparticles. The neutron 
capture therapy is a promising radiation therapy for treating cancers. This cancer therapy 
utilizes, in the case of gadolinium, γ-rays and electrons emitted by the 157Gd (n, γ)158Gd 
reaction in order to kill tumor cells, as shown in figure 4. The 157Gd as a neutron capture 
element has some advantages over the 10B, which has been widely used. First, neutron capture 
cross section of 157Gd is 66 times larger than that of 10B. Secondly, the emitted γ-rays have a 
long range (> 100 µm), so that considerable tumor killing effects can be expected even if 
gadolinium is only in the vicinity of cells. Thirdly, emitted Auger electrons may additionally 
lead to an efficient destruction of DNA because of their high linear energy transfer and short 
range [42-45]. 
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Figure 4: Scheme of neutron capture process of 157Gd. 
The prerequisite for Auger emission is a vacant inner shell orbital. Processes other than 
photoionisation, such as electron capture and internal conversion, also result in Auger electron 
cascades. The connection between Auger electrons and 157Gd neutron capture resides in the 
fact that internal conversion is associated with (n,γ) reactions. In particular, the conversion 
electron spectrum of the 157Gd(n, γ)158Gd reaction yields 0.8 conversion electrons per neutron 
capture event. Moreover, the vacancies left by the conversion electrons would be expected to 
result in Auger electron emission [45]. Herein, the higher on-site concentration of gadolinium 
in targeted nanoparticles leads to higher γ-ray and Auger electron emissions, and therefore a 
better therapeutic effect [70]. 
6.3.4. Toxicological properties 
Despite the fact that gadolinium is known as a heavy metal toxin, the intravenous gadolinium 
chelates, approved for human use, have been shown to be remarkably stable and safe 
pharmaceutical agents, due to the high stability and fast clearing of the used complexes in 
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vivo. On the other hand, free gadolinium ions are known to block the reticuloendothelial 
system, and their intravenous administration inhibits the phagocytic activity of Kuppfer cells 
(liver macrophages) [71]. Nevertheless, the full impact of gadolinium toxicity in vivo is not 
completely enlightened. Therefore, the cytotoxic effects of gadolinium nanoparticles were 
investigated by some research groups. They found satisfactory biocompatibility in all tested 
dosages for different cell lines and differently prepared and composed particles, and 
moreover, very low leaking of toxic gadolinium ions over time from the particles [72]. 
However, the toxicity depends not only on the inorganic composition, but also on the size and 
the coating stability of the particles, as for all nanoparticulate species. For a successful 
application of new nanoparticulate contrast agents, detailed toxicological investigations are 
necessary. 
6.4. Coating of Gadolinium Oxide Nanoparticles 
Reduced toxicity, water-solubility, biocompatibility, and the possibility for functionalization 
to enable tissue-specific targeting are requirements to be met by the nanopartilces for in vivo 
imaging application. This can be achieved by the molecular and biomolecular 
functionalization of the particles. However, different approaches have been suggested for such 
modifications. In contrast to quantum dots, very little “tailor-made” coatings are published for 
of rare earth oxides and especially gadolinium oxide. In the majority of the cases common 
coatings for transition metal oxides are employed, whereas the coatings developed for iron 
oxide nanoparticles are of biggest relevance, due to their approved application in in vivo 
imaging [73].  
Nevertheless, different coating methods and grafting groups are utilized for lanthanide oxide 
nanoparticles. The most prominent coating method is embedding of the metal oxide core in a 
silica shell. This inorganic network is yielded by the hydrolysis – condensation of 
tetraethylorthosilicate and aminopropyltriethoxysilane. However, the siloxane coating is 
mostly applied for ultra small nanoparticles fabricated by the above mentioned “polyol 
route”[44-47]. The particles are stabilized with the diethylene glycol, by grafting on the 
surface via the hydroxyl groups [74], as well as by stabilizing the particles in dispersion due 
to the high viscosity of this solvent. This fact saves the often delicate step of redispersion in 
an appropriate medium for functionalization. Furthermore, the silica shell provides the 
possibility of additional modifications. One is the incorporation of organic dyes into the 
matrix, another is the further binding of molecules, targeting ligands, or inert coatings on the 
surface [10]. Nevertheless, silica coating often entails the problem of significant increase in 
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particle size and the limited hydrolytical stability of the shell under physiological conditions 
[75].  
Another method for rendering the particles water-soluble is the coating with acidic groups. 
Here, the carboxylic and phosphonic acid functinalities are the best investigated grafting 
groups, giving rise to a variety of different surface coatings. These groups graft on the 
nanocrystals via bridging binding modes, as displayed in figure 5  
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Figure 5: Binding of carboxylic acid and phosphonic acid on the nanocrystal surface. 
The adsorbed molecules result in additional steric or electrostatic stabilization of the 
nanoparticles in aqueous medium. Some of the well known molecules applied for the 
solubilization of metal oxide particles are citric acid and poly(acrylic acid) [76,77]. These 
polyfunctional molecules (three carboxylic acids for citric acid and one per monomer for 
poly(acrylic acid)) form chelate complexes with the surface of the nanocrystals. However, in 
many examples it is not sufficient to simply add the dispersant. The redispersion is ensured by 
mechanical methods such as shear and high-energy ultrasound [78,79]. 
Table 1: Carboxylic acid containing ligands for coating of lanthanide oxide nanopaticles 
Ligand Structure  Reference  
Citric acid 
OH OH
O OOH
O OH
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Poly(acrylic acid) 
*
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Furthermore, poly(ethylene glycol) modified poly(acrylic acid)s were employed for surface 
functionalization, giving a better stability over a broad pH range, preventing of undesirable 
protein adsorption on the surface and reducing of cross-sensitivty to salt containing solutions 
[80]. In table 1, examples of carboxylic acid containing ligands are displayed. 
Alternatively to the carboxylic acid ligands used, also phosphonic acids are employed in 
many industrial applications as for corrosion inhibition or prevention of calcinations [81-83], 
due to their strong chelation properties. They react with a wide range of alkali and transition 
metals to form metal phosphonates. However, this grafting group binds strongly to different 
metal oxide surfaces, as zirconium oxide, yttrium oxide, or cerium oxide, forming strong M – 
O – P bonds. By the choice of the attached organic part of the phosphonic acid, the 
hydrophilic characteristics of the resulting coating can be controlled. The bonding occurs at 
room temperature, yielding a stable ligand film on the surface, without formation of 
phosphonate salts. This surface modification also can be easily be performed in water, due to 
the extraordinary high stability of the phosphonic acid – metal bond [84]. Another possible 
functionalization is, again, the use of poly(ethylene glycol) terminated phosphonates, adding 
some biological stealth properties and steric stabilization to the metal oxide nanoparticles 
[85,86]. In table 2, examples of carboxylic acid containing ligands are displayed. 
Table 2: Phosphonic acid containing ligands for coating of lanthanide oxide nanoparticles 
Ligand Structure  Reference 
Phenylphosphonate 
P
OH
OH
O
 
[84] 
Poly(ethylene glycol) 
phosphonate 
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P O
O
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n
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6.5. Applications of Gadolinium Oxide Nanoparticles and conclusion 
The small size of luminescent inorganic nanoparticles allows for replacing fluorescent 
molecules or complexes in analytical applications. Doped gadolinium oxide nanoparticles 
have the advantage of large Stokes´ shifts, narrow emission spectra, and long luminescence 
lifetimes. Furthermore, they do not undergo photobleaching and show no “blinking”, as for 
example single quantum dots, due to the fact that each particle contains a lot of luminescent 
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centers and is protected by the host lattice and a coating layer. In contrast to semiconductor 
quantum dots, their emission wavelength is independent of the particle size, and therefore, 
monodispersity is less crucial for a successful application, leading to lower costs in synthesis. 
Moreover, their optical properties are not much influenced by the surface coating used and 
can be tuned by controlled doping of lanthanide ions into the host material. Another 
advantage over, for example lanthanide complexes, is the reduced luminescence quenching by 
water, which normally does not acess the fluorescent centers in the crystal.  
There are two fast evolving biological areas these particles are applied in. One is the 
development of fluorescent assays, because multiplexed techniques are essential to satisfy the 
growing demands of many fields in bioanalytics, including immunology, drug screening, 
disease diagnosis, and defense against biological threats. The ability to simultaneously 
measure multiple proteins in a single assay offers several advantages, such as higher 
throughput than single-target systems. Nevertheless, multicolor detection and analysis is often 
obstructed by high background signals, the requirement of complicated excitation and/or 
detection schemes, and challenging data collection and analysis [87,88]. Therefore, doped and 
functionalized gadolinium oxide nanoparticles seem to be ideal for these applications. For 
example, particles with double luminescence, i.e. a terbium doped gadolinium oxide core with 
a fluorescein functionalized siloxane shell for biological labeling was designed [10]. 
Moreover, immunoassays detecting phenoxybenzoic acid [89] or particles coated with IgG 
proteins for detection and visualization of antibodies patterned by microcontact printing [90] 
were developed. Another possibility to enhance the detection is the functionalization of the 
nanoparticles with a sensitizing dye molecule for a DNA assay [91]. As well, magnetic 
particles with a shell of europium doped gadolinium oxide were produced to benefit from 
both advantages (the luminescence and the magnetic properties) to detect DNA or IgG 
[92,93].  
The second research area is the mono- or bi-modal in vivo imaging, utilizing the outstanding 
luminescent properties as well as the MRI activity of these particles. During the last few 
decades, MR imaging has become a well-established technique for clinical diagnosis. Today 
there are mainly two contrast agents used in MRI: superparamagnetic iron oxide particles 
(SPIOs) and paramagnetic chelates. However, gadolinium chelates have low relaxivity 
compared to what is theoretically possible, and SPIOs usually generate negative contrast, both 
leading to a loss of signal. Therefore, a particulate agent that generates positive contrast and 
enhanced relaxivity could be an important complement to the existing contrast agents. A 
combination of several detection techniques, provided by the application of bimodal 
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particulate agents ensures a better reliability of the recived data. As a result, benefits can be 
expected for small animal in vivo imaging which is a prerequisite step for clinical application 
but also a very useful tool for biomedical investigation. 
Therefore a range of ultra small (< 5 nm) gadolinium oxide nanoparticles for MRI contrast 
enhancement were developed. Most of these particles, synthesized via the “polyol route” are 
coated with diethylene glycol [8]. Nevertheless, also apoferritin-encapsulated particles [94] 
and nanocrystals with glucoronic or lactobionic acid coating [7] were fabricated. All of these 
particles showed improved relaxivities compared to common gadolinium chelates. For 
bimodal detection in vivo, gadolinium oxide nanoparticles doped with terbium and coated 
with a poly(ethylene glycol) functionalized, dye-labelled siloxane layer were designed. It 
could be shown that these particles exhibit very good relaxivities and fluorescence properties 
in mice and rats [95]. 
A further utilization of the various properties of gadolinium containing nanoparticles is the 
combination of imaging and therapy. The potential of gadolinium neutron capture therapy has 
been suggested in recent years. However, the in vivo performance of commercially available 
gadolinium chelates is not satisfying yet, because they are eliminated rapidly from tumor 
tissues, even if intra tumor injected. This may probably be due to their high hydrophilicity, 
resulting in poor accumulation and retention in tumor. Thus, one of the keys for success in 
gadolinium mediated neutron capture therapy is to develop a device, which is able to maintain 
a sufficient gadolinium concentration in the tumor during treatment [70]. The number of 
gadolinium ions per nanoparticle is relatively high. As a result, the accumulation of these 
particles in cancerous cells is expected to have great potential for therapy. Moreover, these 
particles can combine fluorescence imaging, magnetic resonance imaging and therapy in one 
device. It was shown that the treatment of EL4 cells with the (above mentioned) doped 
gadolinium oxide nanoparticles coated with a poly(ethylene glycol) functionalized dye doped 
siloxane shell, generates a significant cytotoxic effect and leads to cell death [96]. 
Summarizing, doped gadolinium oxide nanoparticles exhibit great potential in various 
biological, analytical and medical applications and can, due to their various orthogonal 
properties, overcome many obstacles of other nanoparticlulate systems. 
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Materials 
7.1. Particles synthesis 
The gadolinium chloride hexahydrate (+99.9%), gadolinium nitrate hydrate (+99.9%), erbium 
chloride hexahydrate (+99.9%), terbium chloride hexahydrate (+99.9%), europium chloride 
hexahydrate (+99.9%), diethlyene glycol (ultra), (3-aminopropyl)triethoxysilane (98%), 
triethylamine (p.a.), polyacrylic acid sodium salt, etidronic acid (purum), was obtained from 
Sigma-Aldrich (Sigma-Aldrich Chemie GmbH, Munich, Germany). The hexa(ethylene 
glycol) bisphosphonate was synthesized by Surfactis Technologies (Surfactis Technologies 
SAS, Angers, France). Sodium hydroxide (p.a.), dimethlysulfoxide (p.a), citric acid (p.a.), 
glycin (p.a.) and urea (p.a.) were provided from Merck (Merck KGaA, Darmstadt, Germany). 
7.2. Cytotoxicity test 
Fetal Bovine Serum (FBS) was purchased from Biochrom (Biochrom KG, Berlin, Germany), 
0.25% Trypsin-EDTA was obtained from Invitrogen (Invitrogen GmbH, Karlsruhe, 
Germany). 3-[4,5-Dimethylthiazol-2-yl]-2,5- diphenyltetrazolium bromide (MTT) was 
purchased from AppliChem (AppliChem GmbH, Darmstadt, Germany). Dulbecco´s modified 
Eagle´s medium (EMEM) and nutrient mixture F-12 HAM were obtained from Sigma-
Aldrich (Sigma-Aldrich Chemie GmbH, Munich, Germany). Titriplex® III 
(ethylendinitrilotetraacetic acid disodium salt dihydrate) (p.a.) was obtained from Merck 
(Merck KGaA, Darmstadt, Germany). 
Methods 
7.3. DEG-mediated Synthesis of Gadolinium Oxide particles 
7.3.1. Synthesis of sub-10 nm Gadolinium Oxide particles 
For the synthesis of sub-5 nm gadolinium oxide particles, 2.0 mmol gadolinium chloride (741 
mg, 1eq) was heated up to 60 °C in 10 mL diethylene glycol for half a hour, subsequently, the 
mixture was heated to 140 °C and held for one hour, until all gadolinium salt has dissolved. 
Then 500 µL of 3 N sodium hydroxide solution (1.5 mmol, 0.75eq) was added, and the 
reaction temperature was raised to 180 °C and held for 4 hours (see figure 1). The clear 
solution was cooled to room temperature and dialysed 3 days against diethylene glycol for 
purification [1]. 
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GdCl3*6H2O + NaOH
DEG
 
Figure 1: Reaction scheme of sub-10 nm gadolinium oxide nanoparticle formation. 
7.3.2. Coating of sub-10nm Gadolinium Oxide particles with Silica 
The gadolinium oxide particles synthesized according 2.1.1 were coated with a silica shell 
using silicate precursor for encapsulation. First, 0.075 mmol (3-aminopropyl)triethoxysilane 
(17.5 mL) were mixed with 500 µL dimethlysulfoxide, 2.5 mL of the purified 
gadoliniumoxide dispersion and 7.5 mL diethylene glycol, and stirred for 20 min at 40 °C. 
Afterwards, 4.5 µL 0.1 M triethylamine solution (0.45 mmol) were added and the reaction 
was stirred for one hour. Thereafter, 0.38 mmol (3-aminoproply)triethylsilane (88.5 µL) and 
0.3 mmol tetraethyl orthosilicate (66.8 µL) were mixed with the dispersion and all was stirred 
again for 1 hour °C. At last, 2.3 mmol water were added and the reaction mixture was stirred 
for 48 hours (see figure 2) [2].  
a) APTES, DMSO, DEG
b) TEA 0.1 N
c) APTES, TEOS
d) H2O
 
Figure 2: Reaction scheme of silica coating of sub-10 nm gadolinium oxide nanoparticles. 
The purification was archived via three days dialysis against diethylene glycol followed by 3 
days dialysis against water. 
7.3.3. Synthesis and coating of Gadolinium Oxide Nanoparticles 
The gadoliunium hydroxide particles were prepared via a synthesis route related to the sub-
5nm gadolinium oxide particles. For this synthesis 1.0 mmol gadolinium chloride (371 mg, 
1eq) was dissolved in 15 mL diethylene glycol by heating up the dispersion to 160 °C for 10 
min. Subsequently, 500 µL of a 3 N sodiumhydroxide solution (1.5 mmol, 1.5eq) was added, 
the temperature of the reaction mixture was raised to 210 °C and held for half an hour. At the 
same time, the ligand for particle coating was dissolved. For citric acid were 1.0 mmol (211 
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mg, 1eq), for polyacrylic acid 0.025 mmol (Mw=2000, 500mg, 0.025eq) and for hexa(ethylene 
glycol) bisphosphonate 0.5 mmol (386mg, 0.5eq) dissolved in 5 mL diethylene glycol and 
500 µL 3N sodium hydroxide solution (1.5 mmol, 1.5 eq); etidronic acid (1.0 mmol, 224 mg, 
1eq) was dissolved in 500 µL 3N sodium hydroxide solution (1.5 mmol, 1.5 eq). The 
respective ligand solution was added to the particle dispersion at 210 °C and the reaction 
mixture was cooled to room temperature (see figure 3) [3]. 
GdCl3*6H2O + NaOH
DEG
P RO
O
O
ROH
O
GdCl3*6H2O + NaOH
DEG RO
O
P
OH
O
OH
P
OH
O
OH
R
 
Figure 3: Reaction scheme of gadolinium oxide nanoparticle formation and subsequent coating with carboxylic 
and phosphonic acid derivatives. 
For purification of the particles, methanol was added to the reaction mixture for precipitation 
of the gadolinium hydroxide particles. Subsequently, the particles were centrifuged (8000 g, 
10 min, 18 °C) and the supernatant was removed. The particles were again dispersed in 
methanol, centrifuged (12000 g, 15 min, 18 °C) and the supernatant was removed. At last, the 
particles were dispersed in water or buffer solution. 
After the purification of the particles, the aqueous dispersion was high pressure homogenizied 
with a Gaulin High Pressure Homogenizer three times at 1000 bar. 
7.4. Synthesis of doped Gadolinium Oxide Nanoparticles  
The doping of the particles was obtained by replacement of a given percentage of the 
gadolinium salt with either erbium chloride, terbium chloride or europium chloride. This 
results in different emission colors of the gadolinium oxide nanopaticles. 
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7.4.1. Combustion synthesis 
The gadolinium oxide nanoparticles were synthesized via an ignition of the educts. 1.0 mmol 
gadolinium nitrate (451 mg, 1eq) and 1.0 mmol glycin (75 mg, 1eq) were dissolved in 10 mL 
of water. Afterwards, the water was evaporated under heat until a solid precipitate results, this 
precipitate was heated up further until combustion. The so obtained nanopaticles were 
collected and put in a muffle furnace at 450 °C for 4 h (see figure 4). No further purification 
was needed [4-6].  
Gd(NO3)3*6H2O + O
OH
NH2 ignition annealing 450°C
N2, CO2, H2O ↑
 
Figure 4: Reaction scheme of combustion synthesis. 
7.4.2. Precipitation synthesis 
For the synthesis of gadolinium oxide nanoparticles via the precipitation method, 1.0 mmol 
gadolinium chloride (371 mg, 1eq) and 1.0 mmol urea (61 mg, 1eq) were dissolved in 40 mL 
of water. This solution was refluxed for one hour, resulting in a nanoprecipitaion of 
gadolinium oxide.  
GdCl3*6H2O + 
annealing
NH 2NH 2
O
+H2O
∆T
Gd3+ + Cl- +NH3 + CO2
precipitation
 
Figure 5: Reaction scheme of precipitation synthesis. 
The precipitate was collected via centrifugation (15000 g, 30 min, 18 °C), and heated up in a 
muffle furnace to dedicated temperatures (450 °C for undoped, 200 °C for terbium doped, 700 
°C for erbium and europium doped particles) (see figure 5). The obtained nanoparticulate 
powder needed no further purification [7]. 
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7.4.3. Coating of particles 
The particles obtained via the synthesis in 2.2.2 can be coated with hexa(ethylene glycol) 
bisphosphonate utilizing a procedure related with the nanoparticles synthesis in 7.2.3. 1.0 
mmol of the nanoparticulate powder (362 mg, 1eq) was dispersed in 20 mL diethylene glycol 
and heated up to 210 °C, subsequently, a solution containing 0.75 mmol hexa(ethylene glycol) 
bisphosphonate (363 mg, 0.75eq) in 5 mL diethylene glycol was added. The dispersion was 
cooled to room temperature and purified. 
+
P
OH
O OH
P
OH
O OH
O O O O
O O O
P
O
OO
P
O
O
O O
O 6
H2O ∆T
 
Figure 6: Reaction scheme of gadolinium oxide coating. 
For the purification the nanoparicles were precipitated with methanol and centrifuged (15000 
g, 10 min, 18 °C), the supernatant was removed and the procedure was repeated once. Then, 
the purified particles were dispersed in water (see figure 6). 
7.5. Analysis of particles 
7.5.1. Spectroscopic analysis 
The absorbance spectra of the gadolinium oxide particles were measured with a UVIKON 
941 two-beam spectrophotometer (Kontron Instruments). The excitation and emission spectra 
were measured with a Perkin-Elmer LS 55 (Perkin-Elmer) equipped with a R928 red-sensitive 
photomultiplier and the FL WinLab V4.00.03 software. For all measurements in aqueous 
solution 1 cm quartz cuvettes were used, for measurements of powders a self-made specimen 
holder for powders with a quartz pane was applied. 
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7.5.2. Size and zeta potential analysis with PCS 
The hydrodynamic diameter and the zeta potential of the particles were measured with a 
ZetaSizer 3000 A (Malvern Insruments Inc.) photon correlation spectrometer (PCS). Purified 
water or buffer was used as solvent for the nanaoparticles. Furthermore, all samples were 
filtrated through a 1.0 µm glass fiber syringe filter. All measurements were carried out at 20 
°C. 
7.5.3. Morphological analysis with TEM 
For the morphological analysis a Zeiss EM 10 C/CR (Carl Zeiss AG) transmission electron 
microscope (TEM) with 60 kV operating voltage was used. The samples were prepared on 
3.05 mm formvar/carbon coated copper grids (300 mesh). The water-soluble particles were 
spreaded on the grids and dried using a vacuum pump. 
7.5.4. Determination of gadolinium content 
The samples for the gadolinium content determination were prepared by dissolving a 
dispersion of gadolinium nanopartilces in 0.5 µL concentrated nitric acid and diluting was up 
to 10 mL in a volumetic flask. 
The content of the samples containing no bisphosphonate contamination were determined 
with a Jobin Yvon 70 P (S+S) (Horiba Yovin Ivon GmbH) inductively coupled plasma optical 
emission spectrometer (ICP-OES) in a sequential analysis mode. The standard stock solution 
was composed of 1000 ppm gadolinium chloride in 3% nitric acid. 
The samples containing bisphosphonates were analyzed by ICP-MS according to DIN EN 
ISO 17294-2 (E29) (UST) at the Umweltanalytische Labor Dr. Mehrer. 
7.5.5. Analysis of crystal structure with P-XRD 
The crystal structure analysis was achieved by powder x-ray diffraction of the dry, grinded 
samples in a flat specimen holder. The measurement was carried out on a Stadip STOE 
powder diffractometer with Cu Kα radiation (λ = 1.54056 Å) and a germanium 
monochomator. The samples were analyzed in a transmission geometry and a PS detector. 
The data were evaluated with the WinXPow 1.08 software. 
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7.5.6. Determination of radio-opaqueness with CT Imaging 
For the determination of the radio-opaqueness of the gadolinium oxide nanoparticles a 1.5 T 
Siemens Sensation 16 CT scanner (Siemens AG) computer tomograph (CT) was used. The 
data was evaluated with the SIENET sky software. The gadolinium oxide samples were 
prepared by dispersing coated or uncoated gadolinium oxide nanoparticles in water. The 
dispersions were transferred to 2 mL eppendorf cups and put into a cryo box. This cryo box 
was then placed in the computer tomtograph and the data were recorded. The evaluation of 
the CT images was done with the SINET Sky – DICOM CD-viewer and all HU values were 
calculated as average of HU values of 10 different layers throughout the whole cup. 
7.5.7. Cytotoxicity test 
The used cell lines for the cytotoxicity test were L929 and CHO cells. The L929 cells were 
grown in T-75 cell culture flasks containing 20 mL EMEM supplemented with 10% FBS. The 
CHO cells were grown in T-75 cell culture flasks containing 20 mL of HAM supplemented 
with 10% FBS. Both cell lines were cultured at standard cell culture conditions (37°C, 95%) 
relative humidity, and 5% CO2. The growth medium was changed every third day. The cells 
were harvested at 90% confluence by exposure to a 0.25% trypsin-EDTA solution (3 
mL/flask) and resuspended at a densitity of 50000 cells/mL for the MTT assay.  
This colorimetric assay was based on the conversion of yellow, water-soluble MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] by the mitochondrial 
dehydrogenases of viable cells, to the purple, water insoluble, end-product formazan. 
N N
N
+N
N
S
Br
N
N N
H
N
N
S
 
Figure 7: Reaction scheme of MTT to MTT formazan. 
All MTT assays were carried out in 96-well plates. The cells were seeded at a density of 
10,000 cells/well and solution of MTT was prepared by dissolving 2.5 MTT/mL in sterile 
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PBS. The L929 cells were grown for 24 h in 200 µL EMEM supplemented with 10% FBS at 
standard cell culture conditions; the CHO cells were grown for 24 h in 200 µL HAM 
supplemented with 10% FBS at standard cell culture conditions. 200 µL of nanoparticle 
dispersions of different concentrations in the respective medium containing 10% FBS were 
added to the cells and incubated for 4h at standard cell culture conditions. After incubation the 
nanoparticles were removed and the cells were washed with 200 µL sterile PBS. The MTT 
stock solution was diluted to a concentration of 0.625 mg/mL with the according medium, 
added to the cells and incubated for 4 h at standard cell culture conditions. Afterwards, the 
MTT solution was removed carefully and finally, 200 µL of 10% SDS in PBS were added to 
each well for further 24 h [8-10]. The absorbance of each well was determined on a 
TitertekPlus Microplate Reader (Friedrich S. Bartolomey) with 550 nm as test wavelength 
and 630 nm as reference wavelength. 
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Synthesis of Gadolinium Oxide Nanoparticles 
8.1. DEG mediated synthesis of Gadolinium Oxide Nanoparticles 
As already mentioned in chapter 6.2, the “polyol” route is a very comfortable way for 
synthesizing ultra small, dispersable nanoparticles. Nevertheless, it also can yield particles of 
bigger sizes, depending on the chosen reaction parameters. Herein, nanocrystals with two 
different were synthesized and differently coated.  
8.1.1. Synthesis and coating of sub-10 nm Gadolinium Oxide particles  
Particles of about 10 nm diameter were produced adding a sub-stoichiometric amount of 
sodium hydroxide to the dissolved gadolinium chloride in diethylene glycol. The resulting 
reaction mixture was heated for 4 h to 180°C to achieve particle formation as described in 
chapter 7.3.1. In figure 1 the results of PCS and TEM analysis are shown. The measured 
solvatodynamic diameter of the nanoparticles in diethylene glycol is about 10 nm, which is in 
good accordance to the TEM results. 
 
Figure 1: PCS measurement and TEM image of Gd2O3 nanoparticles after synthesis in diehtylene glycol 
Nevertheless, the nanocrystals obtained are still dispersed in diethylene glycol, always 
causing problems with size measurement due to the high viscosity of the solvent. 
Furthermore, the bare gadolinium oxide nanoparticles are not dispersable in aqueous medium 
without subsequent aggregation and degradation. To render the particles water soluble, a 
coating with a stable, protecting, and hydrophilic shell is mandatory. A very common way of 
stabilizing nanoparticles is the incorporation into an additional silica shell. This silica shell is 
grown on the surface of the particles in a Stöber-like process [1], using the gadolinium oxide 
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nanoparticles as condensation nuclei. In figure 2 the PCS and TEM picture of as synthesized 
silica coated gadolinium oxide nanoparticles are displayed.  
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Figure 2: PCS measurement and TEM image of Gd2O3 nanoparticles in a silica shell 
The core/shell gadolinium oxide/silica particles have an overall hydrodynamic diameter of 
about 50 nm, which is also visible in the TEM images. Nevertheless, more than one 
gadolinium oxide particle seems to be incorporated in the silica shell. Furthermore, not all 
nanocrystals are embedded and a lot of bare silica particles were formed, causing problems 
with sufficient purification of the particle dispersions. As a result of these purification 
problems, a thixotropic gel was formed after transferring the particles into aqueous solution, 
indicating a swelling of the silica shells and consequently an incomplete separation of the bare 
silica particles [2]. Therefore, another variation of the “polyol” route with an integrated 
coating step was performed, yielding “bigger” particles. Additionally, other coating 
possibilities were also investigated, to avoid the problems with the silica shell. Therefore, four 
different ligands with either carboxy- or phosphonic acid groups were chosen [3-7]. 
8.1.2. Synthesis and coating of Gadolinium Oxide Nanoparticles 
The synthesis of “bigger” (~ 50-80 nm) gadolinium oxide nanoparticles was achieved by 
adding a higher amount of sodium hydroxide to the reaction mixture. Furthermore, the 
temperature was raised to 210°C for the reaction of the starting materials, as described in 
chapter 7.3.3. The formed particles can be coated in the same reaction vessel by only adding 
the dissolved ligand solution to the hot reaction mixture.  
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Influencing the size of coated Gadolinium Oxide particles 
In figure 3 a TEM image of the obtained non-coated gadolinium oxide nanoparticles is 
displayed. The particles are in the size range between 20 and 80 nm with an almost spherical 
morphology. Nevertheless, an agglomeration of the particles is observable upon coating. 
Therefore, an additional high pressure homogenization step was necessary in order to destroy 
the particle aggregates and achieve a homogenous particle distribution. The working principle 
of high pressure homogenization is the destruction of aggregates by pressing particles with 
high pressure in a dispersion medium through a tight nozzle [8]. Due to the construction of 
the opening cavitation can occur, which breaks up the aggregates. This homogenization 
principle depends on the viscosity and boiling point of the solvent. The higher the boiling 
point of the solvent is, the higher the applied pressure has to be. Hence, the particle 
aggregates, which are held together by electrostatic and steric interactions of the ligands, 
should be destroyed. Nevertheless, the gadolinium oxide nanoparticles itself are not broken up 
due to their high solidity. 
 
Figure 3: TEM image of uncoated Gd2O3 nanoparticles 
In figure 4 three diagrams are displayed, showing the development of differently 
homogenized particle dispersions with repeated treatment. The influence of homogenization 
pressure and solvents were tested. The first diagram illustrates the particle development in 
diethylene glycol as solvent with a homogenization pressure of 500 bar. In this experiment, 
the unpurified particle dispersion after synthesis was used. However, it is obvious that 
homogenization in this solvent is not appropriate, maybe due to the high viscosity and boiling 
point, making cavitation impossible. The aggregate destruction in water was achieved after 
purification of the samples. Herein, pressures of 500 and 1000 bar were used. The diagrams 
visualize the good homogenization of etidronic acid, PEG-bisphosphonate and poly(acrylic 
acid) coated particles with both pressures. A lowering of the hydrodynamic diameters with 
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repeated homogenization steps is observable and all finally obtained diameters of the particles 
are below 200 nm. Moreover, the polydispersity indices of these homogenized particle 
dispersions drop with on going processing. For the etidronic acid coated particles they are 
below 0.1, indicating monodispersity. On the other hand, the citric acid coated particles show 
strong flocculation after homogenization. Breaking up the aggregates may influence their 
surface charge disadvantageously. However, no reasonable hydrodynamic diameters could be 
measured due to the obtained strong aggregation and sedimentation of the particles after 
homogenization. Therefore, high pressure homogenization in water was not suitable for citric 
acid coated particles. 
0
200
400
600
800
Etidronic
acid
Citric
acid
Poly(acylic acid)PEG-
Bisphosphonate
Si
ze
 
/n
m
* *
* PI 1,00
0,0
0,2
0,4
0,6
0,8
1,0
P
olydisp
e
rsitiy
 ind
e
x
Diethylene glycol, 500 bar 
0
100
200
300
Etidronic
acid
Citric
acid
Poly(acylic acid)PEG-
Bisphosphonate
Si
ze
 
/n
m
* PI 1,00
0,0
0,2
0,4
0,6
0,8
1,0
* *
P
olydisp
e
rsitiy
 inde
x
*
Water, 500 bar 
0
100
200
300
*
Etidronic
acid
Citric
acid
Poly(acylic acid)PEG-
Bisphosphonate
Si
ze
 
/n
m
**
* PI 1,00
0,0
0,2
0,4
0,6
0,8
1,0
P
olydisp
e
rsitiy
 ind
e
x
 
Water, 1000 bar 
Figure 4: Influence of pressure (500, 1000 bar) and dispersant (dethylene glycol, water) during high pressure 
homogenization of differently coated Gd2O3 nanopartilces. 
The TEM images of the nanoparticles coated with all four ligands, respectively, are displayed 
in figure 5. The coated crystals demonstrate a slightly rough surface compared to the non-
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coated particles, indicating the presence of the ligands on the surface. Moreover, the 
diameters of the different coated particles visible in TEM show differences in size, maybe due 
to the different amount of dry ligand or adhering salts on the surface. The etidronic acid 
coated particles are the smallest, whereas those coated with the poly(acrylic acid) are the 
biggest in size. The particles functionalized with etidronic acid, poly(acrylic acid), and citric 
acid are not aggregated in contrast to the PEG-bisphosphonate coated particles. Nevertheless, 
an already mentioned problem with the preparation of TEM specimen is the drying of the 
samples on the TEM grid. This can lead to the formation of artifacts or “drying aggregates” 
and a distinction between “real” aggregates and aggregates caused by drying can not easily be 
done. Considering the PCS analysis of the PEG-bisphosphonate particles, no aggregation was 
detectable. Therefore, the formation of these aggregates due to the drying process is very 
likely.  
250 nm 250 nm250 nm 250 nm
 
Figure 5: TEM images of coated Gd2O3 nanoparticles with etridronic acid, PEG-bisphosphonate, Poly(acrylic 
acid) and citric acid (left to right). 
Another striking disagreement is the visible size in TEM and the according PCS 
hydrodynamic diameters as shown in table 1. The TEM sizes appear to be only half as large 
as the hydrodynamic diameters obtained by PCS. This is on the one hand, due to the hydration 
of the ligand corona in aqueous environment, which is, of course, not visible in the dried 
TEM samples.  
Nevertheless, the hydrodynamic diameters should not be twice as high. It is also possible that 
the results of PCS analysis affected by a systematic error due to the strongly pronounced core-
shell nature of the produced particles. The “soft” hydrated ligand shell has a considerable 
different refractive index than the “dense” particle core, and therefore an imprecise 
measurement and an inherent bias can be caused by the nature of the particles. 
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Table 1: Comparision of hydrodynamic diameters and TEM determined size 
Sample Hydrodynamic diameter 
/nm 
Polydispersity index Diamenter by TEM 
/nm 
Gd2O3@ES 126 nm 0,171 ~ 60 
Gd2O3@Bp-PEG 175 nm 0,194 visible agglomerates 
Gd2O3@PA 172 nm 0,292 ~90 
Gd2O3@CA 274 nm 0,238 ~80 
 
However, the error always should be the same for the differently coated particles and their 
aggregates, and hence the PCS results can still be used as an indicator for size estimation and 
aggregation during the preparation and processing of the particles. 
Testing the particle stability after drying in different media 
For the application of these particles as CT contrast agents, the preparation of stable, 
superposable powders is necessary, allowing redispersion right before application. Therefore, 
the particle stability concerning irreversible aggregation after drying in different media and 
the subsequent redispersability was examined. First of all, an experiment on the drying 
behavior was performed, as shown in figure 6.  
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Figure 6: Influence of different drying methods in two dispersants on the aggregation of coated Gd2O3 
nanoparticles. 
Herefore, the hydrodynamic diameter of differently coated particles before and after drying 
was recorded. The drying was performed from water or methanol, which is used during the 
purification step. Moreover, vacuum drying and freeze drying were contrasted with each 
other. To summarize the most appropriate method for all coated particles, the freeze drying in 
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water provides the best results. Freeze drying seems to be the only suitable alternative for 
citric acid, due to the strong aggregation after vacuum dying for all samples. The other kinds 
of particles show no overall tendency. 
The next step was to investigate the stability of the coated particles upon freeze drying in 
water and buffer solution (PBS) and the subsequent redispersion in one of these media. The 
dispersability in isotonic buffer is a prerequisite for the in vivo application. Therefore, the 
particles were homogenized in water or buffer solution and freeze dried subsequently. 
Afterwards, these lyophilized samples were redispersed in water or buffer solution. 
Additionally, the reaction time as a parameter for the size of the particles was investigated. As 
a result, all experiments were conducted with particle formation times of half an hour and 1 ½ 
hours, respectively, as shown in figure 7. 
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Figure 7: Influence of freeze drying and redispersion in different media on the aggregation of coated Gd2O3 
nanoparticles 
The particles coated with etidronic particles show good redispersability under all tested 
conditions. However, the freeze drying in water causes the lowest increase in polydispersity, 
at least for the samples reacted for ½ hour. Intersetingly, the influence of the reaction time on 
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the etidronic acid coated particles is exceptional and not comparable to the particle systems 
with the other ligands as coating material. For the PEG-bisphosphonate coated particles, the 
freeze drying in water causes significantly less aggregation after redispersion compared to the 
processing in buffer, correlating with the results for poly(acrylic acid). A contrary result is 
obtained for the citric acid coated particles. Here, the buffer solution seems to stabilize the 
particles during homogenization and freeze dying, which is maybe founded in the high 
surface charge and low stabilization of the coated crystals, as already assumed before. 
Moreover, the zeta potential for all tested particles and parameters was determined, giving 
quite low values of about -40 mV for etidronic acid, poly(acrylic acid), and citric acid and 
high values of ~+40 mV for PEG-bisphosphonate. The positive zeta potential for the PEG-
bisphosphonate coated particles, is due to the shielding of the negative acidic charge of the 
bisphosphonate group achieved by the PEG part of the ligand. 
Summarizing, the particles coated with either ligand are small, stable, and storable, enabling 
them for application as CT contrast agents. Nevertheless, the luminescent feature has still to 
be introduced to the nanoparticles, to achieve bimodal imaging with CT and additionally 
optical fluorescence detection. Unfortunately, this can hardly be achieved by the “polyol” 
mediated synthesis, due to the often observed amorphous structure of the particles. This is 
likely to prevent the formation of effective luminescent centers [9]. A new synthesis route 
yielding more crystalline particles for this purpose was mandartory. 
8.2. Annealing based Gadolinium Oxide Nanoparticles 
As already mentioned in chapter 6.2, there are different methods to prepare gadolinium 
containing precursor particles with high temperature annealing based syntheses routes. Two 
of the most prominent preparation methods are the combustion and the precipitation route, 
resulting in gadolinium oxide carbonate particles. These particles are then annealed at 
temperatures up to 900°C for 30 min to 4 hours, yielding gadolinium oxide nanoparticles of 
quite different size and morphology, depending on the reactants and the synthesis route used. 
8.2.1. Combustion synthesis 
One way of fabricating the precursor particles is the combustion synthesis. Here, the starting 
materials, gadolinium nitrate and an organic reducing agent are mixed in aqueous solution. 
Subsequently, the mixture is evaporated to dryness and overheated until combustion occurs. 
The precursor particles form a fluffy white powder of gadolinium oxide carbonate, which can 
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subsequently be annealed in a muffle furnace for conversion into gadolinium oxide 
nanoparticles.  
As can be seen in figure 8, the TEM images of oxide nanoparticles synthesized with urea, 
glycine and citric acid as reducing agents turn out to be quite different in size and shape. The 
particles fabricated with urea are fairly homogenous, odd shaped with a size ranging from 20 
to 150 nm, whereas the glycine based nanocrystals seem to be sintered together with a 
primary nanoparticle size of about 50 to 100 nm. Last, the citric acid prepared crystals are 
highly inhomogeneous with mostly not observable discrete particles up to a size of 250 nm. 
Therefore, the nanoparticles formed with the urea as reaction partner are the most promising 
particles achieved in those three experiments. Unfortunately, the hydrodynamic sizes of the 
as-obtained uncoated nanoparticles can not be measured due to the strong aggregation in 
water.  
 
Figure 8: TEM images of Gd2O3 nanoparticles synthesized via combustion synthesis with urea, glycine and citric 
acid as reaction partner (left to right). 
Nevertheless, figure 9 displays the PCS analysis of uncoated and PEG-bisphosphonate coated 
gadolinium oxide nanoparticles pointing out the above mentioned problem with aggregation. 
The expected result would have been the uncoated particles being smaller in size than the 
coated ones. However, the uncoated particles seem to form quite homogenous aggregates (PI 
~ 2.1) of over 300 nm in size and no big improvement with coating of the particles is visible. 
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Figure 9: PCS analysis of Gd2O3 nanoparticles before and after coating with PEG-bisphosphonate; TEM image 
of coated Gd2O3 aggregates. 
Therefore, the particles formed by combustion synthesis seemed not to be suitable for further 
investigations, due to their strong aggregation tendency. This may be founded in a 
disadvantageous surface charge and their quite irregular shape caused by the “uncontrolled” 
combustion process. 
8.2.2. Precipitation synthesis 
Another way of fabricating precursor particles for the formation of gadolinium oxide 
nanocrystals is the precipitation method. This synthesis route relies on the nanoparticle 
formation in aqueous solution, achieved by the reaction of gadolinium chloride, again, with a 
reducing agent like urea. This synthesis also yields gadolinium oxide carbonate particles, 
which can subsequently be annealed at high temperatures to form gadolinium oxide. 
Influencing the size of Gadolinium Oxide particles 
A big advantage over the combustion route is the possibility to influence the particle size via 
the chosen reaction conditions. Due to the fact that the synthesis has to be carried out in 
boiling water, and therefore the reaction temperature can not be altered, the two influenced 
parameters of particles the size are the educt concentration and the applied equivalents of the 
reducing agent.  
The figure 10 shows the development of the particle size and their size distribution with 
reaction time and different educt concentrations. As can be seen, the lower the concentration 
of reactants used is, the lower the resulting particle diameter after sufficient reaction time. 
Additionally, the reaction time plays a role upon size development. 
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Figure 10: Size development of Gd2O3 precursor nanoparticles synthesized via precipitation synthesis in 
increasing reactant concentrations: (white) 16.6 mM; (grey) 25.0 mM; (dark grey) 50.0 mM; (yellow) 100 mM; 
and with different equivalents of reducing agent. 
As can be seen by the obtained polydispersity indices, under all reaction conditions, after 15 
min of “boiling”, the particle formation is not yet completed, whereas after 30 min the PI 
values drop under 0.1 indicating that discrete particles of a low dispersity have been formed. 
Continuing the reaction, the particles show further increase in size. Concerning the second 
parameter, the higher the equivalent of reducing agent the higher the size of the particles is. 
Nevertheless, the measured hydrodynamic diameters resemble only the non annealed 
precursor particles, because the final gadolinium oxide nanocrystals are not dispersable in 
aqueous medium without further stabilizing coating. Consequently, upon annealing a further 
reduction of size can still be expected, which can not be investigated without the necessary 
coating. 
Influencing the emission properties of doped Gadolinium Oxide 
particles 
Another advantage of the precipitation synthesis used is the easiness of a controlled doping of 
the produced particles. The doping is achieved by mixing the different lanthanide educts in 
the respective amount and subsequently, the synthesis route described in chapter 7.4.2. is 
performed. As doping elements europium, terbium and erbium were chosen, to obtain 
particles luminescing in the blue, green and red range of the spectrum. To find out the optimal 
doping amount for these elements, experiments with increasing ratios of doping agent were 
carried out and the resulting fluorescence spectra were recorded. 
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Figure 11: Development of the emission characteristics of Gd2O3 nanoparticles with different doping agents and 
doping amounts 
Figure 11 shows three different diagrams with spectra of gadolinium oxide nanoparticles 
doped with different agents in increasing amounts from 0.1 to 10 or 20%. For terbium the 
maximal emission is reached at 5%, with europium at 10% and for erbium the optimal doping 
amount is 0.2%. Furthermore, the best annealing temperature for all three dopands was tested 
as shown in figure 12. As well as the doping amount, the annealing temperature has a great 
influence on the emission intensity. Depending on the doping element, different optimum 
temperatures were found. For terbium an annealing temperature of 200°C was the most 
favorable in contrast to europium and erbium, where 700°C gave the best results. The 
measured emission spectra resemble quite well emission lines of the respective elements 
known from literature [10,11]. Terbium doped gadolinium oxide shows several emission lines 
at 485, 544, 585 and 620 nm originating from the 5D4→7F6, 5D4→7F5, 5D4→7F4 and 5D4→7F3 
transitions. The europium emission is composed of lines at 586, 595, 618, 653 and 700 nm 
resembling to the transitions of 5D0→7F0, 5D0→7F1, 5D0→7F2, 5D0→7F3 and 5D0→7F4. An, on 
the first sight, anomaly can be seem in the emission spectra of erbium, where a strong change 
in the intensity weighting of the emission lines occurs upon annealing. Nevertheless, this 
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alteration of the spectrum is founded in a change in the crystal structure of the gadolinium 
environment. The most of the found emission lines at 418, 484, 530, 543 and 618 nm can be 
dedicated to transitions of the 2G9/2→4I15/2, 4F7/4→4I15/2, 2H11/2→4I15/2, 4S3/2→4I15/2 and 
4F9/2→4I15/2 states.  
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Figure 12: Development of emission characteristics of Gd2O3 nanoparticles with different annealing 
temperatures 
The change in the crystal structure upon annealing was further investigated with powder x-ray 
diffraction. The respective diffractogramms of samples annealed at 200, 400, 700 and 900°C 
were recorded, as shown in figure 13. A clear development of amorphous to crystalline 
nanoparticles can be seen. As expected, the higher the annealing temperature, the higher the 
crystallinity of the samples get. The XRD patterns of the crystalline samples are similar to 
gadolinium oxide chloride (GdOCl, JCPDS no. 85-1199), a unit cell and crystal symmetry 
information is given in this JCPDS file. The literature gives the parameters for GdOCl as 
follows, a tetragonal phase with a = 3.95 Å, c = 6.67378 Å and volume = 104.1 Å3 and a 
space group of P4/nm. The fitting of the as derived results gave the same unit cell (see 
supplement), nevertheless there is only a small amount of indexable lines given in the 
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diffractogramms. Unfortunately, the XRD diffractograms show, that not Gd2O3 but the 
corresponding chloride is formed indicating that the precipitated nanocrystals had 
considerable amount of chloride impurities. 
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Figure 13: P-XRD pattern of the gadolinium oxide chloride nanoparticles with increasing annealing temperature; 
comparison of peak patterns of literature and as-synthesized particles. 
Nevertheless, the advantageous characteristics of the particles are not influenced by the 
composition [12]. The particles are luminescent, in the case of terbium doping, the amorphous 
structure even seem to be better for the emission intensity, and the CT attenuation also should 
not be influenced significantly by the composition of the particles. Nevertheless, the particles 
will still be referred to as “gadolinium oxide” nanoparticles.  
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Coating of Gadolinium Oxide Nanoparticles with PEG-
bisphosphonate 
As already mentioned earlier, for an application of the nanoparticles in aqueous environment, 
coating with a water-soluble ligand is necessary to obtain stable particle dispersions. To avoid 
particle aggregation, the coating was performed using the poly(ethylene glycol) 
biphosphonate ligand, which was already used in chapter 8.1.2. to render the “polyol” route 
synthesized particles water dispersable. In figure 14 TEM images of the non coated and 
coated particles are displayed.  
 
Figure 14: TEM images of uncoated and PEG-bisphosphonate coated Gd2O3 nanoparticles 
The uncoated particles are, as expected, strongly aggregated due to the disadvantageous 
preparation method of the TEM specimen. In contrast, the coated particles are discrete, round 
shaped nanocrystals with visible, less contrasted, ligand on the surface, indicated by the 
particle roughness. Again, as already mentioned, the problem of the correlation between TEM 
and PCS analysis is given, suggesting once more the inherent problem of the performed PCS 
analysis. The particles shown on the TEM image (~ 80 nm) give a size of about 170 nm for 
their hydrodynamic diameter as shown in figure x, second bar. Nevertheless, it was possible 
to synthesize coated nanoparticles of different sizes by varying the reaction parameters as 
exemplary shown in figure 15. The lowest measurable hydrodynamic diameter was about 50 
nm in size indicating that the measured particles are even smaller.  
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Figure 15: PCS analysis of PEG-bisphosphonate coated Gd2O3 nanoparticles synthesized in two different sizes. 
These as coated particles of different diameters were applied in an in vitro CT experiment. 
For this experiment particles of different sizes coated with PEG-bisphosphonate and dispersed 
in water, were filled into small vessels of 2 mL volume and put into the computer tomograph. 
The as-derived HU amounts for the samples were correlated to the gadolinium content of the 
samples in table 2.  
Table 2: CT contrast, corresponding gadolinium content and HU per mg gadolinium of in vitro CT experiment. 
Composition of sample Hydrodynamic 
diameter /nm 
CT contrast of 
sample /HU 
Concentration 
/mg/mL 
HU per mg Gd 
GdCl3 in H2O - 209 3.28 64 
H2O - 71 0 - 
Air - 0 0 - 
Gd2O3@PEG-bisphosphonate 
 
~ 170 244 4.14 59 
 ~ 80 234 3.72 63 
 ~ 50 255 4.24 60 
 
All concentrations of the gadolinium samples were checked with ICP-MS and put into 
relation to their CT contrast. Furthermore, the attenuation of water and air, which must be 
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zero, was measured. The coated nanoparticles give good in vitro CT contrast, with about 60 
HU per mg gadolinium. These, about 60 HU correspond to the HU values of gadolinium 
chloride in aqueous solution, and marks the inherent attenuation of gadolinium. Therefore, the 
measured CT contrast of the particulate samples is in very good accordance to the expected 
values, and no alteration with particle formation and particle size is visible. In figure 16, a 
cross section of the investigated samples with the respective HU values is shown. 
(1) 255 HU
(5) 0 HU
(3) 244 HU
(4) 209 HU
(2) 234 HU
(6) 71 HU
 
Figure16: CT image of nanopariclulate G2O3@PEG-bisphosphonate in 3 different sizes and the corresponding 
control vials (1) Gd2O3 50 nm; (2) Gd2O3 80 nm; (3) Gd2O3 170 nm; (4) GdCl3 in H2O; (5) air; (6) water. 
The brightness of the samples marks their attenuation, and therefore a good visibility of the 
nanoparticle dilutions in vivo is expected. Moreover, the particles, functionalized with 
targeting functions, will give remarkably higher contrast at the site of interest and longer 
circulation times due to the targeting function. A last thing to investigate is the cytotoxicity of 
these nanoparticles.  
8.2.3. Cytotoxicity tests of Gadolinium Oxide Nanoparticles with different coatings 
The cytotoxicity of the coated gadolinium oxide nanoparticles and free gadolinium ions was 
tested according to the MTT cytotoxicity test described in chapter 7.5.7. For the assay freshly 
prepared dispersions of coated nanoparticles in medium, using two different serial dilutions 
were applied. The chosen concentrations of the nanoparticulate samples and the gadolinium 
ion concentrations are based on the known toxic gadolinium amount [13]. The amount of 
particles used was only related to the overall gadolinium concentration in the sample detected 
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by ICP-OES or ICP-MS, due to the imprecise PCS data. According to this data, no accurate 
determination of the particle diameter is possible, and therefore, no calculation of the particle 
concentration. However, all investigated particles had hydrodynamic diameters of about 200 
nm, making the experiment comparable. Moreover, the investigated range of gadolinium ion 
concentration well covers the theoretical amounts of the element in all of the nanoparticulate 
samples (0.5 – 0.01 µM). The variations of the used nanoparticle amounts, respecting 
gadolinium concentration, result from the preparation procedure of the particles.  
Table 3: Concentrations of nanopartilulate and gadolinium ion samples and their respective cytotoxicity 
Concentration Gd3+ Cytotocicity /% Composition of sample 
/µmol/L /µg/mL L929 CHO 
0.539 85.0 1.2 15.7 
Gd2O3@PA 
0.054 8.5 -6.8 12.0 
0.119 18.8 6.2 2.8 
Gd2O3@CA 
0.012 1.9 2.3 -5.4 
0.445 70.0 5.7 4.5 
Gd2O3@ES 
0.045 7.0 0.1 -10.3 
0.774 121.8 11.7 6.6 
Gd2O3@PEG-bisphosphonate 
0.077 12.2 -8.0 -10.2 
6.5 1.03·103 66.3 32.4 
0.65 103.0 2.2 -13.8 
0.07 10.3 10.7 -2.6 
Gd3+ 
0.01 1.0 9.8 -7.3 
 
All investigated nanoparticulate concentrations show, as expected, only very low to no 
observable toxicity toward the chosen cell lines. In contrast, the highest gadolinium 
concentration shows a considerable effect on the viability of the cells. In table 3 the 
gadolinium ion concentrations of the nanoparticles and the control with their respective 
cytotoxicity on two different cell lines are shown. Figure 17 displays the viability of both cell 
lines under nanoparticulate and control treatment. 
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Figure 17: Viability of L929 and CHO cells under treatment with differently coated Gd2O3 nanoparticles and 
Gd3+, * significantly different p < 0.01. 
For the different gadolinium ion solutions, the faster proliferating and more robust CHO cells 
always showed a slightly lower response in comparison to the L929 cell line. In contrast, for 
the particulate sample no general trend was observed. This indicates that the observed 
variations are due to minor variations of the cell numbers or growth activity, but not founded 
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in toxic or proliferative effects. Therefore, the gadolinium oxide nanoparticles can be said to 
be not toxic in the tested concentration ranges. 
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9.1. Discussion 
Two different synthesis methods for the fabrication of gadolinium oxide nanoparticles were 
successfully established to provide nanoparticulate gadolinium oxide for imaging 
applications. They both have advantages and disadvantages. It turned out that the different 
synthesis approaches result in different particles concerning size, optical properties, and 
detectability in the CT. The “polyol” mediated route yields coated particles immediately after 
synthesis, whereas the annealing based routes give luminescent nanocrystals after additional 
high temperature treatment.  
 
Figure 1: Diagramm of the size and the optical properties of the synthesized Gd2O3 nanoparticles. 
The first investigated “polyol” route allowed synthesizing differently coated nanoparticles in 
a size range of 50 – 200 nm (see figure 1). A subsequent stable coating can be achieved very 
easily by only adding the dissolved ligand to the hot particle solution, immediately after the 
particle formation. Moreover, these as-coated nanoparticles can be further high pressure 
homogenized and freeze dried to give stable, storable, and redisperable powders, with ideal 
properties for the application as CT contrast agents. As shown in the first experiments 
(chapter 8.1.1.), the coating with a silica shell raises significant problems with purification 
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and subsequent swelling of the shell material, due to the excess of not removable silica 
formed during the particle preparation. 
These drawbacks can be circumvented by applying more specific organic molecules as 
coating materials [1-5]. For this approach, hydrophilic and charged molecules with known 
high affinity to metal oxides were chosen, carrying either carboxylic acid or phosphonic acid 
groups. They turned out to be adequate stabilizers for the synthesized gadolinium oxide 
nanoparticles in dispersion either via a introduced surface charge (etidronic acid, citric acid, 
poly(acrylic acid)) or via a steric stabilization of the nanoparticles (PEG-bisphosphonate). 
Nevertheless, a slightly modified synthesis was applied, considering the additional sodium 
hydroxide consumption of the ligands, also yielding “bigger” particles with a diameter of 
about 50-80 nm (see figure 1). The bigger size of the particles is certainly founded in a higher 
concentration of sodium hydroxide added for the particle formation, resulting in a higher 
amount of gadolinium hydroxide. This gadolinium hydroxide precipitates and forms the 
particles, which are subsequently converted to gadolinium oxide. Moreover, the direct 
addition of the respective ligand to the reaction solution seems to influence the particle 
diameter as well. Therefore, it seems to be reasonable that the differing pKa values of the 
ligands have to be taken into account. For example, etidronic acid has four pKa values (1.35; 
2.87; 7.03; 11.3) in contrast to citric acid, having three pKa values (3.13; 4.76; 6.40) [6,7]. 
Hence, more sodium hydroxide is consumed to fully deprotonate the bisphosphonate 
containing ligand. Therefore, less sodium hydroxide is available for gadolinium hydroxide 
formation and the particles get smaller. Nevertheless, this may not be the only reason for the 
observed size variation of the particles. The etidronic acid coated particles were the smallest, 
likely due to the tight binding of the phosphonic acid group to the surface and the small size 
of the ligand molecule. On the other hand, the citric acid functionalized particles caused the 
biggest problems with stabilization against aggregation, although citric acid is a quite small 
ligand as well. These particles also have the biggest diameters in the TEM as well as in the 
PCS analytics. This may be founded in more unspecific aggregation of the citric acid 
molecules on the nanoparticle surface, resulting in an inferior stabilization. Moreover, the 
interaction of the ligand mediated excess surface charge with counterions in buffer solutions, 
stabilizing the particles to a satisfying extent, supports this assumption. On the one hand, the 
cations present in the buffer can interact with the citric acid molecules, which are well known 
for their metal-complexing properties, and therefore stabilizing the surface charge. On the 
other hand, the phosphate ions of the buffer salt can replace the citric acid, due to their 
superior binding affinity, and hence stabilizing the particles to a greater extent. The crystals 
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coated with the bigger polymeric ligands, poly(acrylic acid) and PEG-bisphosphonate, 
exhibited hydrodynamic particle diameters of about 150 - 250 nm, and displayed a good steric 
stabilization. No significant differences in particle size under homogenization and drying 
could be observed, suggesting that the longer chains of the ligands protect the particle core 
more efficiently. 
The “polyol” synthesized particles coated with citric acid were already applied in a 
preliminary animal experiment with female rats at Bayer Schering Pharma, giving very good 
intra-uterine CT contrast, as it can be seen in figure 2. The citric acid coated particles used 
were developed especially as a model to image the intra-uterine transport of nanoparticles. 
Therefore, no additional targeting function was necessary, because the particles were applied 
with a syringe via the vagina directly into the rat uterus. The citrate coated particles were used 
due to the assumed best biocompatibility of excess citrate ions in the acidic milieu. CT images 
of citric acid coated Gd2O3 nanoparticles (size = 330 nm, concentration = 200 mg/mL) in rat 
uteri with give an in vivo contrast 450 HU (see figure 2). 
amimal 2 (midestrus rat) 
(midestrus rat = very dry uterus) 
animal 4 (estrus rat) 
(estrus rat = liquid filled uterus) 
Vappl = 150 µL, after 1min Vappl = 100 µL, after 1 min 
  
Figure 2: CT images of 330 nm citric acid coated Gd2O3 nanoparticles in rat uteri with a concentration of 200 
mg/mL particles; in vivo contrast 450 HU. 
A drawback for the analysis of the coated particles were the inconsistent results obtained by 
the PCS measurements, not allowing to compare the obtained hydrodynamic diameters with 
the TEM results. The very pronounced core/shell structure of the particles probably caused an 
inherent bias in the data for the measured diameters. As already mentioned in chapter 8.1.2, 
the strongly differing refractive indices of the “hard” inorganic core and the “soft” organic 
 Gadolinium Oxide Nanoparticles - Discussion 
 – 157 – 
shell may be an explanation for the observed mismatch. The soft shell, of course, contributes 
about 20 to 30 nm to the overall hydrodynamic diameter, but should not completely double it. 
Another possible source of error for the calculation of the hydrodynamic radii may also be the 
viscosity of the chosen dispersion medium. All measurements were carried out in purified 
water or buffer solution. Thus the viscosity of water was considered for the calculation of the 
diameters of the particles. However, the influence of the desorbed ligand molecules from the 
nanoparticles is not fully understood. This effect may additionally alter the viscosity of the 
dispersion medium, which could not be taken into account for the size calculations. A 
concentration dependent formation of bigger particle aggregates was excluded by size 
measurement of the particles at various dilutions, always yielding similar particle diameters. 
Moreover, the good polydispersity indices obtained for most particle types (except citric acid) 
indicate that there is only one single particle species in the samples. Hence, the hydrodynamic 
diameters obtained with PCS were only taken as an indicator for the aggregation tendency and 
the size development of the nanoparticles. Nevertheless, TEM images were taken as often as 
possible to verify the absolute particle sizes.  
 
The preparation of small, stably coated, fluorescent, and CT active nanoparticles was 
successful, applying the secondly investigated “annealing based” synthesis methods. These 
advantageous properties can compensate the additional reaction step needed, compared to the 
“polyol” route, to achieve the coating of the nanocrystals,. Due to the annealing step, the 
nanocrystals exhibit bare oxidic or carboxylic surfaces, making coating procedures more 
difficult. Hence, the PEG-bisphosphonate ligand was chosen as coating material, since the 
phosphonic acid groups provide a very good and stable grafting on the nanoparticulate 
surface. Moreover, an effective stabilization against aggregation and reduced adsorption of 
counterions from the medium is provided by the uncharged PEG chains of the ligand. 
The combustion synthesis route with urea as reducing agent yielded appropriate particles. 
Nevertheless, coating procedures turned out to be rather difficult. The nanoparticles had a 
strong tendency to stick together, and therefore build aggregates of about 250 nm in size. This 
is likely due to the quite irregular shape and disadvantageous surface charge of the particles 
caused by the combustion. Moreover, the reaction offered no possibilities to influence the 
particle size in an appropriate manner, due to the “uncontrollable” combustion event. 
The nanoparticles synthesized by means of the alternative precipitation method, on the one 
hand, display very good optical properties. On the other hand, this synthesis method provides 
the possibility to tailor size of the particles. Hence, the precipitation synthesis was applied for 
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further particle preparation. Three different emission colors could be obtained via doping of 
the nanocrystals, using europium, terbium, and erbium ions. Particles with blue, green, and 
red emission were successfully prepared. They display sharp emission lines and a broad 
excitation spectrum, due to the surrounding host lattice. The gadolinium oxide host lattice can 
also absorb in a broad spectral range, subsequently transferring the energy to the dopand 
centers [8]. Moreover, a successful optimization of the emission properties with respect to the 
doping concentration and the annealing temperature could be achieved. It was proved that the 
synthesized particles display the typical emission lines of the respective doping agents [9,10]. 
A significant reduction in emission intensity was observed when exceeding the optimal 
doping amount. This decrease in emission can be dedicated to a direct interaction of the 
luminescent centers in the nanocrystal, thus giving rise to non-radiative deactivation processes 
[11]. The dependence of luminescence intensity on the annealing temperature also could be 
seen. This dependence is based on a change in crystallinity of the particles. The europium and 
erbium doped particles have an optimum emission intensity when an annealing temperature of 
700 °C is applied. As a result, it can be stated, that these dopands need a high crystallinity to 
exhibit high luminescence intensity. On the other hand, the terbium doped nanoparticles have 
their highest emission intensity, when annealed at low annealing temperatures, resulting 
particles with an amorphous structure. This result suggests an oppression of luminescence due 
to the symmetry of the dopand centre in the respective structure. 
Another result of the powder x-ray diffraction patterns was the assignment of the crystalline 
diffractogramms to the structure of gadolinium oxide chloride [12]. The matlockite-type 
PdFCl structure of the lighter lanthanide oxide chlorides (Ln = La – Er, Y) belongs to the 
crystal system space group with P4/nmm – D4h7 (no. 129, Z = 2) [9]. The overall structure is 
formed by altering layers of [LnO]nn+ complex cations and Cl- anions in a typical way for all 
tetragonal lanthanide oxycompounds such as oxybromide, -iodides, -sulfates, -nitrates and 
some oxycarbonates [13]. In GdOCl the Gd3+ cation is coordinated to four oxygens and five 
chlorides yielding a monocapped square antiprism for coordination polyhedron. This 
arrangement results in C4v point symmetry of the Gd3+ site. Moreover, the presence of a 
sensitive forbidden transition 5D0 → 7F0 in the spectra of the europium doped crystals 
supports the lanthanide oxychloride structure [9]. The result shows clearly, that even the 
highest annealing temperature for the particles is not sufficient enough to form pure 
gadolinium oxide, and significant amounts of chloride impurities are present after 
precipitation. Nevertheless, this does not alter the properties of the emission, as the [LnO]nn+ 
cation has been shown to play the dominant role in determining the crystal field effect on the 
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energy level scheme of the doped ions in several lanthanide oxysalts [13]. Besides, the GdOCl 
composition is known to form luminescent materials very efficient upon doping. Moreover, it 
has been proved in another experiment that the CT-contrast for the coated GdOCl 
nanoparticles is not altered compared to Gd2O3. Therefore, the particles are referred to as 
“gadolinium oxide” nanoparticles, even if there are some chloride impurities. 
By tuning the reaction conditions, a straight forward procedure to tailor-make particles of 
about 50 to over 100 nm in diameter was developed. With tuning the concentration, amount 
of reducing agent and reaction time, the size of the particles can be influenced. This is, of 
course, based on in the reaction equilibrium, where lower concentrations and lower amounts 
of reducing agent lead to smaller particles. The investigation of the reaction times revealed 
that the reaction needs a certain time to form distinct particles, which are increasing in size 
with ongoing reaction.  
Moreover, after coating of these particles with PEG-bisphosphonate, they showed no 
aggregation predisposition in dispersion. Particles of different hydrodynamic diamters (50, 
80, 170 nm) were applied in an in vitro CT-experiment, illustrating the very good X-ray 
attenuation of gadolinium oxide chloride nanoparticles. The measured HU values correspond 
to the HU values for dissolved gadolinium chloride of the same concentration. Thus, it can be 
stated that no alteration of the attenuation properties upon particle formation or due to 
differently sized particles occurs. 
Hence, a very good in vivo CT-contrast is to be expected for the particles, as already shown 
for the “polyol” derived particles. Moreover, a suitable tailoring of the nanocrystal size 
aiming for different applications is possible. With an additional targeting of the particles to a 
specific site of interest, a superior contrast compared to gadolinium chelates can be obtained 
due to the much higher local gadolinium concentration at one specific point. This targeting 
can be achieved by using an amino functionalized PEG-bisphosphonate ligand comparable to 
the ligand used herein. Therefore, this kind of coated nanocrsytals can easily be applied for 
multimodal imaging, combining CT and luminescent properties. Moreover, the gadolinium in 
the nanoparticle opens the door for further applications as MRI contrast agent [14], and in the 
described neutron capture therapy [15], resulting in superior results compared to e.g. 
gadolinium chelates due to their nanoparticulate nature. 
The cytotoxicity tests of the prepared nanoparticles with the different coating materials, 
etidronic acid, citric acid, poly(acrylic acid), and PEG-bisphosphonate showed no significant 
toxicity in different cell cultures, neither due to the heavy metal nature, nor due to the size of 
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the particles. Therefore, a save application can be assumed, at least for cell based or small 
animal in vivo imaging.  
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10.1. Summary 
The enhancement of existing and development of new nanoparticular probes is a promising 
field of research, emanating from the increasing demand on nanoparticular contrast agents for 
luminescence and CT imaging. Moreover, newly developed systems give the possibility of 
combining both to overcome the limitations of each. In this work, the synthesis and 
functionalization of two quite different inorganic nanoparticular systems for imaging 
applications, and moreover with the prerequisites for molecular imaging applications, were 
presented. The first developed system is an ultra small inorganic semiconductor based 
nanoparticle with unique optical properties, ranging from size tunable emission to very high 
photostability. These quantum dots have drawn tremendous attention in the field of in vitro 
and small animal in vivo fluorescence imaging in the last decade (part I of the thesis). The 
second investigated nanoparticulate system is a lot less prominent on the field of molecular 
imaging till now. Nevertheless, the inherent properties of gadolinium oxide nanoparticles are 
as unique as those of the quantum dots. These nanoparticles are not only applicable in 
fluorescence imaging, but open up the way to combined multi-modal imaging and therapy 
(part II of the thesis). 
10.1.1. Quantum Dots 
Following this evolution, herein, an organometallic synthesis for long-wavelength emitting 
quantum dots with an effective surface passivation of the semiconductor core was developed. 
The synthesis parameters were optimized with respect to the emission wavelength and 
quantum yield. Moreover the most prominent influence factors could be dedicated. The 
choice of the type of Te-precursor and its respective concentration in the reaction solution is a 
crucial factor. The reaction scale has great influence on the quality of the synthesized 
quantum dots. In contrast the effect of the Cd-precursor is quite low, and the influence of the 
temperature was not observable in this experiments. Nevertheless, for the trioctylphosphine 
precursor, the use of a high precursor concentration, low reaction scale and the oleic acid 
cadmium precursor gives the best results. The tributhylphosphine precursor based synthesis, 
on the other hand, yields the best particles, with respect to wavelength and quantum yield, 
with a comparably low precursor concentration. 
The further modification of these particles rendering them water-soluble was achieved using 
different surface ligands. Within the tested ligands, the PEG based molecules gave the most 
promising stabilization of the inorganic particles against aggregation and oxidation in aqueous 
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environment. The developed procedure allowed the preparation of long-term stable, water-
soluble quantum dots in a simple ligand exchange reaction. Furthermore, it could be shown 
that the coated nanocrystals have very small diameters of sub-10 nm. Moreover, the 
functionalization of the nanocrystal surface with amino groups, and therefore the prerequisite 
for further modification with e.g. targeting functions, was achieved. 
 
Figure 1: Picture of CdSe quantum dots with different emission wavelength under UV excitation. 
Furthermore, a way to tune the amount of amino ligands, and hence, functionizable groups on 
the surface was developed. The examination of the cytotoxicity of as well the quantum dots, 
the ligands, as free cadmium ions, showed that the observed toxicity can be attributed to the 
attached ligands, and not to the released cadmium ions.  
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Table 1: Summary of all synthesized quantum dot compositions, reaction parameters, coating ligands, and 
tunable characteristics.  
Composition Parameters Ligands Characteristics 
CdSe, 
CdSe/ZnS 
Te-Precursor Tributhylphosphine Wavelength 
CdTe, 
CdTe/CdSe, 
CdTe/CdZnS 
Cd-Precursor Trioctylphosphine 
Quantum yield 
 Precursor concetration Mercaptoundecanol Size 
 Injection temperature Dihydrolipoic acid Hydrophilicity 
 Shell growth temperature Tri(ethylene glycol) 
mercaptoundecyl ether Toxicity 
 Reaction scale Hexa(ethylene glycol) 
mercaptoundecyl ether  
  Amino poly(ethylene 
glycol)750 
mercaptoundecyl ether 
 
  Amino poly(ethylene 
glycol)2000 
mercaptoundecyl ether 
(PEG2000-NH2) 
 
 
However, the tested dilutions of quantum dots exceeded the usually applied ones about three 
orders of magnitude, suggesting that the quantum dots can be regarded as non toxic for 
cellular experiments. Therefore, this preparation method turned out to be an easy way to 
stable biocompatible and functionizable quantum dots for biomedical applications. In table 1 
a summary of all realized compositions, tested parameters, coating ligands, and the therefore 
tunable characteristics of these nanoparticles is displayed.  
10.1.2. Gadolinium Oxide Nanoparticles 
Concerning the second nanoparticulate system, two different routes were applied o synthesize 
those particles. One route yields bigger particles for CT contrast agent use only, the other 
synthesis procedure leads to particles for bimodal fluorescence- and CT-imaging. The 
“polyol” mediated synthesis yielded nanoparticles of bigger sizes. However, the coating step 
was already included into the particle formation. Herein, four ligands giving different particle 
properties were applied (citric acid, poly(acrylic acid), etidronic acid, PEG-bisphosphonate). 
All those particle species were investigated in terms stability after high pressure 
homogenization, freeze drying and redispersion in different media, to fabricate a stable, 
storable and redisperable powder for CT imaging applications. One of those as-coated 
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nanoparticle systems was investigated in an animal experiment, resulting in very good 
contrast properties in vivo.  
The precipitation synthesis, on the other hand, gave smaller nanoparticles with very good 
luminescent properties (see figure 2). The luminescence was achieved by doping the 
nanocrystals with different lanthanide elements, yielding blue, green and red emission 
wavelengths. The parameters for optimal doping amount and annealing temperature were 
investigated. Moreover, the influence of the reaction time, reducing agent concentration and 
overall concentration on the nanoparticle size was studied. 
Therefore, highly luminescent and, independently size tunable, particles could be successfully 
prepared. The coating of these nanocrystals was achieved using a bisphosphonate 
functionalized PEG ligand, giving very good stabilization against aggregation of the particles. 
These coated particles were applied in an in vitro CT experiment, testing the X-ray 
attenuation of the nanocrystals in aqueous environment. This resulted in a very good CT 
contrast of about 60 HU per milligram of gadolinium. 
 
Figure 2: Picture of doped GdOCl nanoparticlulate powder under UV excitation 
The testing of the cytotoxicity of all coated particles proved that there is no observable 
toxicity. Therefore, a successful preparation of stable, biocompatible, size-tunable, 
luminescence-tunable and CT active nanoparticles was achieved. In table 2 a summary of all 
prepared gadolinium containing nanoparticles, tested reaction parameters, applied coating 
ligands, used doping elements and the resulting tunable particle characteristics are shown. 
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Table 2: Summary of all synthesized gadolinium containing nanoparticles, synthesis parameters, coating ligands, 
doping elements, and tunable characteristics. 
Composition Reaction 
Parameters 
Coating ligands Doping elements Characteristics 
Gd2O3 NaOH equivalents Silica Europium Size 
GdOCl Reaction temperature Citric acid Terbium Wavelength 
 Homogenization 
pressure Poly(acrylic acid) Erbium X-ray attentuation 
 Homogenization 
dispersant Etidronic acid  Surface  
 Freeze dying 
parameters PEG-bisphosphonate   
 Reaction 
concentration    
 Equivalents reducing 
agent    
 Reaction time    
 
10.2. Conclusion 
Summarizing, both of the developed systems have unique optical properties (see figure 1&2), 
such as “tunable” emission wavelength and high photostabilities. Within the quantum dots the 
emission is dependent on the size of the particles. Whereas, the emission of the gadolinium 
oxide nanocrystals is coupled to the respective dopand used, and the wavelength is size 
independent. The coated non functionalized quantum dots have remarkably low diameters 
giving the possibility to apply them as probes for particulate diffusion experiments into living 
tissues. The functionalized ones obviously offer the possibility to add targeting moieties, 
using them for cell experiments as well as for small animal in vivo imaging. Another research 
field, the nanocrystals with coatings of different hydrophilicites can be implemented in, is the 
incorporation into micro- or nanoparticulate dosage forms to image different processes during 
the formation and dissolution of these drug delivery systems. The luminescent gadolinium 
oxide nanoparticles, can, of course, also be used for the above mentioned approaches. 
Moreover, they provide a superior contrast in TEM compared to the semiconductor 
nanoparticles, giving the possibility to investigate the cellular fate of the particles on the 
nano-scale. Furthermore they open up an exciting way for new bi- or multimodal imaging 
applications. The non-doped particles proved to give very good CT contrast within rats, and 
therefore the luminescent nanocrystals can be applied for combined small animal in vivo CT 
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and fluorescence imaging. One promising feature, which has still to be investigated with the 
herein synthesized gadolinium oxide nanoparticles, is their MRI contrast. This is expected to 
be superior to those of the gadolinium chelates currently used. The second and even more, 
interesting feature is the application for neutron capture therapy, enabling this unique 
nanoparticulate system to overcome the limitations of diagnostics for a combination of 
imaging and therapy. 
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A    absorbance of sample 
AIBN    α,α´azoisobutyronitril 
APTES   (3-aminopropyl)triethoxysilane 
AR integrated area under the corrected fluorescence spectrum of the 
reference fluorophore 
AS integrated area under the corrected fluorescence spectrum of the 
tested substance 
 
BOC    (tert-butly)carbonate 
BP-PEG   hexa(ethylene glycol) bisphosphonate 
BRET    bioluminescence resonance energy transfer 
 
c    concentration of sample  
CA    citric acid 
CT    computer tomography 
 
D    diameter of the nanaoparticles  
d    length of penetratured medium  
D±     size distribution of the diameter of the nanoparticles  
DEG    diethylene glycol 
DHLA    dihydrolipoic acid 
DMSO   dimethlysulfoxide 
DNA    desoxyribonucleic acid 
 
EDTA    ethylendinitrilotetraacetic acid disodium salt dehydrate 
EMEM   Dulbecco´s modified Eagle´s medium 
ER absorbance at the excitation wavelength of reference 
fluorophore 
ES    absorbance at the excitation wavelength of the tested substance  
ES    etidronic acid 
 
FBS    fetal bovine serum 
Fluram®   fluorecamine 
FRET    Förster resonance energy trasnsfer 
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fwhm    full width at half maximum 
HAD    hexadecylamine 
HAM    nutrient mixture F-12 HAM 
1H NMR   proton nuclear magnetic resonance 
HPLC    high pressure liquid chomatograpy 
HU    Houndsfield unit 
 
I    transmitted X-ray intensity 
I0    incident X-ray intensity 
ICP-MS   inductively coupled plasma mass spectrometry 
ICP-OES   inductively coupled plasma optical emission spectroscopy 
 
K    magnification constant 
knr    rate of non radiative processes 
 
MRI    magnetic resonance imaging 
MTT    3-[4,5-Dimethylthiazol-2-yl]-2,5- diphenyltetrazolium bromide 
MWCO   molecular weight cut-off 
 
nR     refractive index of the solvent for the reference fluorophore 
nS    refractive index of the solvent for the tested substance  
 
ODE    octadecene 
 
PA    poly(acrylic acid) 
PAMAM   poly(amidoamine) 
PBS    phosphate buffered saline 
PCS    photon correlation spectroscopy 
PEG     poly(ethylene glycol) 
PEG2000-NH2   amino poly(ethylene glycol)2000 mercaptoundecyl ether 
PEG3    tri(ethylene glycol) mercaptoundecyl ether 
PEG6    hexa(ethylene glycol) mercaptoundecyl ether 
PEG750-NH2   amino poly(ethylene glycol)750 mercaptoundecyl ether 
PEG-bisphosphonate  hexa(ethylene glycol) bisphosphonate 
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PEI    poly(ethylene imine) 
PES    poly (ether sulfon) 
PET    positron emission tomography 
PXDR    powder X-ray diffraction 
 
Q    quantum yield 
QD    quantum dot 
 
Sn    Singlet ground state 
SPECT   single photon emission computed tomography 
SPIO    superparamagnetic iron oxide 
 
T1    longitudinal relaxation time  
TBP    tributylphosphine 
TEA    triethylamine 
TEM    transmission electron microscope/microscopy 
TEOS    tetraethyl orthosilicate 
THF    tretahydrofuran 
Tn    Triplet ground state 
TOP    trioctylphosphine 
TOPO    trioctylphosphine 
 
UD    mercaptouncdecanol 
US    ultrasound 
 
x    thickness of matter  
XRD    X-ray diffraction 
 
Z    atomic number 
 
Γ    rate of luminescence of the fluorophore 
δ    Compton effect 
ε     decadic molar absorbance coefficient  
λmax     wavelength of the first absorbance maximum  
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µ    mass attenuation coefficient of the absorber  
µp    linear attenuation coefficient of a pixel  
µw    linear attenuation coefficient of water  
τ    photoelectron effect  
ΦF    quantum yield 
ΦR    quantum yield of the reference 
ΦS    quantum yield of the substance to be determined 
ω    coherent scattering  
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